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ABSTRACT 
Despite almost 40 years of investigation, the mechanism of action of amphotericin B 
(AmB), a potent but toxic antimycotic, has eluded the scientific community. The leading 
hypothesis involves insertion into the lipid bilayer of fungal cells followed by self-assembly into 
ion permeable channels that disrupt the transmembrane electrochemical gradient and induce cell 
death. This self-assembly into a protein-like ion channel complex puts AmB outside the 
paradigm of most chemotherapeutic agents which operate via the inhibition of protein targets. In 
this way, AmB also represents an outstanding prototype for small molecules that replicate the 
function of protein ion channels whose deficiency underlies currently incurable human diseases. 
Understanding the mechanism of this unique natural product at an atomistic level would also 
further enable the synthesis of antifungal derivatives with a better therapeutic index. However, 
due to the challenges present in the synthesis of this complex natural product and its derivatives, 
structure/function data are limited.  
The study of AmB would be greatly aided by the development of a modular and flexible 
total synthesis of this complex small molecule and its derivatives. Toward this end, we 
developed a strategy for the synthesis of polyene natural products via the iterative Suzuki-
Miyaura cross-coupling of bifunctional polyenyl MIDA boronate building blocks. This 
methodology was taken on to complete efficient total syntheses of all-trans-retinal, β-parinaric 
acid, and one half of AmB. 
In order to validate this iterative cross-coupling methodology as an effective endgame 
strategy, we proceeded with a semisynthesis of AmB. Degradation of the natural product allowed 
access to an excellent model for an advanced intermediate in the proposed total synthesis. The 
iterative cross-coupling strategy then proved effective in converting this intermediate into the 
final product, validating the endgame strategy of the total synthesis. This same methodology was 
then applied to the semisynthesis of an AmB derivative lacking the C35 hydroxyl group. The 
completion of this synthesis required the development of a protecting group strategy that was 
robust to various chemical transformations, but also able to be cleaved under mild conditions 
such that the sensitive structure of the derivative could survive. 
The lessons learned from the synthesis of C35 deoxy AmB have informed the synthetic 
strategies currently under investigation towards a total synthesis of the natural product and will 
hopefully lead to the rapid synthesis of other mechanistically informative derivatives. With a 
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solid understanding of the molecular underpinnings of the mechanism of action of AmB, we 
stand to enable the synthesis of derivatives with a better therapeutic index. Additionally, 
amphotericin B may serve as a prototype for the development of a new class of pharmaceuticals 
that can serve as substitutes for defective protein-based ion channels, thus operating as molecular 
scale prosthetics.   
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CHAPTER 1 
INTRODUCTION 
 
1-1 AMPHOTERICIN B AS A LAST LINE OF DEFENSE 
Amphotericin B (AmB, 1.1, Figure 1.1) is a prototypical natural product that can form 
membrane-permeabilizing ion channels in living eukaryotic cells.
1
 The proper function of such 
cells is normally dependent on protein ion channels that regulate the transmembrane 
electrochemical gradient. However, there is a class of diseases that stem from the lack of 
properly functioning protein ion channels, such as cystic fibrosis, that cannot be treated with the 
normal paradigm of a small molecule binding to a protein target.  An advanced understanding of 
how AmB interacts with living systems thus stands to enable efforts to develop small molecules 
that serve as surrogates for these deficient or dysfunctional protein ion channels that underlie 
currently incurable human diseases.
2,3,4
  
 
Figure 1.1. Chemical Structure and numbering system of AmB. 
In addition, as the population with immunodeficiency has expanded over the past three 
decades, systemic fungal infections have emerged as one of the leading causes of human 
morbidity and mortality worldwide. Between the years 1979 and 2000 alone, the annual number 
of cases of sepsis caused by fungal organisms increased by 207%.
5
 In fact, Candida species 
remain the fourth most common cause of hospital-acquired bloodstream infection and 40% of 
those cases result in death of the patient.
6
 In addition to its mortality rate, the economic cost of 
fungal infections is also extremely high. It was estimated that in 1998 the United States spent 
$2.6 billion on systemic fungal infections.
7
 Many of these problems have arisen because 
resistance to most currently available antifungal agents is becoming increasingly common. In 
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contrast, AmB has remained the last line of defense in the treatment of these invasive infections 
for over 50 years.  
AmB was first isolated by Gold and coworkers in 1955 from a culture of Streptomyces 
nodosus
8
 and was approved by the FDA for clinical use in the treatment of systemic fungal 
infections only two years later. AmB belongs to a larger class of antifungal natural products 
known as the polyene macrolides and in 1970, over a decade after its first clinical use, it became 
the first of its class to be fully structurally characterized.
9,10
 This natural product has enjoyed 
over 5 decades of continuous clinical use in the treatment of systemic fungal infections and 
despite this incredibly extended period of time, there have been remarkably few documented 
cases of resistance to this drug.
11
 Albeit refractory to resistance, the challenge associated with the 
broad spectrum application of AmB to invasive mycoses is not associated with its antifungal 
effectiveness, but its toxicity. At therapeutic doses, it is known to be extremely nephrotoxic and 
can cause cardiac arrhythmias as well as hemolytic anemia. In one study comparing AmB to 
caspofungin, an alternative antifungal agent, 32% of patients treated with AmB had moderate to 
severe infusion-related side effects as compared to 0.9% with caspofungin.
12
 Due to this 
extensive toxicity, in many cases an effective dose of AmB cannot be tolerated by the patient and 
this has led to the high mortality rate in these types of infections. While the therapeutic index has 
been marginally improved by the introduction of lipid-based delivery methods,
13
 the 
development of a less toxic derivative of AmB has been limited by the lack of understanding of 
its mechanism of action. 
 
1-2 CLASSIC MODEL OF AMPHOTERICIN B’S MECHANISM OF ACTION 
The current leading model of AmB’s mechanism of action involves insertion into the 
lipid bilayer of fungal cells followed by self-assembly into ion-permeable channels that disrupt 
the transmembrane electrochemical gradient and induce cell death.
14,15 
This hypothesis originates 
as early as the 1960s when it was observed that AmB had membrane permeabilizing activity.
15,16
 
Further evidence for the channel mechanism of action was obtained by Ermishkin and coworkers 
in 1976.
1
 Through use of planar lipid bilayers, they were able to observe single AmB ion channel 
conductance. Additionally, these ion channels had characteristics of gating and ion selectivity 
that are similar to protein ion channels.  
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The size and nature of AmB ion channel were further studied by looking at the membrane 
permeability of small non-ionic solutes.
16b
 There was found to be a strong correlation between 
hydrodynamic radius and permeability through the ion channel. Small solutes such as urea and 
glycerol were able to permeate readily in the presence of AmB whereas larger molecules, such as 
glucose, remained relatively impermeable. Based on this data, in particular the low permeability 
of glucose, Andreoli and coworkers predicted that AmB formed channels of a defined size 
between 7 and 10 angstroms (Å) in diameter. 
These observations led to the now classic “barrel-stave” model for AmB action.17 Despite 
the existence of this model for over 35 years, the exact nature of this self-assembled complex is 
still poorly understood.  However, based upon experimental
1,18
 and computational
19
 studies, 
AmB is predicted to self-assemble into an octameric complex giving a pore with an interior 
diameter of about 8 Å (Figure 1.2). In this model the AmB molecules are aligned such that the 
hydrophilic polyol units line the water filled interior of the pore while the hydrophobic polyene 
units interact with the non-polar chains of the phospholipids. In addition to the hydrophobic 
effects, the classic model predicts that there are two rings of stabilization. The first ring of 
stabilization is thought to be a salt bridge between the C41 carboxylate and the C3´ amine. A 
second proposed interaction is a hydrogen bond between the C8 and C9 hydroxyl groups at the 
interior of the pore. Additionally, in some models the mycosamine appendage, specifically the 
C3’ amine20 and the C2’ hydroxyl group21 have been proposed to form a hydrogen bonding 
interaction with the β-hydroxyl group in sterols. In other models, the sterols do not form direct 
contacts with AmB but instead modify the global membrane properties in a manner that is 
conducive with channel assembly.
22
 Finally, it has been proposed that the C35 hydroxyl group 
may be critical for forming transmembrane pores in the lipid bilayer. Specifically, AmB is 
roughly half the length of a lipid bilayer and hydrogen bonding between C35 hydroxyl groups 
may be critical for the dimerization of AmB to form a membrane-spanning complex (Figure 
1.2C).
23,24
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Figure 1.2. (A) The barrel stave model for AmB with the polyol pointing in to form a hydrophilic pore and the 
polyene pointing out towards the hydrophobic lipid bilayer. (B) The proposed C41 carboxylate /C3’ amine salt 
bridge and C8 alcohol/C9 alcohol hydrogen bonding interaction. (C) The tail-to-tail dimer of AmB pores stabilized 
by C35 hydroxyl group hydrogen bonding. 
Adapted with permission from Palacios, D.S.; Anderson, T.M.; Burke, M.D. J. Am. Chem. Soc. 2007, 129, 13804-
13805. Copyright 2007 American Chemical Society. 
This self-assembly into a protein-like ion channel complex puts AmB outside the 
paradigm of most chemotherapeutic agents which operate via the inhibition of protein targets. A 
potential outcome of understanding AmB’s ion channel formation is that this small molecule 
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could serve as a prototype for the development of a new class of pharmaceuticals that can act as 
substitutes for defective protein-based ion channels, thus operating as molecular scale 
prosthetics.  This strategy has the potential to treat diseases caused by deficiencies in ion channel 
function, which to date, remain outside the reach of modern medicine. However, such a goal 
cannot be achieved without a molecular understanding of its mechanism of action. 
 
1-3 DELETION STRATEGY FOR UNDERSTANDING THE MECHANISM OF ACTION 
While the channel model of AmB action described above is widely accepted, there is 
very little experimental evidence to confirm its accuracy. In fact, work from the Burke group 
demonstrated that the C41 carboxylate, proposed to be critical for the salt bridge ring of 
stabilization, is not necessary for potent antifungal activity.
3
  In a degradative synthesis from the 
natural product, Palacios et al. were able to synthesize derivatives missing the C41 carboxylate, 
the mycosamine, and both functionalities. The derivatives were tested against two strains of 
yeast, Saccharomyces cerevisiae and Candida albicans, and as predicted, the mycosamine was 
found to be critical for antifungal activity. However, the derivative lacking the C41 carboxylate 
was equipotent to the natural product, bringing into question the importance of the salt bridge in 
the classical barrel-stave model. To confirm that this activity was not caused by a change in the 
shape of AmB, NMR studies were done confirming that these modifications had not changed the 
conformation of the macrolactone core. Many earlier studies had attempted to understand the 
role of these two functional groups via covalent modification of the acid and the amine.
25
 It is 
difficult to draw conclusions about the importance of the functional groups from these studies 
given that it is known that the self-assembly of small molecules, such as AmB, can be sensitive 
to steric encumbrance.
26
 However, by simply deleting the functional groups in question, the 
importance of the C41 carboxylate in antifungal activity was discernable without the added 
complication of steric perturbation. 
These functionally deficient derivatives were then taken on into more in-depth 
biophysical studies to understand the role of the mycosamine in the antifungal activity of AmB. 
In particular, is had long been recognized that lipid bilayers containing sterols are uniquely 
vulnerable to permeabilization by AmB, but it had not been clear if this was an effect of sterol-
mediated global membrane properties
22
 or due to direct sterol binding.
20,21
 Through isothermal 
calorimetry studies with the functionally deficient derivatives, Palacios et al. demonstrated that 
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AmB directly binds membrane-embedded ergosterol in a manner that requires the presence of 
the mycosamine.
2
 Deletion of this appendage yielded a derivative, amphoteronilide B, that 
cannot bind ergosterol, is unable to form channels, and has no antifungal activity. 
 This work further revealed that this functional group deletion-based approach is a 
powerful way to illuminate the molecular underpinnings of AmB function.
2,3,24
 It is interesting to 
note that an analogous strategy, known as alanine scanning, has been widely used in the protein 
sciences as a systematic method to understand the role of important residues.
27
 It is our goal to 
use this method as a general strategy to understand the role of protic functional groups in 
biologically active small molecules, in particular, AmB. By systematically deleting each of the 
alcohols on the AmB skeleton, essentially performing a “methylene scan,” we hope to gain an 
atomistic understanding of AmB’s mechanism of action. In order to be able to take on such a 
strategy, many of the derivatives will need to be accessed through total synthesis, meaning that 
the challenges of synthesizing AmB will need to be addressed.  
 
1-4 SYNTHETIC STUDIES 
 The challenge of making AmB has drawn the interest of many synthetic chemists due to 
its structural complexity and interesting biological activity. Since the 1980s, more than a dozen 
synthetic groups have worked on the total synthesis of this natural product including 
Masamune,
28
 McGarvey,
29
 Carreira,
24,30
 and Solladié,
31
 but to date, the only completed total 
synthesis was achieved by Nicolaou and coworkers in 1987.
32,33
 Nicolaou’s retrosynthesis of 
AmB begins with the disconnection of the mycosamine to get back to the macrolactone core 
(Figure 1.3).
32
 The aglycone was then divided into two components 1.3 and 1.4 via a Horner-
Wadsworth-Emmons (HWE) macrolactonization transform and an esterification transform. 
These two molecules were then further disconnected into five key building blocks via a HWE 
transform as well as several steps in between. Building blocks 1.5 and 1.9 were both made from 
(+)-diethyltartrate and 1.6 and 1.7 were accessed from carbohydrate starting materials as well as 
through Sharpless asymmetric epoxidation chemistry.
32b
 In the forward direction this strategy 
proved to be effective in accessing the protected form of amphoteronilide B.
32c
 One of the main 
challenges in completing the total synthesis was the final attachment of the mycosamine. Use of 
anchimeric assistance by the neighboring C2’ acetate ensured the proper β-glycosyl linkage, 
however, this step had low conversion and competitive formation of the orthoester resulting from 
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attack on the acetoxonium carbon.
32d
 After its attachment the stereochemistry of the C2’ 
hydroxyl group was then inverted to match the natural product.  
  
 
Figure 1.3. Nicolaou’s retrosynthesis of AmB. 
Carreira and coworkers utilized a similar HWE-based macrolactonization strategy 
followed by mycosamine attachment in the synthesis of C35-deoxy AmB methyl ester.
24,34
 In the 
context of this synthesis the Carreira group made several important synthetic advances. In earlier 
syntheses of the polyol subunit, the stereochemistry was largely determined by use of chiral pool 
starting materials or the Sharpless asymmetric epoxidation. The Carreira group recognized that 
the repeating 1,3-diol motif could, instead, be accessed from δ-hydroxy-β-keto esters derived 
from a vinylogous Mukaiyama aldol reaction (Figure 1.4).
30a
  With this in mind, they set out to 
develop a catalytic, enantioselective method for aldol additions that relied on the recursive 
generation of chiral enolates rather than Lewis acid activation of the aldehyde.
35
 It was found 
that a Tol-BINAP∙CuF2 complex generated in situ promoted an aldol addition of dienolate 1.15 
to a broad range of aldehydes in up to 98% yield and 97.5:2.5 e.r (Scheme 1.1).
36
 In particular, 
furfural was an excellent substrate proceeding in 95% yield and e.r. = 97:3. 1.13 and ent-1.13 
were then used in the synthesis of 1.11 and 1.12, respectively. 
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Figure 1.4. Carreira’s retrosynthesis of the polyol fragment of AmB. Both 1.11 and 1.12 come from asymmetric 
dienolate (1.15) aldol addition to furfural (1.14). 
 
Scheme 1.1. General scheme for Carreira’s catalytic, asymmetric vinylogous Mukaiyama aldol reaction. 
In moving forward with their synthesis, 1.18 and 1.19 needed to be connected through an 
addition of the alkyne to the aldehyde. However, coupling of lithiated 1.18 to 1.19 produced the 
undesired (S)-C8 epimer of 1.20 as the major product.
24a
 The Carreira group had previously 
developed an asymmetric zinc acetylide addition to aldehydes to generate a wide variety of 
enatioenriched propargylic alcohols in up to 99% yield and e.r. = 99.5:0.5.
37
 The formation of 
1.20 allowed them to test if this methodology could overcome substrate bias in a complex 
system. Treatment of 1.18 with Zn(OTf)2, (-)-N-methyl-ephedrine ((-)-NME), Et3N, and 
aldehyde 1.19 produced 1.20 in 98% yield and d.r. = 16:1 (Scheme 1.2).
24a
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Scheme 1.2. Carreira’s asymmetric zinc acetylide addition for the synthesis of AmB’s polyol subunit.  
In addition to their novel synthesis of the polyol, the Carreira group was able to better 
address the challenge of the glycosidation in their synthesis. They hypothesized that by using a 
bulky, but electron pore acyl protecting group on C2’ that they could drive conversion and 
disfavor orthoester formation.
24b
 In a head-to-head comparison on suitably protected 
amphoteronilide B (1.21), the acetate gave 4% yield of desired product 1.23 with 12% orthoester 
1.24 formation and 75% recovered starting material (Scheme 1.3). Use of the bulkier group 2-
chloroisobutyrate improved the reaction to give 27% of desired product with only 11% 
orthoester and 57% recovered starting material. Finally, switching the acid activator from 
pyridinium para-toluenesulfonate (PPTS) to 2-chloro-6-methyl-pyridinium triflate (CMPT) gave 
complete conversion and a 43% yield of desired product. These conditions translated to their 
C35-deoxygenated derivative to give a 45% yield.
38
 Using this material they were able to access 
C35-deoxy AmB methyl ester. Challenges with the deprotection of the methyl ester due to the 
sensitivity of AmB derivatives lacking protic functional groups prohibited the synthesis of the 
singly modified derivative. Despite this challenge, the synthesis of this derivative inspired the 
development of new methodology including a catalytic, enantioselective Mukaiyama aldol 
reaction, an asymmetric zinc acetylide addition to aldehydes, and an improved glycosidation 
reaction. 
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Scheme 1.3. The optimization of the glycosidation of suitably protected amphoteronilide B. Carreira’s use of the 2-
chloro-2-methylpropanoic ester decreased the amount of undesired orthoester formation. Also, switching the 
activator from PPTS to CMPT allowed for complete conversion of starting material 1.21.  
 While the total synthesis of AmB has allowed for the development of new methodology 
and the synthesis of a deoxygenated derivative, it is not the only route to accessing derivatives of 
this small molecule. Top-down degradative syntheses as well as hybrid top-down/bottom-up 
syntheses have the potential to access derivatives in a much more efficient manner. Along these 
lines, Nicolaou,
39
 Masamune,
40
 and researchers at SmithKline Beecham
41
 have looked at the 
chemistry of the natural product via degradation studies. Both Nicolaou and Masamune found 
that the oxidative conditions of N-bromosuccinimide (NBS) and 2,3-Dichloro-5,6-dicyano-1,4-
benzoquinone (DDQ), respectively, could cleave the mycosamine to form a heptaenone. 
Additionally, chemists at SmithKline Beecham explored a range of protecting groups to give 
optimal working characteristics to the natural product. AmB, in its fully deprotected form, is 
difficult to work with due to its lack of solubility in most organic solvents. They found that use 
of a 9-fluorenylmethoxycarbonyl (Fmoc) protecting group on the C3’ amine made the compound 
easier to work with and it was easy to deprotect under mild conditions that are compatible with 
AmB’s sensitive core. Also, in trying to silylate the free hydroxyl groups, it was found that the 
hemiketal at C13 can eliminate to form dihydropyran 1.26 when treated with triethylsilyl 
trifluoromethane sulfonate (TESOTf) in polar solvents like dichloromethane (DCM) (Scheme 
1.4).
41
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Scheme 1.4. SmithKline Beecham’s TES protection of AmB. Use of the polar solvent DCM with TESOTf caused 
elimination of the hemiketal to form dihydropyran 1.26. 
 In addition to the deglycosidation studies, Nicolaou and coworkers also explored the 
chemistry of the macrolactone.
39
 After suitable protection to access 1.27, it was found that 
ozonolysis could effectively cleave the polyene section of the molecule and after reduction give 
the free alcohols (1.29, Scheme 1.5). The western half of the molecule could subsequently be 
cleaved with methanolysis. In the synthesis of a derivative with a rigid, non-polyene core (1.35), 
Rychnovsky and coworkers used a similar oxidative cleavage of the polyene with a PPh3 workup 
to give the bisaldehyde of AmB (Scheme 1.6).
42
 Subsequent Takai olefination allowed access to 
a bisvinyliodide derivative of AmB. A similar degradation/Takai olefination sequence was 
employed by Murata and coworkers in the synthesis of an AmB derivative having a fluorine at 
C28 in the polyene (Scheme 1.7).
43
 Stille coupling of fragments 1.36 and 1.37 followed by 
macrolactonization and deprotection yielded the targeted AmB derivative (1.38). 
 
Scheme 1.5. Nicolaou’s degradation of AmB. 
12 
 
Scheme 1.6. Rychnovsky’s hybrid synthesis of an AmB derivative with a rigid non-polyene core. 
 
Scheme 1.7. Murata’s semisynthesis of fluorine labeled 1.38. 
 
1-5 ITERATIVE CROSS-COUPLING STRATEGY 
 Even with the strides that have been made in the synthesis and degradation of AmB, there 
are still clear challenges in making a full class of deoxygenated derivatives in order to elucidate 
its mechanism of action. For example, Nicolaou’s route to AmB, while a classic in total 
synthesis, is quite long (>100 steps, 47 steps in the longest linear sequence), making it less 
favorable for making derivatives. Additionally, the hybrid routes of Rychnovsky and Murata, 
while very useful for modifying the C21-C40 section of the macrolactone, do not allow for 
derivatization of the C1-C20 fragment or the mycosamine. Therefore, overcoming these 
challenges with a modular and efficient synthesis would enable access to AmB derivatives in 
quantities suitable for testing. We envisioned that the simplest way to disconnect the molecule 
was through a series of Suzuki-Miyaura (SM) transforms and a macrolactonization transform 
giving four key building blocks (Figure 1.5). Such a strategy would allow for all of the 
functionality and oxidation states to be preinstalled in the building blocks and then one mild 
reaction, the SM reaction, could bring them all together. This would also allow for deoxygenated 
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derivatives to be accessed by modifying only the building block containing the functional group. 
For such a strategy to work we needed to use a protecting group for boron that would allow for 
iterative cross-coupling of bifunctional building blocks, but could be removed under mild 
conditions. 
 
Figure 1.5. Our proposed retrosynthesis of AmB via iterative cross-coupling. 
 In 2007, Gillis et al. reported the development of a protecting group for boronic acids 
known as N-methyliminodiacetic acid, or MIDA.
44
 Earlier data suggested that a free and Lewis 
acidic boron p-orbital is necessary for the transmetallation of boronic acids.
45,46
 Gillis et al. found 
that the trivalent ligand, MIDA, is capable of complexing to boronic acids, rehybridizing them to 
sp
3
 MIDA boronates and effectively removing the p-orbital (Figure 1.6). These B-protected 
haloboronic acids are able to selectively cross couple at the halide under anhydrous SM coupling 
conditions then subsequent mild deprotection with NaOH reveals the free boronic acid for 
further chemistry. Analogous to iterative peptide coupling, this has allowed for the synthesis of 
small molecules from building blocks having all of the required functional groups pre-installed 
in the correct oxidation states and with the desired stereochemical relationships. They can then 
be sequentially linked via iterative application of one mild reaction.
44,47
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Figure 1.6. Iterative Suzuki-Miyaura cross-coupling of B-protected haloboronic acids. The MIDA protecting group 
allows for selective cross-coupling of the halide terminus, then mild basic deprotection reveals the reactive boronic 
acid for iteration. 
1-6 SUMMARY 
 AmB is the archetype for small molecule-based ion channels. Its ability to form discrete 
ion channels in eukaryotic cells suggests that small molecules may possess untapped potential to 
replicate the functions of protein ion channels that are deficient in a wide range of currently 
incurable human diseases. Additionally, it is a clinically vital antifungal agent, however its high 
toxicity has limited its effective use. The development of a small molecule surrogate for protein 
ion channels and/or a derivative with a better therapeutic index would be greatly aided by a 
molecular understanding of AmB’s mechanism of action. Given the success of the deletion 
strategy in understanding the role of the mycosamine and the C41 carboxylate, we propose 
systematically deleting each of the protic functional groups on AmB and studying the biological 
and biophysical properties. In order for such a strategy to be possible we need to develop a 
modular, flexible, and mild synthesis of AmB that would be compatible with the synthesis of 
derivatives. The following thesis describes the expansion of the MIDA boronate methodology to 
the synthesis of polyene natural products and a semisynthesis of AmB. Additionally, this 
15 
 
chemistry was successfully employed in a semisynthesis that accessed the targeted deoxygenated 
derivative C35-deoxy AmB. The lessons learned from this synthesis stand to assist in the 
development of a general platform to access all of the deoxygenated derivatives of AmB. 
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CHAPTER 2 
SYNTHESIS OF POLYENE NATURAL PRODUCTS VIA ITERATIVE CROSS-COUPLING 
 
Polyenes are a common structural motif in natural products, but the sensitivity of the 
conjugated framework complicates the preparation of these molecules. This chapter describes the 
discovery of bench-stable and highly versatile B-protected haloalkenylboronic acid building 
blocks that enabled the synthesis of polyenes via iterative Suzuki-Miyaura cross-coupling. In 
contrast to their boronic acid equivalents, the intermediate polyenylboronate esters are 
remarkably stable to both column purification and storage. Moreover, the reactive boronic acids 
can be cleanly liberated using very mild aqueous base. This methodology has facilitated the 
simple, efficient, and modular total syntheses of all-trans-retinal, β-parinaric acid, and the 
heptaenyl portion of the amphotericin B skeleton, which at the time of its completion was the 
longest polyene synthesized by the Suzuki-Miyaura reaction. We additionally demonstrated the 
first selective cross-coupling with a differentially ligated diboron reagent and the first cross-
couplings between polyenyl chlorides and vinylboronic acids. These new building blocks can 
enable the efficient synthesis of polyene natural products and their derivatives. Suk Joong Lee 
contributed to the work presented in this chapter by performing the experiments described in 
schemes 2.1 and 2.7. James Paek completed the synthesis described in scheme 2.6. Portions of 
this chapter were adapted from Lee, S.J.; Gray, K.C.; Paek, J.S.; Burke, M.D. J. Am. Chem. Soc. 
2008, 130, 466-468. Copyright 2008 American Chemical Society. 
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2-1 BACKGROUND 
Most biologically active small molecules exert their effects via the perturbation of 
macromolecular targets.
1
 There are a few, however, that operate via higher-order mechanisms 
that lie outside this paradigm. The class of “polyene natural products”2 is particularly rich with 
examples. Perhaps most notable is the antifungal heptaene macrolide AmB, which self-
assembles into a membrane-spanning channel complex with functional properties reminiscent of 
protein-based ion channels.
3,4
 Other polyenes are known to provide structural support for cell 
membranes,
5
 transduce solar energy into mechanical energy,
6
 serve as pigments for efficient 
light harvesting
7
 and/or species-specific coloration,
8
 act as fluorescent probes,
9
 and/or quench 
reactive oxygen species.
10
 The existence of these natural prototypes suggests that the potential 
for small molecules to perform useful functions in living systems likely extends far beyond that 
which is currently utilized. Unfettered synthetic access to these compounds and their derivatives 
is paramount for realizing this potential. 
The synthesis of polyenes is made challenging by the sensitivity of conjugated double 
bond frameworks to light, oxygen, and many common synthetic reagents, especially protic and 
Lewis acids. Controlling stereochemistry during the formation of each double bond is also a 
critical issue. Syntheses based on palladium-mediated cross-coupling are attractive due to the 
mild, nonacidic, and stereospecific nature of these methods.
11,12
 Among these, the Suzuki- 
Miyaura (SM) reaction
11d
 stands out due to its use of nontoxic boronic acid reagents and well 
precedented functional group compatibility. However, polyenylboronic acids are notoriously 
unstable,
13
 which precludes their general utilization. Gillis et al. in 2007 developed a simple and 
flexible strategy for making small molecules involving the iterative cross-coupling of 
haloboronic acids protected as the corresponding pyramidalized N-methyliminodiacetic acid 
(MIDA, 2.5, Scheme 1) adducts.
14
 This chapter reports a novel collection of B-protected 
haloalkenylboronic acid building blocks 2.1, 2.2, and 2.3 (Figure 2.1) that are strikingly stable to 
purification and storage and highly selective toward a wide range of cross-coupling reactions. 
This stability is maintained in the resulting polyenyl MIDA boronate ester intermediates, thereby 
enabling the simple, efficient, and modular construction of a variety of polyene natural products 
with higher-order functions. 
22 
 
 
Figure 2.1. Chemical structure of bifunctional polyene building blocks 2.1-2.3. 
 
2-2 POLYENE BUILDING BLOCKS 
The first targeted building block containing a single double bond (2.1) was prepared via 
complexation of (E)-(2-bromoethenyl)-dibromoborane 2.4
15
 with MIDA (Scheme 2.1). This 
reaction was performed on >20 g scale (75 mmol) to yield the desired bifunctional olefin 2.1 as a 
crystalline, free-flowing solid. X-ray analysis confirmed unambiguously the pyramidalized 
nature of the boron center. Remarkably, this densely functionalized alkene is stable to silica gel 
chromatography and storage for at least 1.5 years on the benchtop under air. 
Moreover, 2.1 was found to be a very versatile cross-coupling partner (Scheme 2.1). For 
example, the sp
3
-hybridized boronate ester terminus was inert to Buchwald’s anhydrous SM 
conditions,
16
 thus enabling a selective cross-coupling with (E)-styrenylboronic acid 2.6 to 
provide dienyl boronate 2.8 in excellent yield.
17,18
 A Stille coupling between 2.1 and vinyl 
stannane 2.9 was similarly efficient, yielding butadienyl boronate 2.10. Finally, a Heck coupling 
with methyl acrylate 2.11 yielded the unsaturated methyl ester 2.12 as a single regio- and 
stereoisomer. 
A series of novel bismetalated lynchpin-type reagents
12
 were also created. Specifically, 
Sonogashira coupling between 2.1 and TMS acetylene 2.13 generated hetero-bismetalated enyne 
2.14. Although Miyaura borylations
19
 with (E)-1,2-disubstituted vinyl halides are challenging,
19b
 
we found that ligand 2.7
19c
 enabled the smooth conversion of 2.1 into the novel bisborylated 
olefin 2.16 (an X-ray structure of 2.16 is shown in Scheme 2.2). Like 2.1, 2.16 is a column and 
shelf stable crystalline solid (stable under air for at least 1.5 years). Finally, Negishi cross-
coupling between 2.1 and the heterobismetalated vinyl zinc reagent 2.17
12d
 yielded lynchpin 2.18 
in a novel triply metal selective (Zn vs Sn and B) reaction. Use of Buchwald ligand 2.7 was 
required to get complete conversion of 2.1 at the low temperature of 0 °C required to keep 
Negishi reagent 2.17 transiently stable. In contrast, Pd(PPh3)4 was able to provide some product, 
however it gave low and irreproducible conversion. 
23 
 
 
Scheme 2.1. Utility of building block 2.1 in making polyene building blocks through selective palladium-catalyzed 
reactions at the bromide terminus. Building blocks 2.14, 2.16, and 2.18 can serve as lynchpin-type reagents.  
 
Reproduced with permission from Lee, S.J.; Gray, K.C.; Paek, J.S.; Burke, M.D. J. Am. Chem. Soc. 2008, 130, 466-
468. Copyright 2008 American Chemical Society. 
With the goal of developing robust, shelf-stable building blocks for polyene synthesis, we 
designed di- and trienyl halides 2.2 and 2.3 as the corresponding vinyl chlorides.
20
 A direct route 
to the targeted dienyl chloride 2.2 was envisioned via a concomitant metal- and halogen selective 
SM cross-coupling between bisborylated olefin 2.16 and (E)-1-chloro-2-iodoethylene 2.19
21
 
(Scheme 2.2). Due to the absence of a boron p-orbital,
14a
 we hypothesized that the sp
3
-hybridized 
MIDA boronate terminus of 2.16 would be unreactive relative to the sp
2
-hybridized 
pinacolboronic ester. In fact, as shown in scheme 2.2, single-crystal X-ray diffraction analysis 
confirmed the distinct hybridization states of the two boron termini of 2.16, and a halogen- and 
boron-selective cross-coupling with 2.19 yielded the targeted bifunctional diene 2.2 as a column- 
and shelf-stable crystalline solid. This novel type of selective cross-coupling with a differentially 
ligated diboron reagent has since proven to be generally useful.
22,23
 
24 
 
The final targeted polyene building block containing three double bonds (2.3) was 
prepared via another metal-
12i
 and halogen-selective cross-coupling between bisfunctionalized 
reagents 2.18 and 2.3 (Scheme 2.2). Despite containing a potentially sensitive triene moiety, 2.3 
is also both column- and shelf-stable. 
 
Scheme 2.2. Synthesis of bifunctional building blocks 2.2 and 2.3. The crystal structure of 2.16 is shown to its left. 
The crystal structure shows that the pincol boronic ester terminus is sp
2
-hybridized while the MIDA boronate is sp
3
-
hybridized. This allows for boron selective cross-coupling of the pinacol boronic ester terminus. 
 
Adapted with permission from Lee, S.J.; Gray, K.C.; Paek, J.S.; Burke, M.D. J. Am. Chem. Soc. 2008, 130, 466-468. 
Copyright 2008 American Chemical Society. 
 
2-3 SYNTHESIS OF ALL-TRANS-RETINAL 
With the three targeted building blocks 2.1-2.3 in hand and their potential for selective 
cross-couplings verified, we explored the utility of these new reagents in the context of total 
syntheses of polyene natural products that perform higher-order functions. For example, the 
carotenoid all-trans-retinal (2.23) has the ability to transduce solar energy into mechanical 
energy and is a critical functional component of the light-driven proton pump found in 
Halobacteria and the photoreception machinery utilized by most animals.
6
 Structure/function 
studies with this natural product have unique potential to enable the understanding of these 
phenomena at the molecular level.
6c 
The B-protected haloalkenylboronic acid 2.1 was utilized in a highly modular three-step 
synthesis of retinal from known starting materials (Scheme 2.3).
24
 Specifically, the selective SM 
coupling between 2.1 and trienylboronic acid 2.20
24d
 yielded the tetraenyl MIDA boronate 2.21. 
Notably, although the instability of 2.20 precludes its isolation in concentrated form,
24d
 tetraenyl 
25 
 
MIDA boronate 2.21 was isolated via column chromatography as a crystalline solid that can be 
stored refrigerated for at least 1 month without decomposition. 
A key feature of the MIDA protective group is its capacity for removal under mild, 
aqueous basic conditions.
14a
 Given the sensitive nature of polyenylboronic acids,
13
 the B-
deprotection of intermediate 2.21 presented a rigorous test for this methodology. In the event, 
this deprotection proceeded smoothly, and subsequent SM coupling of the resulting solution of 
crude boronic acid with the known α-bromo enal 2.2225 succeeded in generating the targeted all-
trans-retinal. 
 
Scheme 2.3. Synthesis of all-trans-retinal using bifunctional building block 2.1. 
 
Adapted with permission from Lee, S.J.; Gray, K.C.; Paek, J.S.; Burke, M.D. J. Am. Chem. Soc. 2008, 130, 466-468. 
Copyright 2008 American Chemical Society. 
 
2-4 SYNTHESIS OF β-PARINARIC ACID 
Another interesting polyene, β-parinaric acid 2.28, has been used for more than three 
decades as a fluorescent probe for membrane properties.
9,26
 In addition, related tetraenoic acids 
demonstrate remarkable aggregation behaviors,
27
 including the formation of antipodal chiral 
aggregates from a single enantiomer.
27b
 The utility of 2.28 and/or its analogues would benefit 
from more efficient and modular synthetic access to this class of compounds.
28
 
In this vein, the B-protected chlorodienylboronic acid 2.2 was employed in a modular 
synthesis of β-parinaric acid from readily available starting materials (Scheme 2.4). (E)-1-
Butenylboronic acid 2.24 was synthesized in one step by hydroboration of 1-butyne.  A selective 
coupling between the bifunctional dienylchloride 2.2 and 2.24 yielded the column-stable all-
trans-trienyl boronate 2.26. While the coupling of polyenyl chlorides is difficult, Buchwald 
ligand 2.25 allowed for this reaction to proceed at 23 °C. The B-deprotection of 2.26 was 
achieved under mild aqueous basic conditions, and subsequent cross-coupling with vinyl iodide 
2.27 yielded β-parinaric acid as a fluorescent solid. The capping building block 2.27 was 
26 
 
synthesized in three steps from methyl oleate 2.29 (scheme 2.5). Ozonolysis followed by Takai 
olefination
29
 generated the vinyl iodide in a 10:1 E:Z ratio. Subsequent saponification of the 
methyl ester then provided building block 2.27 with all the proper functionality and the correct 
oxidation state.   
 
Scheme 2.4. Synthesis of β-parinaric acid using bifunctional building block 2.2. 
 
Adapted with permission from Lee, S.J.; Gray, K.C.; Paek, J.S.; Burke, M.D. J. Am. Chem. Soc. 2008, 130, 466-468. 
Copyright 2008 American Chemical Society. 
 
Scheme 2.5. Synthesis of the capping building block (2.27) for β-parinaric acid. 
 
2-5 SYNTHESIS OF ONE HALF OF AMPHOTERICIN B 
As a final example, the polyene macrolide AmB represents a potential prototype for small 
molecules that replicate the functions of protein-based ion channels.
30
 An efficient and flexible 
total synthesis of AmB stands to enable the first systematic dissection of the structure/function 
relationships that underlie this small molecule-based ion channel activity.
4
 
In order to access one half of AmB, the western portion of the molecule needed to be 
synthesized. The key to a short and effective route to 2.38 (Scheme 2.6) was recognizing that all 
the desired stereochemistry is contained in previously reported diol 2.32 derived from (S)-2-
methyl-3-hydroxypropionate via a Paterson aldol reaction.
31
 Selective acylation with lipase PS in 
the presence of vinyl acetate gave a 5:1 mixture of the desired C37 monoacylated hydroxyl 
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(2.34) and the undesired C35 monoacylated hydroxyl, respectively. Secondary alcohol 2.34 was 
than treated with TESOTf to provide 2.35 in 88% yield. Subsequent benzyl deprotection and 
Swern oxidation generated aldehyde 2.36 in excellent yields. Finally, exposure to modified Takai 
olefination conditions
32
 followed by SM coupling to 2.19 provided the desired dienyl choride 
2.38.  
 
Scheme 2.6. Synthesis of the western portion of AmB. 
In contrast to strategies based on lynchpin-type reagents,
12
 the cross-coupling of B-
protected haloboronic acids has the theoretical capacity for limitless iteration.
14
 Harnessing this 
potential, the synthesis of one-half of the AmB macrolide skeleton via recursive SM coupling, 
has been achieved (Scheme 2.7). Specifically, boronic acid 2.39 was joined with 2.1 to generate 
dienylboronate 2.40. A subsequent series of B-deprotection and coupling of the resulting 
dienylboronic acid with trienyl chloride 2.3 yielded column-stable pentaenyl MIDA boronate 
2.41. Finally, taking advantage of the recent discovery in our laboratories that MIDA boronates 
can be used directly as surrogates for boronic acids under aqueous SM conditions,
33
 a one-pot B-
deprotection and cross-coupling with dienyl chloride 2.38 yielded one-half of the AmB skeleton 
2.42. At the time of its development this was the longest polyene ever synthesized using the SM 
reaction. This pathway provides a strong starting point for the development of an efficient and 
flexible total synthesis of this notoriously challenging natural product.
34
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Scheme 2.7. Synthesis of ½ of AmB via iterative Suzuki-Miyaura cross-coupling of bifunctional building blocks 2.1 
and 2.3. 
 
Adapted with permission from Lee, S.J.; Gray, K.C.; Paek, J.S.; Burke, M.D. J. Am. Chem. Soc. 2008, 130, 466-468. 
Copyright 2008 American Chemical Society. 
 
2-6 SUMMARY 
In summary, B-protected haloalkenylboronic acid building blocks such as 2.1-2.3 have 
potential for broad utility in the context of total syntheses of polyene natural products. In 
particular these buifunctional building blocks were highly enabling for the mild and efficient 
synthesis of all-trans-retinal, β-parinaric acid, and one-half of AmB. In addition to attenuating 
the reactivity of boronic acid, the MIDA boronate has also been shown to impart outstanding 
stability to these traditionally difficult to isolate fragments. This simple, efficient, and modular 
strategy stands to enable the more effective study and widespread utilization of this class of 
highly functional small molecules. 
 
2-7 EXPERIMENTAL SECTION 
Materials.  Pd(PPh3)4 was a generous gift from Sigma-Aldrich. Commercial reagents were 
purchased from Sigma-Aldrich, Strem, Fisher Scientific, Alfa Aesar, or Lancaster Synthesis and 
were used without further purification unless otherwise noted. Solvents were purified via passage 
through packed columns as described by Pangborn and coworkers
35
 (THF, Et2O, CH3CN, 
CH2Cl2: dry neutral alumina; hexane, benzene, and toluene: dry neutral alumina and Q5 reactant; 
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DMSO, DMF: activated molecular sieves). Triethylamine and 2,6-lutidine were freshly distilled 
under an atmosphere of nitrogen from CaH2. The following compounds were prepared according 
to literature precedent: (E)-(2-bromoethenyl)dibromoborane (2.4)
15
, (E)-1-chloro-2-iodoethylene 
(2.19)
36
, (1E,3E)-2-methyl-4-(2,6,6-trimethylcyclohex-1-enyl)buta-1,3-dienylboronic acid 
(2.20)
37
, (E)-3-bromobut-2-enal (2.22)
38
, (E)-(2-(tributylstannyl)vinyl)zinc chloride (2.17)
39
, (E)-
methyl 10-iododec-9-enoate (2.30)
40
, diol 2.32
31
, dichloromethylpinacolboronic ester 2.37
41
. 
 
General Experimental Procedures.  All palladium-mediated cross-coupling reactions were 
performed under an atmosphere of argon in oven- or flame-dried I-Chem or Wheaton vials 
sealed with PTFE-lined plastic caps. All other reactions were performed in oven- or flame-dried 
round-bottom or modified Schlenk flasks fitted with rubber septa under a positive pressure of 
argon or nitrogen unless otherwise indicated. Organic solvents were concentrated via rotary 
evaporation under reduced pressure. Reactions were monitored by analytical thin layer 
chromatography (TLC) performed using the indicated solvent on E. Merck silica gel 60 F254 
plates (0.25 mm). Compounds were visualized by exposure to a UV lamp (λ = 254 and 365 nm), 
a solution of KMnO4, a solution of ceric ammonium molybdate (CAM), or an acidic solution of 
p-anisaldehyde followed by brief heating using a Varitemp heat gun. Flash column 
chromatography was performed as described by Still and coworkers
42
 using EM Merck silica gel 
60 (230-400 mesh) and/or Aldrich Florisil
®
 (an activated magnesium silicate: 100-200 mesh). 
 
Structural Analysis.  
1H NMR spectra were recorded at 23 ˚C on one of the following 
instruments: Varian Unity 400, Varian Unity 500, Varian Unity Inova 500NB. Chemical shifts 
() are reported in parts per million (ppm) downfield from tetramethylsilane and referenced to 
residual protium in the NMR solvent (CDCl3, = 7.24; CD3CN, = 1.93; (CD3)2CO, = 2.04; 
DMSO-d6, = 2.49, center line). Data are reported as follows: chemical shift, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, qn = quintet, sept = septet, dd = doublet of doublets, 
dt = doublet of triplets, ddt = doublet of doublet of triplets, dtd = doublet of triplet of doublets, m 
= multiplet, b = broad), coupling constant (J) in Hertz (Hz), and integration. 
13
C NMR spectra 
were recorded at 23 ˚C on one of the following instruments: Varian Unity 500 or Varian Unity 
Inova 500NB. Chemical shifts () are reported in ppm downfield from tetramethylsilane and 
referenced to carbon resonances in the NMR solvent (CDCl3, = 77.0; CD3CN, = 1.30; 
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(CD3)2CO, = 29.8; DMSO-d6, = 39.5, center line). Carbons bearing boron substituents were 
not observed (quadrupolar relaxation).
11
B NMR were recorded using a General Electric 
GN300WB instrument and referenced to an external standard of (BF3•Et2O). High resolution 
mass spectra (HRMS) were performed by Furong Sun and Dr. Steve Mullen at the University of 
Illinois School of Chemical Sciences Mass Spectrometry Laboratory. Infrared spectra were 
collected from a thin film on NaCl plates on a Mattson Galaxy Series FTIR 5000 spectrometer 
with internal referencing. Absorption maxima (max) are reported in wavenumbers (cm
-1
). X-ray 
crystallographic analysis of 2.1 and 2.16 were carried out by Dr. Scott Wilson at the University 
of Illinois George L. Clark X-Ray facility. 
 
 
(E)-(2-bromoethenyl)dibromoborane (2.4)
15  
In a subdued light environment, an oven-dried 100 mL one-neck round bottom flask, equipped 
with a magnetic stir bar and a rubber septum, was flushed out with acetylene gas three-times 
using a five-inch balloon attached to needle. The flask was attached to three balloons filled with 
acetylene gas and cooled to 0 °C. To a flask at 0 °C was added boron tribromide (75.0 g, 299.4 
mmol) dropwise via syringe over 15 minutes with stirring. The reaction mixture was allowed to 
warm to 23 ˚C and then stirred at 23 ˚C for 24 hours. (Each balloon was refilled with acetylene 
gas after the acetylene gas in the balloon was consumed). In a subdued light environment, the 
resulting dark-blue crude mixture was distilled three-times under high vacuum connected with 
two dry ice/acetone traps to provided 2.4 (45.20 g, 163.4 mmol) as a colorless oil in 55 % yield. 
(bp = 50-55 °C/13mmHg). (The fractional vacuum distillation was carried out at 23 ˚C for 30 
minutes before heating to remove a small amount of residual boron tribromide and then the 
crude mixture was slowly heated to around 65 ˚C using an oil-bath until distillation was 
completed. The oil-bath temperature was carefully maintained below 70 ˚C to inhibit a 
polymerization reaction). The freshly distilled title compound 2.4 was used immediately in the 
next reaction.   
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1
H NMR (500 MHz, CDCl3)  
δ 7.97 (d, J = 15.0 Hz, 1H), 7.08 (d, J = 15.0 Hz, 1H).  
 
 
 
Bromoethenyl MIDA Boronate 2.1  
In a subdued light environment, to a stirred mixture of N-methyliminodiacetic acid (MIDA, 2.5) 
(16.93 g, 113.9 mmol, 1.5 eq) and 2,6-lutidine (17.69 mL, 151.86 mmol, 2 eq) in DMSO (250 
mL) at 0 °C under an atmosphere of nitrogen was added freshly distilled 2.4 (21.00 g, 75.93 
mmol, 1 eq) dropwise via syringe over 15 minutes. The reaction mixture was allowed to warm to 
23 ˚C and then stirred at 23 ˚C for 48 hours. The resulting yellow mixture was treated with water 
(300 mL) and extracted with THF:diethyl ether 1:1 (3 × 500 mL).  The combined organic phases 
were washed with brine (3 × 350 mL), dried over anhydrous magnesium sulfate, and 
concentrated under reduced pressure to provide a light yellow solid. The crude product was 
purified by column chromatography on silica gel (50% EtOAc/petroleum ether  EtOAc  
10% MeCN/EtOAc) to give the title compound 2.1 as a colorless crystalline solid (11.98 g, 45.75 
mmol, 60%). Crystals suitable for X-ray crystallography analysis were grown by slow 
evaporation from ethyl acetate at 23 ˚C. This material was stored under air at 23 ˚C for one 
year and six months without decomposition. 
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TLC (EtOAc) 
Rf = 0.46, visualized with KMnO4. 
 
1
H NMR (500 MHz, CD3CN) 
δ 6.69 (d, J = 15.0 Hz, 1H), 6.33 (d, J = 14.5 Hz, 1H), 3.97 (d, J = 17.0 Hz, 2H), 3.82 (d, 
J = 17.0 Hz, 2H), 2.80 (s, 3H). 
 
13
C NMR (125 MHz, CD3CN) 
       δ 169.0, 118.8, 62.6, 47.9. 
 
HRMS (ESI) 
       Calculated for C7H9NO4BrB (M+H):   261.9886 
       Found:                                            261.9874 
 
11
B NMR (100 MHz, CD3CN) 
     δ 10.5. 
 
IR (thin film, cm
-1
) 
3005.5, 2961.9, 1754.7, 1589.2, 1450.5, 1337.5, 1285.7, 1196.2, 1152.2, 1117.5, 1079.7, 
1025.1, 1008.8, 960.9, 893.2, 871.5, 772.7, 677.7.  
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Phenyl Diene 2.8 
A solution of the catalyst was prepared as follows: An oven-dried Wheaton vial equipped with a 
magnetic stir bar was charged with Pd(OAc)2 (5.6 mg,  0.025 mmol,  1 eq) and 2-
dicyclohexylphosphino-2’,6’-dimethoxy-1,1’-biphenyl 2.7 (20.5 mg, 0.050 mmol,  2 eq) in an 
argon-filled glovebox. Toluene (3.0 mL) was added and the vial was sealed with a PTFE-lined 
plastic cap. The resulting mixture was stirred at 23 ˚C for 45 minutes resulting in a yellow Pd/2.7 
catalyst solution (0.00833 M Pd in toluene). 
This catalyst solution was then utilized in the following procedure: An oven-dried Wheaton vial 
equipped with a magnetic stir bar was charged with 2.1 (0.262 g, 1.00 mmol, 1 eq) and trans-2-
phenylvinylboronic acid (2.6) (0.229 g, 1.50 mmol, 1.5 eq) and sealed with a PTFE-lined plastic 
cap. The vial was evacuated and refilled with argon three times and then moved into an argon-
filled glovebox. KF (0.116 g, 2.00 mmol, 2 eq), toluene (7.0 mL) and the catalyst solution (1.2 
mL, 0.01 mmol, 1 mol% Pd) was added and vial was sealed with a PTFE-lined plastic cap. The 
sealed vial was removed from the glovebox and stirred for 24 hours at 23 ˚C. The resulting 
heterogeneous yellow mixture was diluted with acetonitrile (10.0 mL) and filtered through short 
pad Celite using acetonitrile (100 mL). The filtrate was concentrated in vacuo. The crude product 
was purified by column chromatography on silica gel (50% EtOAc/petroleum ether  EtOAc  
33% MeCN/EtOAc) to give the title compound 2.8 as a colorless crystalline solid (0.263 g, 0.922 
mmol, 92 %). 
 
TLC (EtOAc) 
       Rf = 0.85, visualized by UV lamp (λ = 254 nm) or with KMnO4. 
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1
H NMR (500 MHz, DMSO-d6)  
δ 7.48 (d, J = 7.5 Hz, 2H), 7.33 (t, J = 7.5 Hz, 2H), 7.24 (t, J = 7.5 Hz, 1H), 6.93 (dd, J = 
15.5, 10.5 Hz, 1H), 6.65 (d, J = 15.5 Hz, 1H), 6.63 (dd, J = 17.0, 10.5 Hz, 1H), 5.78 (d, J 
= 17.5 Hz, 1H), 4.24 (d, J = 17.5 Hz, 2H), 4.03 (d, J = 17.0 Hz, 2H), 2.78 (s, 3H). 
 
13
C NMR (125 MHz, DMSO-d6)  
       δ 169.3, 142.0, 136.9, 132.9, 130.9, 128.7, 127.8, 126.5, 61.4, 46.8. 
 
HRMS (ESI) 
      Calculated for C15H16NO4B (M+H):   286.1251 
      Found:       286.1249 
 
11
B NMR (100 MHz, DMSO-d6) 
       δ 11.4. 
 
IR (thin film, cm
-1
) 
2967.4, 1741.1, 1697.9, 1681.8, 1650.7, 1556.4, 1445.9, 1338.0, 1309.4, 1257.5, 1112.7, 
1082.0, 1012.9, 950.0, 884.8, 864.7, 750.4, 693.8, 653.5. 
 
 
Diene 2.10 
An oven-dried Wheaton vial equipped with a magnetic stir bar was charged with 2.1 (0.262 g, 
1.00 mmol, 1 eq) and sealed with a PTFE-lined plastic cap. The vial was evacuated and refilled 
with argon three times and then moved into an argon-filled glovebox. Pd2dba3 (0.037 g, 0.040 
mmol, 4 mol% Pd), Fur3P (0.021 g, 0.090 mmol, 9 mol%), DMF (8.0 mL) and tributyl(vinyl)tin 
(2.9) (0.346 mL, 1.15 mmol, 1.15 eq) was added and vial was sealed with a PTFE-lined plastic 
cap. The sealed vial was removed from the glovebox and stirred for 12 hours at 45 ˚C. The 
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resulting reddish mixture was diluted with brine (50 mL) and then extracted with ethyl acetate (3 
× 100 mL).  The combined organic fractions were dried over anhydrous magnesium sulfate and 
concentrated in vacuo. The crude product was purified by column chromatography on silica gel 
(50% EtOAc:petroleum ether  EtOAc  6% MeCN/EtOAc) to give the title compound 2.10 
as a colorless crystalline solid (0.190 g, 0.909 mmol, 91%). 
 
 
TLC (EtOAc) 
       Rf = 0.46, visualized with KMnO4. 
 
1
H NMR (500 MHz, CD3CN) 
δ 6.56 (dd, J = 17.5, 10.5 Hz, 1H), 6.43 (dtd, J = 17.0, 10.0, 0.5 Hz, 1H), 5.66 (dd, J = 
17.5, 0.5 Hz, 1H), 5.28 (ddt, J = 17.0, 2.0, 0.5 Hz, 1H), 5.14 (ddt, J = 10.0, 2.0, 0.5 Hz, 
1H), 3.96 (d, J = 17.0 Hz, 2H), 3.79 (d, J = 17.0 Hz, 2H), 2.76 (s, 3H). 
 
13
C NMR (125 MHz, CD3CN) 
       δ 169.5, 144.3, 140.1, 119.0, 62.3, 47.6. 
 
HRMS (ESI) 
       Calculated for C9H12BNO4 (M+Na):   232.0757 
       Found:       232.0757 
 
11
B NMR (100 MHz, CD3CN) 
       δ 10.9. 
 
IR (thin film, cm
-1
) 
3006.3, 2959.8, 1769.8, 1709.9, 1636.0, 1591.8, 1459.5, 1423.9, 1337.9, 1286.0, 1193.7, 
1154.2, 1124.7, 1087.9, 1024.3, 958.4, 892.5, 873.9, 836.6, 719.4, 648.4. 
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Dienyl Methyl Ester 2.12 
An oven-dried Wheaton vial equipped with a magnetic stir bar was charged with 2.1 (0.262 g, 
1.00 mmol, 1 eq), PPh3 (0.0159 g, 0.060 mmol, 6 mol%) and sealed with a PTFE-lined plastic 
cap. The vial was evacuated and refilled with argon three times and then moved into an argon-
filled glovebox. Pd(OAc)2 (0.0067 g, 0.030 mmol, 3 mol% Pd), Et3N (0.279 mL, 2.00 mmol, 2 
eq), methyl acrylate (2.11) (0.136 mL, 1.50 mmol, 1.5 eq), and DMF (7.0 mL) were added and 
the vial was sealed with a PTFE-lined plastic cap. The sealed vial was removed from the 
glovebox and stirred for 12 hours at 45 ˚C. The resulting mixture was diluted with brine (50 mL) 
and extracted with ethyl acetate (3×100 mL).  The combined organic layers were dried over 
anhydrous magnesium sulfate and concentrated in vacuo. The crude product was purified by 
column chromatography on silica gel (50% EtOAc/petroleum ether 1:1  EtOAc  6% 
MeCN/EtOAc) to give the title compound 2.12 as a light yellow solid (0.240 g, 0.898 mmol, 
90%). 
 
TLC (EtOAc) 
       Rf = 0.33, visualized by UV lamp (λ = 254 nm). 
 
1
H NMR (500 MHz, CDCl3) 
δ 7.20 (dd, J = 15.5, 10.5 Hz, 1H), 6.68 (dd, J = 17.0, 10.5 Hz, 1H), 6.02 (d, J = 17.5 Hz, 
1H), 5.89 (d,  J = 15.5 Hz, 1H), 4.11 (d, J = 17.0 Hz, 2H), 3.79 (d, J = 17.0 Hz, 2H), 3.67 
(s, 3H), 2.82 (s, 3H). 
 
13
C NMR (125 MHz, CDCl3) 
       δ 168.8, 167.3, 145.4, 140.9, 122.4, 61.7, 51.6, 47.2. 
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HRMS (ESI)  
       Calculated for C11H14BNO6 (M+Na):  290.0812 
       Found:       290.0812 
 
11
B NMR (100 MHz, CDCl3) 
       δ 9.9. 
 
IR (thin film, cm
-1
) 
3005.0, 1751.2, 1734.3, 1718.1, 1700.5, 1696.2, 1684.7, 1653.5, 1595.2, 1559.8, 1437.1, 
1334.0, 1281.3, 1232.7, 1129.1, 990.8, 862.8, 716.1, 662.4. 
 
 
Enyne 2.14 
An oven-dried Wheaton vial equipped with a magnetic stir bar was charged with 2.1 (0.262 g, 
1.00 mmol, 1 eq) and sealed with a PTFE-lined plastic cap. The vial was evacuated and refilled 
with argon three times and then moved into an argon-filled glovebox. Pd(PPh)4 (0.058 g, 0.050 
mmol, 5 mol%), CuI (0.019 g, 0.100 mmol, 10 mol%), piperidine (0.227 mL, 2.30 mmol, 2 eq), 
THF (5.0 mL), and trimethylsilylacetylene (2.13) (0.166 mL, 1.15 mmol, 1.5 eq) were added and 
vial was sealed with a PTFE-lined plastic cap. The sealed vial was removed from the glovebox 
and stirred for 3 hours at 23 ˚C. The resulting mixture was diluted with EtOAc (5.0 mL) and 
filtered through short pad silica gel using EtOAc (100 mL). The filtrate was concentrated in 
vacuo, and the resulting crude product was purified by column chromatography on silica gel 
(50% EtOAc/petroleum ether  EtOAc) to give the title compound 2.14 as a colorless 
crystalline solid (0.203 g, 0.728 mmol, 73%). 
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TLC (EtOAc) 
       Rf = 0.60, visualized by UV lamp (λ = 254) or with KMnO4). 
 
1
H NMR (500MHz, CDCl3) 
δ 6.12 (d, J = 18.0 Hz, 1H), 6.04 (d, J = 18.5 Hz, 1H), 4.08 (d, J = 17.0 Hz, 2H), 3.70 (d, 
J = 17.0 Hz, 2H), 2.82 (s, 3H), 0.15 (s, 9H). 
 
13
C NMR (125 MHz, CDCl3) 
       δ 168.7, 123.7, 104.6, 96.4, 61.6, 47.2, -0.2. 
 
HRMS (ESI) 
       Calculated for C12H18BNO4Si (M+H):  280.1176 
       Found:       280.1178  
 
11
B NMR (100 MHz, CDCl3) 
       δ 11.5. 
 
IR (thin film, cm
-1
) 
3015.6, 2959.2, 2898.4, 2152.4, 1759.7, 1600.2, 1451.2, 1422.6, 1341.6, 1292.6, 1251.2, 
1169.5, 1116.2, 1065.7, 1024.9, 1002.5, 952.9, 841.9, 759.5, 734.4, 678.8. 
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Pinacolboronic Ester 2.16 
A solution of the catalyst was prepared as follows: An oven-dried Wheaton vial equipped with a 
magnetic stir bar was charged with PdCl2(CH3CN)2 (7.9 mg, 0.030 mmol, 1 eq) and 2-
dicyclohexylphosphino-2’,6’-dimethoxy-1,1’-biphenyl 2.7 (38.0 mg, 0.090 mmol,  3 eq) in an 
argon-filled glovebox. Toluene (3.0 mL) was added and the vial was sealed with a PTFE-lined 
plastic cap. The resulting mixture was stirred at 23 ˚C for 30 minutes yielding a clear yellow 
Pd/2.7 catalyst solution.  
 
This catalyst solution was then utilized in the following procedure: An oven-dried Wheaton vial 
equipped with a magnetic stir bar was charged with 2.1 (0.262 g, 1.00 mmol, 1 eq) and sealed 
with a PTFE-lined plastic cap. The vial was evacuated and refilled with argon three times and 
then moved into a glovebox. Bis(pinacolato)diboron (2.15) (0.324 g, 1.25 mmol, 1.25 eq), 
potassium acetate (0.297 g, 3.00 mmol, 3 eq), toluene (5.0 mL) and catalyst solution (3.0 mL, 3 
mol% Pd ) were then added and the vial was sealed with a PTFE-lined plastic cap. The sealed 
vial was removed from the glovebox and stirred for 36 hours at 45 ˚C. The resulting 
heterogeneous mixture was diluted with ethyl acetate (5.0 mL) and filtered through short pad of 
Celite. Concentration of the filtrate in vacuo provided a light yellow solid. This crude product 
was purified by column chromatography on silica gel (50% EtOAc/petroleum ether  EtOAc  
6% MeCN/EtOAc) to give the title compound 2.16 as a colorless crystalline solid (0.219 g, 0.710 
mmol, 71%).  Crystals suitable for X-ray crystallography analysis were grown by slow 
evaporation from EtOAc at 23 ˚C.  This material was stored under air at 23 ˚C for one year and 
six months without decomposition. 
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TLC (EtOAc) 
       Rf = 0.23, visualized with KMnO4. 
 
1
H NMR (500 MHz, CD3CN)  
δ 6.67 (d, J = 20.5 Hz, 1H), 6.11 (d, J = 21.0 Hz, 1H), 3.96 (d, J = 17.0 Hz, 2H), 3.80 (d, 
J = 17.0 Hz, 2H), 2.76 (s, 3H), 1.22 (s, 12H). 
 
13
C NMR (125 MHz, CD3CN) 
      δ 169.4, 84.1, 62.5, 47.7, 25.1. 
 
HRMS (ESI)  
       Calculated for C13H21NO6B2 (M+H):   310.1633 
       Found:       310.1638 
 
11
B NMR (100 MHz, CD3CN)  
       δ 29.7 (sp2), 10.2 (sp3). 
 
IR (thin film, cm
-1
) 
2979.4, 1762.2, 1700.8, 1653.7, 1559.9, 1458.2, 1374.3, 1332.2, 1297.1, 1143.7, 1109.9, 
1088.3, 1023.7, 967.2, 877.7, 846.9, 808.5, 673.0. 
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Dienyl Stannane 2.18 
A solution of the catalyst was prepared as follows: To a 4 mL vial equipped with a stir bar and 
containing 2-dicyclohexylphosphino-2’,6’-dimethoxy-1,1’-biphenyl (2.7) (15.2 mg, 0.037 mmol, 
2 eq) was added a solution of Pd(OAc)2 in THF (0.095 M, 0.19 mL, 0.018 mmol, 1 eq). The vial 
was sealed with a PTFE-lined cap and maintained at 23 ˚C with stirring for 15 minutes yielding a 
clear yellow Pd/2.7 catalyst solution.  
 
This catalyst solution was then utilized in the following procedure: (E)-(2-
(tributylstannyl)vinyl)zinc chloride (2.17) was prepared according to literature precedent:
39
 To a 
solution of trans-1,2-bis(tri-n-butylstannyl)ethylene (231 mg, 0.382 mmol, 2 eq) in THF (0.4 
mL) at –78 ˚C was added n-butyllithium (1.55 M in hexanes, 0.27 mL, 0.42 mmol, 2.2 eq). After 
30 minutes at –78 ˚C, a freshly prepared solution of ZnCl2 (57 mg, 0.42 mmol, 2.2 eq) in THF 
(0.84 mL) was added causing rapid discoloration.  The solution was then warmed to –20 ˚C. 
During the formation of Negishi reagent 2.17, to a slurry of 2.1 (50 mg, 0.191 mmol, 1 eq) in 
THF (0.2 mL) at 23 ˚C was added the catalyst stock solution described above (0.10 mL, 0.0095 
mmol Pd, 5 mol% Pd) and the resulting slurry was stirred for 30 minutes before cooling to 0 
o
C.  
Negishi reagent 2.17 was then cannulated into the 2.1 solution over 5 minutes.  After 2 hours at 0 
˚C the reaction was diluted with EtOAc (10 mL) and was concentrated in vacuo.  The resulting 
red oil was dissolved in EtOAc and filtered through a small pad of silica gel with copious 
amounts of EtOAc, and the filtrate was concentrated in vacuo.  The resulting crude product was 
purified by column chromatography on silica gel (50% EtOAc/hexanes  EtOAc) to yield 2.18 
as a pale yellow foam (62.2 mg, 0.125 mmol, 66%).   
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TLC (EtOAc) 
 Rf = 0.45, visualized with KMnO4. 
 
1
H NMR (500 MHz, acetone-d6) 
 6.65 (dd, J = 9.5, 18.5 Hz, 1H), 6.52 (dd, J = 10.0, 17.5 Hz, 1H), 6.31 (d, J = 18.5 Hz, 
1H), 5.63 (d, J = 17.0 Hz, 1H), 4.21 (d, J = 17.0 Hz, 2H), 4.03 (d, J = 17.0 Hz, 2H), 3.00 
(s, 3H), 1.54 (m, 6H), 1.32 (m, 6H), 0.95 (t, J = 8.0 Hz, 6H), 0.88 (t, J = 7.5 Hz, 9H).  
 
13
C NMR (125 MHz, acetone-d6) 
 169.0, 150.2, 146.2, 135.2, 62.3, 47.3, 29.9, 27.9, 13.9, 9.9. 
 
11
B NMR (300 MHz, acetone-d6) 
  11.3. 
 
HRMS (CI+) 
 Calculated for C21H38O4NBSn (M+H)
+
:  500.1994       
 Found:                                                     500.1992 
 
IR (thin film, cm
-1
) 
 2955, 2925, 2871, 2848, 1762, 1616, 1557, 1463, 1338, 1289, 1167, 1116, 1022, 957,  
873, 844. 
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Dienyl Chloride 2.2 
In a glove box, to a 20 mL I-Chem vial equipped with a stir bar was added bis-borylated olefin 
2.16 (320 mg, 1.05 mmol, 1 eq), finely ground anhydrous K3PO4 (669 mg, 3.15 mmol, 3 eq), 
PdCl2dppfCH2Cl2 (26 mg, 0.32 mmol, 3 mol%), and (E)-1-iodo-2-chloroethylene (2.19)
36
 (396 
mg, 2.10 mmol, 2 eq).  The vial was sealed with a teflon-lined septum cap and DMSO (8.4 mL) 
was added via syringe. The resulting mixture was stirred at 23 ˚C for 9 hours.  The reaction was 
quenched with the addition of 0.5 M pH 7 phosphate buffer (8 mL) and the resulting mixture was 
extracted with THF:Et2O 1:1 (4 x 15 mL).  The combined organic extracts were washed with 
brine (1 x 25 mL), dried over Na2SO4, and concentrated in vacuo. The resulting residue was 
diluted with acetone (15 mL) and concentrated onto Florisil.  The resulting powder was dry-
loaded on top of a silica gel column and eluted with 50% EtOAc/hexanes  EtOAc  10% 
MeCN/EtOAc to yield 2.2 as a colorless crystalline solid (139 mg, 0.571 mmol, 54%).  
 
 
 
TLC (EtOAc) 
 Rf = 0.35, visualized with KMnO4. 
 
1
H NMR (500 MHz, CD3CN) 
 6.58 (dd, J = 10.5, 13 Hz, 1H), 6.53 (dd, J = 10.5, 16.5 Hz, 1H), 6.43 (d, J = 13.0 Hz, 
1H), 5.68 (d, J = 17.0 Hz, 1H), 3.94 (d, J = 17.0 Hz, 2H), 3.78 (d, J = 17.0 Hz, 2H), 2.75 
(s, 3H). 
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13
C NMR (125 MHz, CD3CN) 
 169.3, 139.3, 136.6, 123.1, 62.4, 47.7. 
 
11
B NMR (300 MHz, CD3CN) 
  11.1. 
 
HRMS (EI+) 
 Calculated for C9H11O4NClB (M)
+
:        243.0469 
 Found:                                                       243.0467 
 
IR (thin film, cm
-1
) 
 3019, 1767, 1289, 1215, 1026, 1003, 760, 669. 
 
 
 
Trienyl Chloride 2.3 
In an argon-filled glovebox, an oven-dried Wheaton vial equipped with a magnetic stir bar was 
charged with Pd2(dba)3 (0.021 g, 0.023 mmol, 1.5 mol%), Ph3As (0.014 g, 0.046 mmol, 3 
mol%), 2.18 (0.760 g, 1.53 mmol, 1 eq) as a solution in DMF (5.0 mL), and finally (E)-1-chloro-
2-iodoethylene (0.575 g, 3.05 mmol, 2 eq). The vial was sealed with PTFE-lined plastic cap, 
removed from the glovebox, and stirred at 23 ˚C for 3.5 hours. To the resulting deep reddish 
mixture was then added saturated aqueous Na2S2O3 (50 mL) and the resulting mixture was 
extracted with EtOAc (3 × 85 mL).  The combined organic extracts were washed with brine (3 × 
50 mL), dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to 
provide an orange solid. This crude product was purified by column chromatography on Florisil
®
 
(50% EtOAc/petroleum ether  EtOAc  10% MeCN/EtOAc) to give the title compound 2.3 
as a light yellow solid (0.297 g, 1.10 mmol, 72%). 
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TLC (EtOAc) 
       Rf = 0.46, visualized by UV lamp (λ = 254) or with KMnO4. 
 
1
H NMR (400 MHz, CD3CN) 
δ 6.61-6.53 (m, 2H), 6.39-6.25 (m, 3H), 5.72 (d, J = 17.6 Hz, 1H), 3.95 (d, J = 16.8 Hz, 
2H), 3.79 (d, J = 16.8 Hz, 2H), 2.75 (s, 3H). 
 
13
C NMR (100 MHz, CD3CN) 
       δ 169.4, 143.1, 136.4, 134.6, 130.2, 122.3, 62.3, 47.6. 
 
11
B NMR (100 MHz, CD3CN) 
       δ 10.7. 
 
HRMS (ESI) 
       Calculated for C11H13BNO4Cl (M+H):  270.0704 
       Found:       270.0717 
 
IR (thin film, cm
-1
) 
3009.9, 1764.0, 1619.5, 1562.4, 1458.0, 1337.0, 1287.6, 1234.6, 1190.7, 1153.7, 1115.8, 
1083.3, 1006.2, 955.4, 890.9, 862.2, 829.4, 721.2. 
 
 
 
 
46 
 
 
 
Tetraenyl MIDA Boronate 2.21   
A solution of the catalyst was prepared as follows: To a 4 mL vial equipped with a stir bar and 
containing 2-dicyclohexylphosphino-2’,6’-dimethoxy-1,1’-biphenyl 2.7 (23.1 mg, 0.056 mmol, 2 
eq) was added a solution of Pd(OAc)2 in toluene (0.038 M, 0.740 mL, 0.028 mmol, 1 eq). The 
vial was sealed with a PTFE-lined cap and maintained at 65 ˚C with stirring for 15 minutes. 
This catalyst solution was then utilized in the following procedure: To a 40 mL I-Chem vial 
equipped with a stir bar and containing a solution of 2.20
37
 in toluene (estimated 0.17 M, 11.5 
mL, 1.96 mmol, 1.5 eq) was added anhydrous K3PO4 as a finely ground powder (0.833 g, 3.92 
mmol, 3 eq), 2.1 (0.342 g, 1.30 mmol, 1 eq), and the catalyst solution (0.688 mL, 0.026 mmol 
Pd, 2 mol% Pd).  The resulting mixture was sealed with a PTFE-lined cap and stirred at 23 ˚C for 
60 hours. The mixture was then filtered through a pad of silica gel with copious amounts of 
MeCN. To the resulting solution was added Florisil gel and then the solvent was removed in 
vacuo.  The resulting powder was dry-loaded on top of a silica gel column and eluted with 50% 
EtOAc/hexanes  EtOAc  10% MeCN/EtOAC to yield the desired product as a yellow 
powder (0.377 g, 1.02 mmol, 78%). 
 
 
 
TLC (EtOAc) 
 Rf = 0.45, visualized with KMnO4. 
 
 
47 
 
1
H NMR (500 MHz, acetone-d6) 
 6.98 (dd, J = 11, 17 Hz, 1H), 6.23 (d, J = 16 Hz, 1H), 6.13 (d, J = 11.5 Hz, 1H), 6.10 
(d, J = 16 Hz, 1H), 5.71 (d, J = 17 Hz, 1H), 4.21 (d, J = 17 Hz, 2H), 4.03 (d, J = 17 Hz, 
2H), 3.00 (s, 3H), 2.01 (app t, J = 6 Hz, 2H), 1.94 (d, J = 1 Hz, 3H), 1.68 (d, J = 1 Hz, 
3H), 1.63-1.58 (m, 2H), 1.48-1.45 (m, 2H), 1.01 (s, 6H). 
 
13
C NMR (125 MHz, acetone-d6) 
 169.1, 140.9, 139.3, 138.7, 136.7, 133.1, 129.6, 127.9, 62.2, 47.4, 40.2, 34.8, 33.5, 29.2, 
21.9, 19.9, 12.7.  
 
11
B NMR (300 MHz, acetone-d6) 
  11.7. 
 
HRMS (FAB) 
 Calculated for C21H30NBO4 (M+H)
+
:        372.2346 
 Found:                                                 372.2350 
 
IR (KBr Pellet, cm
-1
) 
 3021, 2959, 2925, 2865, 1773, 1457, 1338, 1301, 1025, 986, 867. 
 
 
 
All-trans-retinal (2.23) 
MIDA boronate 2.21 was converted to boronic acid 2.43 via the following procedure: To a 
stirred solution of 2.21 (35.9 mg, 0.101 mmol, 1 eq) in THF (1.44 mL) at 23 ˚C was added 1 M 
aq. NaOH (0.30 mL, 0.30 mmol, 3 eq) and the resulting mixture was stirred for 15 minutes. The 
reaction was then quenched with the addition of 0.5 M pH 7 phosphate buffer (1.5 mL) and 
diluted with Et2O (1.5 mL). The layers were separated and the aqueous layer was extracted with 
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THF:Et2O 1:1 (3 x 3 mL).  The combined organic layers were dried over MgSO4 and 
concentrated in vacuo until a small amount of THF (~1 mL) remained, yielding a solution of 
2.43; TLC: (EtOAc) Rf = 0.70, visualized by KMnO4.  
 
A solution of the palladium catalyst was prepared as follows: To a 1.5 mL vial equipped with a 
stir bar and containing 2-dicyclohexylphosphino-2’,6’-dimethoxy-1,1’-biphenyl (3.6 mg, 0.0088 
mmol, 2 eq) was added a solution of Pd(OAc)2 in toluene (0.038 M , 0.115 mL, 0.0044 mmol, 1 
eq). The vial was sealed with a PTFE-lined cap and maintained at 65 
o
C with stirring for 15 
minutes. 
 
This catalyst solution was then utilized in the following procedure: To a 4-mL vial equipped with 
a stir bar and containing enal 2.22
38
 (10 mg, 0.067 mmol, 1 eq) was added boronic acid 2.43 as a 
solution in THF (estimated 0.101 M, 1 mL, 0.101 mmol, 1.5 eq), anhydrous K3PO4 as a finely 
ground powder (42.6 mg, 0.201 mmol, 3 eq), and the catalyst stock solution described above 
(0.035 mL, 0.0013 mmol Pd, 2 mol% Pd).  The resulting mixture was sealed with a PTFE-lined 
cap and stirred at 23 ˚C for 5 hours. The reaction was then quenched with the addition of 
saturated aqueous NaHCO3 (2 mL). The layers were separated and the aqueous layer was 
extracted with Et2O (3 x 5 mL).  The combined organic layers were dried over Na2SO4 and 
concentrated in vacuo.  The crude material was purified by silica gel chromatography (3% 
EtOAc/hexanes) to yield all-trans-retinal (2.23) as a bright yellow solid (12.6 mg, 0.044 mmol, 
66%).  
1
H NMR
43
, 
13
C NMR
44
, HRMS, and IR
45
 analysis of synthetic 2.23 were fully consistent 
with the data reported for the isolated natural product.  
 
 
 
TLC (30% EtOAc/hexanes) 
 Rf = 0.65, visualized with KMnO4. 
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1
H NMR (400 MHz, CDCl3) 
 10.10 (d, J = 8.4 Hz, 1H), 7.14 (dd, J = 11.2, 14.8 Hz, 1H), 6.37 (d, J  = 14.8 Hz, 1H), 
6.33 (d, J  = 16.8 Hz, 1H), 6.18 (d, J = 11.2 Hz, 1H), 6.16 (d, J  = 16.4 Hz, 1H), 5.97 (d, J 
= 8.4 Hz, 1H), 2.32 (d, J = 1.2 Hz, 3H), 2.06-2.00 (m, 2H), 2.03 (d, J = 0.8 Hz, 3H), 1.72 
(d, J = 0.8 Hz, 3H), 1.65-1.58 (m, 2H), 1.48-1.45 (m, 2H), 1.03 (s, 6H). 
 
13
C NMR (125 MHz, CDCl3) 
 191.1, 154.8, 141.3, 137.6, 137.0, 134.5, 132.5, 130.5, 129.7, 129.4, 129.0, 39.6, 34.3, 
33.1, 29.0, 21.8, 19.2, 13.1, 13.0.  
 
HRMS (FAB) 
 Calculated for C20H28O (M+H)
+
:         285.2218 
 Found:                                                 285.2219       
 
IR (thin film, cm
-1
) 
2961, 2929, 1865, 2253, 1655, 1573, 1456, 1386, 1334, 1216, 1164, 1135, 968, 908, 734. 
 
 
1
H NMR data for natural
43
 and synthetic all-trans-retinal: H/ppm (integration) 
 
Natural 2.23 
(220 MHz, CDCl3) 
Synthetic 2.23 
(400 MHz, CDCl3) 
10.12 (1H) 10.10 (1H) 
7.15 (1H) 7.14 (1H) 
6.37 (1H) 6.37 (1H) 
6.36 (1H) 6.33 (1H) 
6.20 (1H) 6.18 (1H) 
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6.18 (1H) 6.16 (1H) 
5.98 (1H) 5.97 (1H) 
2.33 (3H) 2.32 (3H) 
2.03 (3H) 2.03 (3H) 
1.72 (3H) 1.72 (3H) 
1.04 (6H) 1.03 (6H) 
 
13
C NMR data for natural
44
 and synthetic all-trans-retinal: C/ppm 
 
Natural 2.23 
(22.63 MHz, CDCl3) 
Synthetic 2.23 
(100 MHz, CDCl3) 
190.7 191.1 
154.5 154.8 
141.1 141.3 
137.6 137.6 
137.1 137.0 
134.5 134.5 
132.4 132.5 
130.3 130.5 
129.6 129.7 
129.4 129.4 
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128.9 129.0 
39.6 39.6 
34.1 34.3 
33.2 33.1 
29.0 29.0 
21.7 21.8 
19.3 19.2 
13.0 13.1 
13.0 13.0 
 
 
 
(E)-1-Butenylboronic acid (2.24) 
In an unoptimized procedure, a 150 mL bomb flask equipped with a stir bar was charged with 
BH3SMe2 (1.8 mL, 19.4 mmol, 1 eq) and THF (11 mL).  The solution was cooled to 0 ˚C and 
(+)--pinene (6.3 mL, 39.7 mmol, 2 eq) was added dropwise. The solution was stirred at 0 ˚C for 
10 minutes then allowed to warm to 23 ˚C and stirred at 23 ˚C for 2 hours, during which time a 
white precipitate formed.  The solution was then recooled to 0 ˚C and an excess of 1-butyne 
(2.44) was condensed into the reaction via a balloon resulting in a clear, colorless solution.  The 
flask was then sealed with a Teflon screw cap and was stirred at 0 ˚C for 30 minutes, warmed to 
23 ˚C, and stirred at 23 ˚C for 1.5 hours.  The solution was recooled to 0 ˚C and acetaldehyde 
(10.4 mL, 185 mmol, 9.5 eq) was added. The bomb flask was resealed with the Teflon screw cap 
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and the reaction was stirred at 40 ˚C for 14 hours.  The reaction was allowed to cool to 23 ˚C and 
water (5 mL) was added. After stirring for 3 hours at 23 ˚C, the solution was diluted with EtOAc 
(50 mL), dried over MgSO4, and concentrated in vacuo.  The resulting residue was taken up in 
hexanes (50 mL) and the resulting mixture was extracted with 10% aqueous NaOH (2 x 10 mL). 
The combined aqueous extractions were washed with hexanes (2 x 20 mL) and then acidified to 
pH 2-3 with conc. HCl.  The acidified aqueous layer was then extracted with EtOAc (3 x 30 
mL), and the combined organic extracts were washed with saturated aqueous NaHCO3 (50 mL), 
dried over MgSO4, and concentrated in vacuo to yield the title compound 2.24 as a colorless 
solid (0.928 g, 9.3 mmol, 48%). 
 
 
TLC (EtOAc) 
 Rf = 0.68, visualized with KMnO4. 
 
1
H NMR (500 MHz, DMSO-d6 : D2O 95:5) 
 6.49 (td, J = 6.5, 17.5 Hz, 1H), 5.32 (d, J = 18 Hz, 1H), 2.08 (ddq, J = 1.5, 7.0, 7.0 Hz, 
2H), 0.96 (t, J = 7.5 Hz, 3H). 
 
13
C NMR (100 MHz, DMSO-d6 : D2O 95:5) 
 151.5, 27.7, 12.5. 
 
11
B NMR (300 MHz, DMSO-d6 : D2O 95:5) 
 28.8. 
 
HRMS (EI+) 
 Calculated for C4H9O2B (M)
+
:         100.0696 
 Found:                                               100.0696     
 
IR (thin film, cm
-1
) 
 3235, 2970, 1633, 1633, 1356, 1233, 1154, 994. 
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Trienyl MIDA Boronate 2.26 
A solution of the palladium catalyst was prepared as follows: To a 4 mL vial equipped with a stir 
bar and containing 2-dicyclohexylphosphino-2’,4’,6’-tri-i-propyl-1,1’-biphenyl (2.25) (17.3 mg, 
0.036 mmol, 2 eq) was added a solution of Pd(OAc)2 in THF (0.0109 M, 1.664 mL, 0.018 mmol, 
1 eq). The vial was sealed with a PTFE-lined cap and stirred at 23 ˚C for 30 minutes. 
 
This catalyst solution was then utilized in the following procedure: To a 7 mL vial equipped with 
a stir bar and containing (E)-1-butenylboronic acid (2.24) (113 mg, 1.13 mmol, 2 eq) was added 
2.2 (138 mg, 0.521 mmol, 1 eq), anhydrous K3PO4 as a finely ground powder (301 mg, 1.42 
mmol, 2.5 eq), and the catalyst stock solution described above (0.780 mL, 0.0085 mmol Pd, 1.5 
mol% Pd). The resulting mixture was sealed with a PTFE-lined cap and stirred at 45 ˚C for 23 
hours. The mixture was then filtered through a pad of silica gel with copious amounts of 
acetonitrile. To the resulting solution was added Florisil gel and then the solvent was removed in 
vacuo.  The resulting powder was dry-loaded on top of a silica gel column and eluted with Et2O 
 20% MeCN/Et2O to yield the desired product as a yellow powder (120 mg, 0.456 mmol, 
88%). 
 
TLC (EtOAc) 
 Rf = 0.35, visualized by UV. 
 
 
 
54 
 
1
H NMR (500 MHz, acetone-d6) 
 6.56 (dd, J = 10.0, 17.5 Hz, 1H), 6.26 (dd, J = 10.5, 15.0 Hz, 1H), 6.19 (dd, J = 10.0, 
15.0 Hz, 1H), 6.10 (tdd, J = 1.5, 10.0, 15.0 Hz, 1H), 5.80 (td, J = 6.5, 15.0 Hz, 1H), 5.63 
(d, J = 17.0 Hz, 1H), 4.19 (d, J = 17.0 Hz, 2H), 4.02 (d, J = 17.0 Hz, 2H), 2.98 (s, 3H), 
2.11 (dq, J = 7.5, 7.5 Hz, 2H), 0.98 (t, J = 7.5 Hz, 3H). 
 
13
C NMR (125 MHz, acetone-d6) 
 168.0, 143.5, 138.3, 134.8, 133.6, 130.4, 62.3, 47.3, 26.4, 13.8. 
 
11
B NMR (300 MHz, acetone-d6) 
  11.6. 
 
HRMS (EI+) 
 Calculated for C13H18O4NB (M)
+
:        263.1329 
 Found:                                                   263.1331 
 
IR (thin film, cm
-1
) 
 3017, 1768, 1216, 1026, 1010, 756, 668. 
 
 
Vinyl iodide 2.31 
In an unoptimized procedure, to a suspension of CrCl2 (454 mg, 3.75 mmol, 7 eq) in THF (1.5 
mL) at 23 ˚C was added dropwise a solution of (E)-methyl 10-iododec-9-enoate (2.30)40 (100 
mg, 0.537 mmol, 1 eq) and iodoform (422 mg, 1.07 mmol, 2 eq) in dioxane (9.2 mL). After 
stirring for 12 hours, the reaction mixture was diluted with Et2O (10 mL) and poured into water 
(10 mL). The layers were separated and the aqueous layer was extracted with Et2O (3 x 15 mL). 
The combined organic extracts were washed with brine (10 mL), dried over MgSO4, and 
concentrated in vacuo. Purification of the crude product by silica gel chromatography (hexanes 
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 10% EtOAc/hexanes) provided the title compound as a yellow oil (105 mg, 0.337 mmol, 
63%). 
1
H NMR indicated an E:Z ratio of 10:1. 
 
 
 
TLC (hexanes:EtOAc 4:1) 
 Rf = 0.45, visualized with KMnO4. 
 
1
H NMR (400 MHz, CDCl3) 
 6.49 (td, J = 7.2, 14.4 Hz, 1H), 5.96 (td, J = 1.6, 14 Hz, 1H), 3.66 (s, 3H), 2.29 (t, J = 
7.6 Hz, 2H), 2.03 (dq, J = 1.2, 6.8 Hz, 2H), 1.64-1.56 (m, 2H), 1.42-1.33 (m, 2H), 1.33-
1.24 (m, 6H). 
 
13
C NMR (100 MHz, CDCl3) 
 174.2, 146.6, 74.4, 51.5, 36.0, 34.0, 29.0, 28.9, 28.7, 28.2, 24.8. 
 
HRMS (CI+) 
 Calculated for C11H19O2I (M+H)
+
:         311.0508 
 Found:            311.0508                                            
 
IR (thin film, cm
-1
) 
2927, 2855, 1738, 1435, 1197, 1172, 946. 
 
 
 
Carboxylic Acid 2.27 
To a solution vinyl iodide 2.31 (51 mg, 0.164 mmol, 1 eq) in THF:H2O 3:1 (3.3 mL) was added 
LiOH (69 mg, 1.64 mmol, 10 eq). The reaction was stirred at 50 ˚C for 4 hours before diluting 
with Et2O (5 mL) and pouring into 1M aqueous HCl (5 mL). The layers were separated and the 
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aqueous layer was extracted with Et2O (3 x 5 mL).  The combined organic layers were washed 
with brine (5 mL), dried over Na2SO4, and concentrated in vacuo.  Purification of the crude 
product by silica gel chromatography (15% EtOAc/hexanes  EtOAc) provided the title 
compound as a pale yellow solid (44 mg, 0.149 mmol, 91%). 
1
H NMR indicated an E:Z ratio of 
10:1 
 
 
 
 
TLC (hexanes:EtOAc 4:1) 
 Rf = 0.14, visualized with KMnO4. 
 
1
H NMR (400 MHz, CDCl3) 
 11.32 (br s, 1H), 6.50 (td, J = 7.2, 14.4 Hz, 1H), 5.97 (td, J = 1.6, 14.4 Hz, 1H), 2.35 (t, 
J = 7.6 Hz, 2H), 2.04 (dq, J = 1.2, 7.2 Hz, 2H), 1.66-1.59 (m, 2H), 1.41-1.25 (m, 8H). 
 
13
C NMR (100 MHz, CDCl3) 
 180.0, 146.6, 74.4, 36.0, 34.0, 29.0, 28.9, 28.7, 28.2, 24.6. 
 
HRMS (CI+) 
 Calculated for C10H17O2I (M+H)
+
:        297.0352 
 Found:                                                    297.0351 
 
IR (thin film, cm
-1
) 
3300-2500 (br), 2928, 2851, 1694, 1464, 1407, 1282, 1185, 936. 
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-parinaric acid (2.28) 
MIDA boronate 2.26 was converted to boronic acid 2.45 via the following procedure: To a 
stirred solution of 2.26 (24.7 mg, 0.094 mmol, 1 eq) in THF (1.34 mL) at 23 ˚C was added 1 M 
aqueous NaOH (0.28 mL, 0.28 mmol, 3 eq) and the resulting mixture was stirred at 23 ˚C for 15 
minutes. The reaction was then quenched with the addition of 0.5 M pH 7 phosphate buffer (1.5 
mL) and diluted with Et2O (1.5 mL). The layers were separated and the aqueous layer was 
extracted with THF:Et2O 1:1 (3 x 3 mL).  The combined organic layers were dried over MgSO4 
and concentrated in vacuo until a small amount of THF (3.7 mL) remained, yielding a solution of 
2.45; TLC (EtOAc): Rf = 0.63, visualized with KMnO4.  
 
A solution of the palladium catalyst was prepared as follows: To a 4 mL vial equipped with a stir 
bar and containing 2-dicyclohexylphosphino-2’,4’,6’-tri-iso-propyl-1,1’-biphenyl ligand (2.25) 
(2.1 mg, 0.0044 mmol, 2 eq) was added a solution of Pd(OAc)2 in THF (0.004 M, 0.545 mL, 
0.0022 mmol, 1 eq). The vial was sealed with a PTFE-lined cap and stirred at 23 ˚C for 30 
minutes.   
 
This catalyst solution was then utilized in the following procedure: To a 20-mL I-Chem vial 
equipped with a stir bar and containing 2.27 (18.5 mg, 0.062 mmol, 1 eq; E:Z 7:1 by 
1
H NMR) 
was added boronic acid 2.45 (3.7 mL, estimated 0.094 mmol, 1.5 eq) and the catalyst stock 
solution described above (0.31 mL, 0.0013 mmol Pd, 2 mol% Pd).  The resulting mixture was 
sealed with a teflon-lined septum cap and 1 M NaOH (0.19 mL, 0.190 mmol, 3 eq) was added.  
The reaction was stirred at 23 ˚C for 40 minutes and was then quenched with the addition of 
saturated aqueous NH4Cl (3 mL). The layers were separated and the aqueous layer was extracted 
with Et2O (3 x 5 mL).  The combined organic extracts were dried over Na2SO4 and concentrated 
in vacuo.  The resulting crude product was purified by silica gel chromatography (20% 
Et2O/hexanes  Et2O) to yield -parinaric acid as a fluorescent solid (14.8 mg, 0.054 mmol, 
86%).  
1
H NMR indicated a 7:1 mixture of -parinaric acid:9-(Z) parinaric acid (arising from E:Z 
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7:1 mixture of 2.27). 
1
H NMR and 
13
C NMR analysis of synthetic 2.28 were fully consistent with 
the data previously reported for -parinaric acid.46,47  
 
 
TLC (50% Et2O/hexanes) 
 Rf = 0.26, visualized by UV. 
 
1
H NMR (500 MHz, CDCl3) 
  10.96 (br s, 1H), 6.22-6.00 (m, 6H), 5.73 (td, J = 7.0 Hz, 15.0 Hz, 1H), 5.68 (td, J = 
7.0, 15.0 Hz, 1H), 2.34 (t, J = 7.5 Hz, 2H), 2.11-2.06 (m, 4H), 1.64-1.61 (m, 2H), 1.43-
1.25 (m, 8H), 1.01 (t, J = 7.5 Hz, 3H). 
 
13
C NMR (125 MHz, CDCl3) 
 179.4, 136.6, 135.0, 132.5, 132.4, 130.9, 130.8, 130.6, 129.6, 33.9, 32.8, 29.2, 29.1, 
29.0, 28.9, 25.9, 24.6, 13.5. 
 
HRMS (ESI+) 
 Calculated for C18H28O2 (M + Na)
+
:      299.1987   
 Found:                                                 299.1990         
 
IR (thin film, cm
-1
) 
 3428, 3020, 2930, 1641, 1215, 761, 669. 
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1
H NMR data for -parinaric acid: H/ppm (integration) 
Previously reported 2.28
46 
(300 MHz, CDCl3) 
Synthetic 2.28 
(500 MHz, CDCl3) 
6.08 (6H) 6.22-6.00 (6H) 
5.75 (2H) 5.73 (1H), 5.68 (1H) 
2.32 (2H) 2.34 (2H) 
2.11 (2H) 2.11 (2H) 
2.10 (2H) 2.13-2.06 (2H) 
1.60 (2H) 1.64-1.61 (2H) 
1.29 (8H) 1.43-1.25 (8H) 
1.08 (3H) 1.01 (3H) 
 
13
C NMR data for -parinaric acid: C/ppm 
Previously reported 2.28
46
 
(125 MHz, CDCl3) 
Synthetic 2.28 
(125 MHz, CDCl3) 
179.0 179.4 
137.0 136.6 
135.4 135.0 
132.9 132.5 
132.8 132.4 
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131.3 130.9 
131.3 130.8 
131.1 130.6 
130.0 129.6 
34.2 33.9 
33.2 32.8 
29.6 29.2 
29.5 29.1 
29.4 29.0 
29.4 28.9 
26.3 25.9 
25.1 24.6 
13.9 13.5 
 
 
Acetate 2.34 
A 200 mL recovery flask was charged with diol 2.32
31
 (1.18 g, 4.69 mmol, 1 eq), Lipase PS (295 
mg, 0.25 mass eq), and hexanes (115 mL) and the resulting slurry was stirred at 50 °C for 15 
minutes. Vinyl acetate (4.33 mL, 47.0 mmol, 10 eq) was then added and the reaction was stirred 
at 50 °C for 40 hours. The resulting mixture was cooled to 23 °C and filtered, and the residual 
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enzyme was washed copiously with Et2O. The filtrate was then concentrated in vacuo and the 
resulting viscous, light yellow oil was purified by flash column chromatography (5%  50% 
EtOAc/hexanes) to yield acetate 2.34 as a pale yellow oil (1.05 g, 3.57 mmol, 76%). 
 
TLC (50% EtOAc/hexanes) 
 Rf = 0.60, visualized with anisaldehyde. 
 
1
H NMR (400 MHz, CDCl3) 
δ 7.37-7.29 (m, 5H), 5.32 (dq, J = 4.0, 6.4 Hz,1H), 4.54 (d, J = 12.0 Hz, 1H), 4.49 (d, J = 
12.0 Hz, 1H), 3.61-3.53 (m, 3H), 2.66 (d, J = 3.2 Hz, 1H), 2.03 (s, 3H), 1.97-1.91 (m, 
1H), 1.91-1.84 (m, 1H), 1.16 (d, J = 6.4 Hz, 3H), 0.95 (d, J = 6.8 Hz, 3H), 0.81 (d, J = 
6.8 Hz, 3H).    
 
13
C NMR (100 MHz, CDCl3) 
 170.4, 138.0, 128.4, 127.7, 127.6, 75.5, 74.9, 73.4, 71.4, 39.6, 34.7, 21.5, 13.8, 10.0, 9.1. 
 
HRMS (CI+) 
 Calculated for C17H26O4 (M+H)
+
:   295.1909 
 Found:       295.1905 
 
IR (thin film, cm
-1
) 
 3497, 2970, 2925, 2873, 1731, 1714, 1453, 1371, 1244, 1101, 1053, 1020, 737, 698. 
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Triethylsilyl Ether 2.35 
To acetate 2.34 (5.98 g, 20.31 mmol, 1.0 eq) in CH2Cl2 (230 mL) at 0 ˚C was added 2,6-lutidine 
(7.84 mL, 67.35 mmol, 3.3 eq) and the resulting solution was cooled to –78 oC.  TESOTf (7.11 
mL, 31.43 mmol, 1.5 eq) was then added dropwise and the resulting solution was stirred at –78 
˚C for 1 hour. The reaction was then quenched with the addition of saturated aqueous NaHCO3 
(115 mL) and allowed to warm to 23 ˚C.  The layers were separated and the aqueous layer was 
extracted with Et2O (3 x 200 mL). The combined organic extracts were dried over MgSO4 and 
concentrated in vacuo to give a yellow oil. Purification by flash column chromatography (12% 
 50% EtOAc/hexanes) provided triethylsilyl ether 2.35 as a yellow oil (7.34g, 17.96 mmol, 
88%). 
 
 
TLC (25% EtOAc/hexanes) 
 Rf = 0.67, visualized with anisaldehyde. 
 
1
H NMR (500 MHz, CDCl3) 
δ 7.35-7.26 (m, 5H), 5.00 (dq, J = 6.5, 6.5 Hz, 1H), 4.49 (d, J = 11.5 Hz, 1H), 4.43 (d, J = 
11.5 Hz, 1H), 3.85 (dd, J = 2.5, 7.0 Hz, 1H), 3.35 (app t, J = 8.5 Hz, 1H), 3.22 (dd, J = 
6.0, 9.0 Hz, 1H), 1.96-1.86 (m, 2H), 1.91 (s, 3H), 1.14 (d, J = 6.5 Hz, 3H), 0.95 (t, J = 8.5 
Hz, 9H), 0.87 (d, J = 7.0 Hz, 3H), 0.84 (d, J = 6.5 Hz, 3H), 0.60 (m, 6H).  
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13
C NMR (125 MHz, CDCl3) 
δ 170.4, 138.6, 128.3, 127.7, 127.4, 73.7, 72.9, 72.2, 71.7, 42.6, 35.5, 21.3, 16.1, 11.2, 
11.0, 7.0, 5.4. 
 
HRMS (ESI+) 
 Calculated for C23H40O4Si (M)
+
:   408.2696 
 Found:       408.2690 
 
IR (thin film, cm
-1
) 
 2953, 2875, 1734, 1453, 1369, 1243, 1093, 1046, 1005, 736, 696, 654. 
 
 
Primary Alcohol 2.46 
Caution: palladium black is pyrophoric and should be maintained under inert atmosphere at all 
times. 
To a 25 mL three-neck round-bottomed flask equipped with a stir bar was added palladium black 
(17.3 mg, 0.163 mmol, 0.6 eq). To this flask was then added via cannula a solution of benzyl 
ether 2.35 (111.0 mg, 0.271 mmol, 1 eq) in EtOH:EtOAc 2:1 (4.65mL). The reaction flask was 
purged with H2 (balloon) and stirred at 23 ˚C for 25 hours under a positive pressure of H2 
(balloon). The resulting mixture was then filtered under N2 pressure through a short column of 
Celite, flushing with copious amounts of EtOH.  Purification by silica gel chromatography (7% 
 20% EtOAc/hexanes) yielded primary alcohol 2.46 as a pale yellow oil (79.1mg, 0.248 mmol, 
91%). 
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TLC (50% EtOAc/hexanes) 
 Rf = 0.56, stained by anisaldehyde. 
 
1
H NMR (500 MHz, CDCl3) 
δ 5.01 (dq, J = 6.0, 6.0 Hz, 1H), 3.85 (dd, J = 2.0, 6.0 Hz, 1H), 3.47 (m, 2H), 2.01 (s, 
3H), 1.93 (m, 1H), 1.79 (m, 1H), 1.16 (d, J = 6.5 Hz, 3H), 0.97 (t, J = 8.0 Hz, 9H), 0.89 
(d, J = 7.5 Hz, 3H), 0.84 (d, J = 7.0 Hz, 3H), 0.62 (q, J = 8.0 Hz, 6H).  
 
13
C NMR (125 MHz, CDCl3) 
δ 170.7, 72.4, 71.7, 66.2, 42.8, 38.0, 21.4, 16.5, 11.2, 11.2, 7.0, 5.3. 
 
HRMS (ESI+) 
 Calculated for C16H34O4Si (M)
+
:   318.2226 
 Found:       318.2230 
 
IR (thin film, cm
-1
) 
 3457, 2954, 2873, 1731, 1714, 1371, 1245, 1044. 
 
 
 
Aldehyde 2.36 
To a stirred solution of oxalyl chloride (3.44 mL, 40.1 mmol, 5 eq) in CH2Cl2 (20 mL) at –78 ˚C 
was added dropwise DMSO (5.70 mL, 80.23 mmol, 10 eq) and the resulting solution was stirred 
at –78 ˚C for 30 minutes. To the reaction was then added via cannula a solution of alcohol 2.46 
(2.56 g, 8.02 mmol, 1 eq) in CH2Cl2 (55.7 mL) and the resulting solution was stirred at –78 ˚C 
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for 1.5 hours. Triethylamine (28 mL, 201 mmol, 25 eq) was then added and the resulting mixture 
was allowed to warm to –15 ˚C over 40 minutes.  The reaction was then quenched with the 
addition of saturated aqueous NH4Cl (50 mL). The layers were separated and the aqueous phase 
was extracted with CH2Cl2 (3 x 50 mL). The combined organic layers were washed with brine 
(50 mL), dried over MgSO4, and concentrated in vacuo to yield aldehyde 2.36 as a yellow oil 
(2.36g, 7.46 mmol, 93%). 
 
 
 
TLC (50% EtOAc/hexanes) 
 Rf = 0.76, stained by anisaldehyde. 
 
1
H NMR (400 MHz, CDCl3) 
δ 9.67 (d, J = 0.8 Hz, 1H), 4.99 (dq, J = 6.4, 6.4 Hz, 1H), 4.21 (dd, J = 2.8, 6.0 Hz, 1H), 
2.44 (ddq, J = 0.8, 3.2, 7.2 Hz, 1H), 2.03 (s, 3H), 1.95 (m, 1H), 1.18 (d, J = 6.4 Hz, 3H), 
1.14 (d, J = 7.2 Hz, 3H), 0.94 (t, J = 8.0 Hz, 9H), 0.90 (d, J = 6.8 Hz, 3H), 0.58 (q, J = 
7.6 Hz, 6H). 
 
13
C NMR (125 MHz, CDCl3) 
δ 204.7, 170.3, 71.2, 71.2, 49.4, 42.7, 21.3, 16.3, 11.2, 8.3, 6.9, 5.2. 
 
HRMS (ESI+) 
 Calculated for C16H32O4Si (M+Na)
+
:   339.1968 
 Found:       339.1972 
 
IR (thin film, cm
-1
) 
 2953, 2877, 1731, 1708, 1458, 1372, 1241, 1049, 1010, 946, 740. 
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Pinacolboronic Ester 2.47 
To a stirred slurry of CrCl2 (0.204 g, 1.66 mmol, 18 eq) in THF (2 mL) at 23 ˚C was added a 
solution of aldehyde 2.36 (29.2 mg, 0.0923 mmol, 1 eq) and dichlomethylpinacol boronic ester 
2.37
41
 (0.117 g, 0.554 mmol, 6 eq) in THF (0.18 mL).  A solution of LiI (0.149 g, 1.11 mmol, 12 
eq) in THF (0.3 mL) was then added and the resulting slurry was stirred at 23 
o
C for 7 hours. The 
reaction was then poured into ice water (2 mL) and extracted with Et2O (2 x 5 mL). The 
combined organic extracts were dried over MgSO4, filtered through Celite, and concentrated in 
vacuo. The crude material was purified by Florisil column chromatography (2%  25% 
EtOAc/hexanes) providing pinacolboronic ester 2.47 as a pale yellow oil (25.7 mg, 0. 58 mmol, 
63%).  
 
 
TLC (50% EtOAc/hexanes) 
 Rf = 0.87, visualized with anisaldehyde. 
 
1
H-NMR (400 MHz, CDCl3) 
δ 6.58 (dd, J = 6.8, 18.0 Hz, 1H), 5.43 (dd, J = 1.2, 18.0 Hz, 1H), 5.04 (dq, J = 6.4, 6.4 
Hz, 1H), 3.57 (dd, J = 4.8, 6.6 Hz, 1H), 2.45-2.36 (m, 1H), 2.01 (s, 3H), 1.91 (m, 1H), 
1.26 (s, 12H), 1.12 (d, J = 6.4 Hz, 3H), 0.98 (d, J = 7.2 Hz, 3H), 0.95 (t, J = 7.6 Hz, 9H), 
0.87 (d, J = 7.2 Hz, 3H), 0.60 (q, J = 8.0 Hz, 6H). 
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13
C-NMR (100 MHz, CDCl3) 
δ 177.2, 158.2, 83.0, 71.5, 42.3, 42.0, 24.8, 24.7, 21.5, 15.7, 13.4, 11.2, 7.1, 5.4. 
 
HRMS (CI+) 
 Calculated for C23H45BO5Si (M+H)
+
:  441.3208 
 Found:       441.3210 
 
IR (thin film, cm
-1
) 
 2974, 2873, 1736, 1636, 1458, 1359, 1322, 1241, 1145, 1004, 970, 848, 731. 
 
 
 
Dienyl Chloride 2.38 
A 15 mL round-bottomed flask fitted with a stir bar was charged with pinacolboronic ester 2.47 
(126.9 mg, 0.288 mmol, 1.5 eq).  To this flask was then added a solution of (E)-1-iodo-2-
chloroethylene (2.19)
36
 (36.2 mg, 0.192 mmol, 1 eq) and Pd(PPh3)4 (16.6 mg, 0.0144 mmol, 5 
mol%) as a solution in THF (4.5 mL) followed by 3M aqueous NaOH (0.192 mL, 0.576 mmol, 2 
eq).  The resulting mixture was stirred at 23 ˚C for 17 hours and then the reaction was quenched 
with saturated aqueous NH4Cl (5 mL).  The resulting mixture was diluted with diethyl ether (5 
mL) and the layers were separated. The aqueous layer was extracted with diethyl ether (3 x 5 
mL) and the combined organic layers were dried over MgSO4 and concentrated in vacuo. 
Purification of the resulting residue by silica gel chromatography (2%  15% EtOAc/hexanes/ 
1% Et3N) provided dienyl chloride 2.38 as a yellow oil (51.0 mg, 0.136 mmol, 71%). 
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TLC (10% EtOAc/hexanes) 
 Rf = 0.34, visualized with KMnO4. 
 
1
H-NMR (500 MHz, CDCl3) 
δ 6.41 (dd, J = 11.5, 13.0 Hz, 1H), 6.11 (d, J = 13.0 Hz, 1H), 5.96 (dd, J = 11, 15.5 Hz, 
1H), 5.65 (dd, J = 8.0, 15.5 Hz, 1H), 5.05 (dq, J = 6.5, 6.5 Hz, 1H), 3.50 (app t, J = 5.5 
Hz, 1H), 2.37 (m, 1H), 2.01 (s, 3H), 1.88 (m, 1H), 1.13 (d, J = 6.0 Hz, 3H), 0.99 (d, J = 
7.0 Hz, 3H), 0.96 (t, J = 8.0 Hz, 9H), 0.89 (d, J = 7.0 Hz, 3H), 0.60 (q, J = 7.5 Hz, 6H). 
 
13
C-NMR (125 MHz, CDCl3) 
δ 170.2, 139.2, 133.7, 125.6, 119.0, 71.6, 71.4, 42.2, 40.3, 21.4, 16.4, 15.5, 11.2, 7.0, 5.4. 
 
HRMS (CI+) 
 Calculated for C19H35ClO3Si (M+H)
+
:  375.2122 
 Found:       375.2122 
 
IR (thin film, cm
-1
) 
 2960, 2873, 1735, 1241, 1015, 800, 655. 
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Dienyl MIDA Boronate 2.40 
A solution of the catalyst was prepared as follows: An oven-dried Wheaton vial equipped with a 
magnetic stir bar was charged with Pd(OAc)2 (5.6 mg,  0.025 mmol,  1 eq) and 2-
dicyclohexylphosphino-2’,6’-dimethoxy-1,1’-biphenyl 2.7 (20.5 mg, 0.050 mmol,  2 eq) in a 
glovebox. Toluene (3.0 mL) was added and the vial was sealed with a PTFE-lined plastic cap. 
The resulting mixture was stirred at 23 ˚C for 45 minutes resulting in a yellow Pd/2.7 catalyst 
solution (0.00833 M Pd in toluene). 
 
This catalyst solution was then utilized in the following procedure: An oven-dried Wheaton vial 
equipped with a magnetic stir bar was charged with 2.1 (0.262 g, 1.00 mmol, 1eq) and (E)-1-
pentenylboronic acid (2.39) (0.171 g, 1.50 mmol, 1.5 eq) and sealed with PTFE-lined plastic cap. 
The vial was evacuated and refilled with argon three times and then moved into a glovebox. KF 
(0.116 g, 2.00 mmol, 2 eq), toluene (7.0 mL) and catalyst solution (1.20 mL, 0.01 mmol, 1 mol% 
Pd) were then added and vial was sealed with PTFE-lined plastic cap. The sealed vial was 
removed from the glovebox and stirred at 23 ˚C for 36 hours. The resulting heterogeneous light 
yellow mixture was diluted with acetonitrile (10 mL) and filtered through a short pad of Celite. 
The filtrate was concentrated under reduced pressure. The crude product was then purified by 
column chromatography on silica gel (50% EtOAc/petroleum ether1  EtOAc  10% 
MeCN/EtOAc) to give the title compound 2.40 as a colorless crystalline solid (0.241 g, 0.959 
mmol, 96 %). 
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TLC (EtOAc) 
       Rf = 0.46, visualized by UV lamp (λ = 254) or with KMnO4. 
 
1
H NMR (500 MHz, CDCl3) 
δ 6.53 (dd, J = 17.5, 10.0 Hz, 1H), 6.06 (dd, J = 15.0, 10.5 Hz, 1H), 5.74 (dt, J = 15.0, 7.0 
Hz, 1H), 5.40 (d, J = 17.5 Hz, 1H), 4.06 (d, J = 17.0 Hz, 2H), 3.70 (d, J = 17.0 Hz, 2H), 
2.79 (s, 3H), 2.02 (q, J = 7.0 Hz, 2H), 1.37 (sept, J = 7.5 Hz, 2H), 0.86 (t, J = 7.5 Hz, 
3H). 
 
13
C NMR (125 MHz, CDCl3) 
       δ 168.9, 144.4, 137.3, 132.2, 61.4, 47.0, 34.6, 22.2, 13.7. 
 
HRMS (ESI) 
       Calculated for C12H18BNO4 (M+H):   252.1407 
       Found:      252.1404 
 
11
B NMR (100 MHz, CD3CN) 
       δ 10.8. 
 
IR (thin film, cm
-1
) 
2957.9, 1762.2, 1646.6, 1603.6, 1458.0, 1337.3, 1297.0, 1195.9, 1153.1, 1119.8, 1084.0, 
1004.7, 954.2, 868.3, 720.0. 
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Pentaenyl MIDA Boronate 2.41 
MIDA boronate 2.40 was converted to a boronic acid via the following procedure: To a stirred 
mixture of 2.40 (25.6 mg, 0.102 mmol, 1 eq) in THF (1.0 mL) at 23 °C was added 1M aqueous 
NaOH (0.306 mL, 0.306 mmol, 3 eq) via syringe. The reaction mixture was stirred at 23 °C for 
15 minutes. The resulting mixture was treated with 1.0 M pH 7 phosphate buffer solution (0.5 
mL) and diluted with Et2O (1 mL). The organic layer was separated and aqueous layer was 
extracted with THF:Et2O 1:1 (3 × 1.5 mL). The combined organic layers were dried over 
anhydrous magnesium sulfate. After filtration, the resulting colorless solution was concentrated 
to ~ 0.5 mL volume of THF in vacuo. THF (5.0 mL) was added and concentrated again to ~ 0.25 
mL volume of THF in vacuo. The isolated yield of the boronic acid was assumed to be 90% 
based on 2.40, and a 0.184 M solution of boronic acid in THF (0.0918 mmol/0.50 mL of THF) 
was prepared using a 1.0 mL (v/v) volumetric vial. This solution was immediately used in the 
next reaction without further purification. TLC (EtOAc) Rf = 0.88, visualized by UV lamp (λ = 
254 nm) or with KMnO4. 
 
A solution of the catalyst was prepared as follows: A 20 mL Wheaton vial equipped with a 
magnetic stir bar was charged with Pd(OAc)2 (5.60 mg, 0.025 mmol, 1 eq) and 2-
dicyclohexylphosphino-2’.4’,6’-triiso- propyl-1,1’-biphenyl (2.25) (24.5 mg, 0.050 mmol, 2 eq). 
Toluene (3.0 mL) was added and the vial was sealed with a PTFE-lined plastic cap. The resulting 
mixture was stirred at 23 °C for 1 hour to yield a reddish Pd/2.25 catalyst solution (0.00833 M 
Pd in toluene).  
This catalyst solution was then utilized in the following procedure: A 10 mL Wheaton vial 
equipped with a magnetic stir bar was charged with 2.3 (16.5 mg, 0.0612 mmol, 1 eq), Cs2CO3 
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(40.0 mg, 0.1224 mmol, 2 eq), the 0.184 N boronic acid in THF solution (0.0918 mmol, 0.50 
mL), and the catalyst solution (0.110 mL, 1.5 mol% Pd). Toluene (1.64 mL) was then added and 
the vial was sealed with a PTFE-lined plastic cap and stirred for 18 hours at 45 °C. The resulting 
deep orange mixture was diluted with EtOAc (5 mL) and filtered through a short pad of 
Florisil®. The filtrate was concentrated in vacuo to provide an orange solid. The crude product 
was purified by flash chromatography on Florisil® (50% EtOAc/petroleum ether → EtOAc → 
10% MeCN/EtOAc) to give the title compound 2.41 as a light yellow solid (8.40 mg, 0.0255 
mmol, 42%). 
 
 
TLC (EtOAc) 
      Rf = 0.48, visualized by UV lamp (λ = 365 nm) or with KMnO4. 
 
1
H NMR (400 MHz, CD3CN) 
δ 6.60 (dd, J = 17.2, 9.6 Hz, 1H), 6.39-6.17 (m, 6H), 6.12 (ddt, J = 15.2, 10.4, 1.6 Hz, 
1H), 5.77 (dt, J = 15.2, 7.2 Hz, 1H), 5.63 (d, J = 17.2 Hz, 1H), 3.93 (d, J = 16.8 Hz, 2H), 
3.77 (d, J = 16.8 Hz, 2H), 2.74 (s, 3H), 2.07 (app q, J = 7.2 Hz, 2H), 1.40 (app sext, J = 
7.2 Hz, 2H), 0.88 (t, J = 7.2 Hz, 3H). 
 
13
C NMR (100 MHz, CD3CN) 
δ 169.4, 143.9, 137.0, 135.3, 135.2, 135.0, 133.0, 131.6, 62.3, 47.6, 35.6, 23.1, 13.9. 
 
11
B NMR (100 MHz, CD3CN) 
δ 10.4. 
 
HRMS (ESI) 
Calculated for C18H24BNO4 (M+H)
+
:   330.1877 
Found:       330.1886 
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IR (thin film, cm
-1
) 
2926, 2359, 1763, 1678, 1463, 1294, 1008, 668. 
 
 
1/2 of the Amphotericin B Macrolide (2.42) 
A solution of the catalyst was prepared as follows: An oven-dried Wheaton vial equipped with a 
magnetic stir bar was charged with Pd(OAc)2 (5.6 mg, 0.025 mmol, 1 eq) and 2-
dicyclohexylphosphino- 2’.4’,6’-tri-iso-propyl-1,1’-biphenyl (2.25) (24.5 mg, 0.050 mmol, 2 eq). 
Toluene (3.0 mL) was added and the vial was sealed with a PTFE-lined plastic cap. The resulting 
mixture was stirred at 23 °C for 1 hour to yield a reddish Pd/2.25 catalyst solution (0.00833 M 
Pd in toluene).  
 
This catalyst solution was then utilized in the following procedure: An oven-dried Wheaton vial 
equipped with a magnetic stir bar was charged with 2.38 (7.0 mg, 0.0187 mmol, 1 eq), 2.41 (14.0 
mg, 0.0421 mmol, 2.25 eq), the catalyst solution (0.034 mL, 1.5 mol% Pd), and THF (1.5 mL), 
and the vial was sealed with a PTFE-lined plastic cap. Degassed 1M aqueous NaOH (0.211 mL, 
0.211 mmol, 5 eq based on 2.41) was added into the vial via syringe. The yellow reaction 
mixture was stirred for 15 minutes at 23 °C and then stirred at 45 °C for 16 hours. The resulting 
heterogeneous deep reddish mixture was diluted with ethyl acetate (5 mL) and dried over 
anhydrous magnesium sulfate. The orange solution was filtered through short pad Florisil® and 
the filtrate was concentrated in vacuo to provide an orange solid. The crude product was purified 
by flash chromatography on Florisil® (1.5% EtOAc/petroleum ether) to give the title compound  
2.42 as a yellow solid (4.60 mg, 0.0090 mmol, 48%). 
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TLC (27% EtOAc/petroleum ether) 
Rf = 0.40, visualized by UV lamp (λ = 365 nm) or with CAM.  
 
1
H NMR (400 MHz, CDCl3) 
δ 6.24-6.18 (m, 10H), 6.11-6.02 (m, 2H), 5.71 (dt, J = 14.8, 7.2 Hz, 1H), 5.62 (dd, J = 
14.8, 8.4 Hz, 1H), 5.03 (qn, J = 6.4 Hz, 1H), 3.49 (t, J = 5.6 Hz, 1H), 2.38 (app sext, J = 
6.8 Hz, 1H), 2.06 (app q, J = 7.2 Hz, 2H), 1.99 (s, 3H), 1.88 (app sext, J = 6.4 Hz, 1H), 
1.39 (sext, J = 7.2 Hz, 2H), 1.11 (d, J = 6.4 Hz, 3H), 0.98 (d, J = 6.4 Hz, 3H), 0.94 (t, J = 
8.0 Hz, 9H), 0.88 (t, J = 7.6 Hz, 3H), 0.87 (d, J = 7.6 Hz, 3H), 0.59 (q, J = 8.0 Hz, 6H). 
 
13
C NMR (100 MHz, CDCl3) 
δ 170.3, 138.8, 135.8, 133.5, 133.3, 133.2, 133.1, 132.9, 132.7, 132.5, 131.5, 130.9, 
130.8, 130.1,71.6, 42.3, 40.5, 35.0, 29.7, 22.5, 21.4, 16.4, 15.7, 13.7, 11.2, 7.0, 5.4. 
 
HRMS (ESI) 
Calculated for C32H52O3Si (M+H)
+
:   513.3764 
Found:       513.3771 
 
IR (thin film, cm
-1
) 
3011, 2957, 2928, 2875, 1736, 1456, 1372, 1243, 1069, 1006, 950, 840, 739. 
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CHAPTER 3 
AN ITERATIVE CROSS-COUPLING BASED SEMISYNTHESIS OF AMPHOTERICIN B 
 
 Given the power of functional group deletion in understanding the mechanism of action 
of AmB, our group has targeted the synthesis of all twelve derivatives lacking each one of the 
protic functional groups. Semisynthesis from AmB has been a powerful tool for accessing 
modifications to the C21-C40 section of the macrolactone, however, in order to access all of the 
proposed derivatives, a simple, efficient, and flexible total synthesis of AmB needs to be 
developed. In our proposed synthesis of AmB we envisioned that the most modular and efficient 
way to disconnect the molecule was through a series of Suzuki-Miyaura (SM) transforms and a 
macrolactonization transform giving four key building blocks. With the completion of one half 
of AmB (see chapter 2) via iterative cross-coupling, the methodology was in place for this total 
synthesis of AmB to be a feasible route, but the polyol and mycosamine containing building 
blocks had not yet been completed. However, a near exact model of the product of their putative 
coupling could be accessed through the utility of semisynthesis from the natural product. This 
chapter describes the synthesis of this intermediate and its use in testing the endgame strategy for 
the total synthesis. The iterative Suzuki-Miyaura cross-coupling strategy proved to be mild and 
efficient in accessing the fully protected AmB core. Subsequent deprotection conditions were 
found to connect back to the natural product. Brandon Wilcock contributed to this section by 
finding that phenyl acyl is a compatible protecting group for the amine on AmB. Pulin Wang 
synthesized model substrate 3.25 used in scheme 3.3. 
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3-1 BACKGROUND 
 In order to access all deoxygenated derivatives of AmB, a simple, modular, and flexible 
total synthesis needed to be designed.
1,2
 With the development of the MIDA protecting group by 
Gillis et al.,
3
 the possibility of iterative Suzuki-Miyaura cross-coupling as a synthetic strategy for 
complex small molecule synthesis was opened. In chapter 2 of this thesis, the expansion of this 
methodology to the synthesis of polyene natural products was described.
4
 The synthesis of one 
half of AmB was an excellent demonstration of the power of this strategy, however it was still a 
very simple system in comparison to the complexity of the natural product. In order to validate 
the proposed endgame strategy for the total synthesis, a better model system needed to be 
developed. The work of Nicolaou,
5
 Rychnovsky,
6
 and Murata
7
 demonstrated that AmB could be 
degraded into a form that would be useful for testing the cross-couplings for the total synthesis. 
In fact, in 2006 Murata and coworkers used the degradation of AmB to access vinyl iodide 
intermediate 3.1 that was competent to do a Stille coupling with hexanene 3.2. Subsequent 
macrolactonization and deprotection provided C28-fluorine labeled derivative 3.3 (Figure 3.1).
7a
 
We recognized that a similar degradative strategy may provide access to an advanced 
intermediate to enable the endgame strategy of our synthesis to be tested. 
 
Figure 3.1. Murata’s semisynthesis of C28-fluorine labeled AmB 3.3. 
 
3-2 DEGRADATION OF AMPHOTERICIN B 
In the context of our proposed total synthesis of AmB, we targeted the advanced 
intermediate 3.9 via a SM cross-coupling of building blocks 3.5 and 3.6 (Figure 3.2). These 
polyol and mycosamine containing sections of the molecule are the most complex and 
synthetically challenging pieces in our synthesis and so we wanted to target a model system of 
the endgame strategy that would make us confident that coupled product 3.9 would give access 
to AmB given the high value of this intermediate. It was recognized that almost this exact 
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intermediate could be accessed via a degradation of the natural product,
6,7
 where all of the 
complexity is preinstalled in the starting material. From this intermediate we would have an 
excellent model to test the iterative cross-coupling endgame strategy. Moreover, this accessible 
intermediate provides a very efficient platform for synthesizing C21-C40 derivatives of the 
macrolactone via semisynthesis.  
 
Figure 3.2. Our proposed retrosynthesis of AmB into four key building blocks. The cross-coupling of 3.5 and 3.6 
would yield dienyl MIDA boronate 3.9, a near exact model of which could be accessed from a top-down 
degradation of AmB. 
AmB is notoriously difficult to work with. It is light, oxygen, and acid sensitive, as well 
as insoluble in most organic solvents.
8,9
 Protection of the amine as a benzyl amide,
10
 followed by 
formation of a methyl ketal and a methyl ester made the compound much easier to work with by 
increasing its solubility. Subsequent ketalization with 1,1’-dimethoxycyclopentanone11 and tert-
butyldimethylsilyl (TBS) protection provided globally protected AmB 3.10 in 36% yield over 5 
steps (Scheme 3.1). Exhaustive ozonolysis effectively cleaved the polyene and double Takai 
olefination gave the bis-vinyl iodide.
6,7,12
 Transesterification using sodium methoxide then 
cleaved the western half of AmB providing polyol fragment 3.11 as well as alcohol 3.12. In 
order to be an accurate model for the total synthesis, the vinyl iodide of 3.11 needed to be 
converted to a dienyl MIDA boronate. Anhydrous SM coupling of vinyl iodide 3.11 and 
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pinacolboronic ester 3.13
4
 proceeded smoothly in 71% yield providing 3.14, the model for the 
total synthesis. Subsequent MIDA deprotection with sodium hydroxide, isolation as a solution in 
THF, and coupling to trienyl chloride 3.15
4
 then provided pentaenyl MIDA boronate 3.17. 
Surprisingly this highly complex boronate was found to be stable to silica gel chromatography 
and storage for at least 6 months in the freezer.
13
 One pot deprotection and SM coupling to 3.18
4
 
using aqueous sodium hydroxide at 45 
°
C for 17h then gave the heptaenyl framework for AmB 
(3.19) in 19% yield.
4,14
  
 
Scheme 3.1. Semisynthesis of the all carbon framework of AmB. Degradation followed by cross-coupling to 
bisborylated compound 3.11 provided 3.14. With the exception of the methyl ketal, 3.14 is the same intermediate 
that will be accessed in the proposed total synthesis. 3.14 was competent to do Suzuki-Miyaura cross-couplings to 
generate the all carbon framework of AmB. A 1:1 mixture of the 1,2 and 1,3 ketal protected diol at C8-C11 was 
carried through the route.  Only the 1,3 ketal is shown for simplicity. 
 
3-3 SYNTHESIS OF THE WESTERN HALF OF AMPHOTERICIN B 
While we were satisfied that the heptaene core of amphotericin B could be made using 
this methodology, a 19% yield was not practical as a late stage step in the total synthesis. We 
hypothesized that the low yield stemmed from the long reaction time, providing opportunities for 
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the pentaenylboronic acid as well as the heptaene product to decompose. We predicted that the 
reaction time could be shortened by switching the coupling partner from a dienyl chloride to a 
more reactive dienyl iodide.
15
   
Starting from the known aldehyde 3.20,
4
 Takai olefination provided vinyl iodide 3.21 
with >20:1 E:Z selectivity (Scheme 3.2).
12
 First attempts at deacylation using K2CO3 in MeOH 
removed the acyl group but also cleaved the TES protecting group. Use of a diisobutylaluminum 
hydride (DIBAL) reduction was able to avoid the desilyation and provide the free alcohol in 91% 
yield. SM cross-coupling to bisborylated 3.13
4
 then gave dienyl MIDA boronate 3.23. We were 
satisfied to see that this MIDA boronate was compatible with the free alcohol under the basic 
conditions of the cross-coupling.
16
 This dienyl MIDA boronate then needed to be converted to a 
dienyl iodide. Brown and coworkers had previously shown that vinylboronic acids could be 
converted to vinyl iodides by first treating with sodium hydroxide then iodine.
17
 Given that 
sodium hydroxide is the exact condition to deprotect MIDA boronates, we hypothesized that the 
dienyl MIDA boronate 3.23 could be directly converted to the dienyl iodide using these same 
conditions. Indeed, treatment of 3.23 with sodium hydroxide followed by iodine generated dienyl 
iodide 3.24 with retention of stereochemistry in 96% yield.
18
 
 
Scheme 3.2. Synthesis of the TES protected western half of AmB. Dienyl MIDA boronate 3.23 was able to be 
converted to dienyl iodide 3.24 in one pot with retention of stereochemistry. 
At this time we had been using a TES protecting group on the C35 hydroxyl group due to 
its greater lability relative to TBS ethers. We predicted that we could have a higher yielding 
desilylation during the deprotection sequence using this group. However, during the synthesis of 
building block 3.24 it was noted that the TES group was labile to the basic conditions attempted 
to remove the acyl group. In their degradative studies of AmB, chemists at SmithKline Beecham 
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had noted that the C35 hydroxyl group was capable of forming the 36-membered macrolide.
8
 
Given this observation, we were concerned that if the TES group was removed prior to 
macrolactonization that we would get competitive cyclization onto the C35 alcohol over the C37 
alcohol. Given that the methyl ester at C1 needed to be hydrolyzed prior to macrolactonization, a 
model system was set up to see if the TES group on building block 3.24 would survive a 
saponification (Scheme 3.3). Even the use of mild reagents such as potassium cyanide and 
barium hydroxide caused extensive desilylation in the time it took to convert methyl ester 3.25 to 
the free acid. Given this problem, we decided to switch to a TBS on the C35 alcohol for both the 
model system as well as the building block for the total synthesis. 
 
Scheme 3.3. Model methyl ester deprotection to explore the viability of a TES ether surviving at the C35 position. 
All conditions tried gave a significant amount of deprotection to form 3.27. 
The initial route to TBS protected 3.8 started with the monoacylated intermediate 3.28.
4
 
However, treatment of 3.28 with tert-butyldimethylsilyl trifluoromethane sulfonate (TBSOTf) 
did not give the predicted product 3.29. Instead, acyl migration followed by silylation of the C37 
alcohol was the only observed product (Scheme 3.4). To avoid this problem we used a 
protection/deprotection strategy reported by Patterson and coworkers.
19
 Double TBS protection 
followed by selective acid deprotection of the C37 TBS group resulted in formation of 3.32 
(Scheme 3.5). Subsequent acylation of the free alcohol gave fully protected 3.29 in 95% yield. 
Debenzylation, Dess-Martin oxidation
20
 of the free alcohol, and Takai olefination
12
 then 
provided vinyl iodide 3.34. Unlike with the TES protected intermediate 3.21, treatment with 
K2CO3 in MeOH smoothly made 3.35 in 86% yield without removing the TBS group.  
Subsequent SM cross-coupling to bisborylated 3.13
4
 followed by MIDA boronate to iodine 
exchange gave desired 3.8 in 7 steps from known intermediates. 
 
Scheme 3.4. TBS protection of 3.28. Treatment of 3.28 with TBSOTf did not form the desired product (3.29). 
Instead, acyl migration followed by TBS ether formation at the wrong alcohol was observed, forming 3.30 as the 
only observed product. 
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Scheme 3.5. Synthesis of the TBS protected western half of AmB. 
 
3-4 SYNTHESIS OF THE AMPHOTERICIN B MACROLACTONE 
 With dienyl iodide 3.8 in hand, we were able to test its effectiveness in the final SM 
cross-coupling of the AmB synthesis. One pot deprotection and SM coupling of dienyl iodide 3.8 
and pentaenyl MIDA boronate 3.17 gave complete and clean conversion to heptaene 3.37 in less 
than four hours (Scheme 3.6). The product was carried forward without purification to address 
our concerns that the lower yield was also due, in part, to heptaene decomposition. Subsequent 
selective deprotection of the C1 methyl ester using lithium hydroxide followed by 
macrolactonization using 2-methyl-6-nitrobenzoic anhydride (MNBA)
21
 as an activator provided 
the macrolactone of AmB (3.38) in 31% over 3 steps (an average of 68% per step).
7
 This was a 
dramatic improvement in yield from the 19% obtained for assembling 3.17 through coupling to  
dienyl chloride 3.18 (Scheme 3.1). 
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Scheme 3.6. Modified cross-coupling reaction and macrolactonization sequence using dienyl iodide 3.8. Switching 
from a dienyl chloride to the dienyl iodide dramatically improved the cross-coupling yield from 19% to 68% (based 
on average of 31% over 3 steps). A 1:1 mixture of the 1,2 and 1,3 ketal protected diol at C8-C11 was carried through 
the route.  Only the 1,3 ketal is shown for simplicity. 
 Given the success of switching from the chloride to the iodide with respect to the final 
coupling, we predicted that changing trienyl chloride 3.15 to a trienyl iodide would improve the 
yield of the previous coupling. Trienyl iodide 3.7 was accessed using a synthesis reported by Lee 
et al.
22
 Deprotection of dienyl MIDA boronate 3.14 followed by SM cross-coupling to iodide 3.7 
provided pentaenyl MIDA boronate 3.17 in 36% yield nearly doubling the throughput compared 
to the chloride coupling (Scheme 3.7). However, 36% was still low for a late stage reaction in the 
context of the total synthesis.  
 
Scheme 3.7. Cross-coupling of trienyl iodide 3.7 to the dienyl boronic acid of AmB. By switching from the trienyl 
chloride to the trienyl iodide the yield was improved from 21% to 36%. A 1:1 mixture of the 1,2 and 1,3 ketal 
protected diol at C8-C11 was carried through the route.  Only the 1,3 ketal is shown for simplicity. 
At the same time this reaction was being optimized, Woerly et al. had shown, in the 
context of the total synthesis of peridinin, that MIDA boronates could directly be converted to 
pinacolboronic esters.
23
 We predicted that the use of this chemistry on dienyl MIDA boronate 
3.14 to provide the dienyl pinacolboronic ester would make a more stable cross-coupling partner 
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than the corresponding boronic acid and thus increase the yield of the triene coupling by 
preventing decomposition of the diene precursor in situ.
24
 Conversion of 3.14 to the dienyl 
pinacolboronic ester proceeded smoothly in near quantitative yield (Scheme 3.8). This 
intermediate was stable to storage for at least 3 days without decomposition, whereas the boronic 
acid counterpart had to be isolated in solution and carried forward immediately to the cross-
coupling. Subsequent SM cross-coupling to trienyl iodide 3.7 gave the pentaene in 51% yield 
thus a total improvement of 30% yield as compared to the original conditions. Interestingly, the 
optimal cross-coupling conditions used in this reaction seem to be somewhat general for the 
cross-coupling of vinyl pinacolboronic esters to vinyl iodides as they are the same conditions 
used to make 3.23 and 3.36. 
With the cross-couplings optimized, all that remained to reach the natural product was a 
series of deprotections (Scheme 3.8). These steps were tested on small scale using known HPLC 
standards to monitor the success of the reactions. Removal of the silyl protecting groups required 
the use of HF/pyridine in MeOH at elevated temperature to give good conversion. It was noted 
that the TBS groups on the mycosamine came off rapidly, while the harsher conditions were 
necessary to remove the C35 TBS group. This is presumably due to the fact that the rigid nature 
of the molecule
25
 locks the C35 alcohol in a sterically encumbered environment. Subsequent acid 
hydrolysis of the ketals and saponification of the methyl ester left only the benzyl amide to be 
cleaved. The reason this protecting group was chosen in the first place was its great stability to a 
wide variety of chemical conditions, but its lability to mild enzyme hydrolysis.
10
 Indeed, 
unoptimized treatment with penicillin G amidase (PGA) in water provided AmB, completing a 
semisynthesis of the natural product. 
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Scheme 3.8. Semisynthesis of AmB. By converting to dienyl pinacolboronic ester 3.40 instead of the boronic acid, 
the yield of the cross-coupling with 3.7 was improved to 51% from the 36% yield in the previous route. A 1:1 
mixture of the 1,2 and 1,3 ketal protected diol at C8-C11 was carried through the route.  Only the 1,3 ketal is shown 
for simplicity. 
 
3-5 MODELING OF THE DEPROTECTION SEQUENCE FOR THE TOTAL SYNTHESIS 
 The above model system demonstrated that the iterative cross-coupling strategy is a 
viable endgame strategy for the total synthesis. Since the development of this model system 
many of the protecting groups for the total synthesis have been modified. In the context of 
synthesizing C35-deoxy AmB (see chapter 4) it was discovered that by simply removing a single 
alcohol, AmB becomes more sensitive to deprotection conditions, in particular to hydroxide 
nucleophiles.
26
 For this reason, the methyl ester was exchanged for a 2-(trimethylsilyl)ethyl 
(TMSE) ester protecting group that can be removed by simple treatment with fluoride. 
Additionally, the benzyl amide was exchanged for an azide protecting group as it was required to 
access building block 3.6. Finally, in the context of the total synthesis the coupling of building 
blocks 3.5 and 3.6 will generate a dihydropyran instead of a methyl ketal. Given these 
modifications, we targeted the synthesis of 3.41 from the natural product to screen deprotection 
conditions (Figure 3.3). 
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Figure 3.3. New protecting group strategy for the total synthesis of AmB. 
 Given the low solubility of AmB, the amine was initially protected as a Fmoc carbamate 
that would later be converted to the azide (Scheme 3.9).
8
 From here the challenge was trying to 
find conditions to put on both the cyclopentylidene ketals as well as form the dihydropyran. 
Given that the ketalization conditions involve the use of acid and MeOH, conditions that would 
presumably convert a dihydropyran to a methyl ketal, the ketalization was done first. It is known 
in the literature that on substrates lacking the cyclopentylidene ketals the treatment of AmB with 
TMSOTf in DCM gives complete elimination to the dihydropyran.
8
 However, it was found that 
with the ketals present, only small amounts of elimination were observed and the dihydropyran 
(3.45) was inseparable from the methyl ketal product (3.44).  
 
Scheme 3.9. Initial attempts to make dihydropyran 3.45. Treatment of 3.43 with TMSOTf only formed small 
amounts of dihydropyran that were inseparable from methyl ketal 3.44. A 1:1 mixture of the 1,2 and 1,3 ketal 
protected diol at C8-C11 was carried through the route.  Only the 1,3 ketal is shown for simplicity. 
 We next attempted to form the dihydropyran prior to ketalization (Scheme 3.10).
8
 After 
Fmoc protection, treatment with TMSOTf in DCM followed by desilylation provided the desired 
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product as the dihydropyran. However, all attempts to ketalize intermediate 3.46 caused 
complete conversion of the dihydropyran to the methyl ketal. While this result made it difficult 
for us to access the model system we were targeting, it suggested that in the presence of 
cyclopentylidene ketals the molecule prefers to exist as the methyl ketal over the dihydropyran, 
which could be used to our advantage in the actual deprotection sequence. Specifically, based on 
this result, we now envision that treatment of the dihydropyran intermediate with CSA in the 
presence of MeOH and 1,1’-dimethoxycyclopentanone will give us the desired methyl ketal in 
the actual deprotection sequence. 
 
Scheme 3.10. Attempted synthesis of dihydropyran 3.48. Formation of the cyclopentylidene ketals cause 
concomitant formation of the methyl ketal from the dihydropyran. This suggests that for the total synthesis, the 
dihydropyran can be converted to the methyl ketal if the cyclopentylidene ketals are present. 
 In looking at the proposed deprotection sequence, we identified an alternative 
intermediate that we expected could be access more readily. In the forward direction the 
proposed deprotection sequence is as follows: 1. Desilylation with HF/pyridine, 2. Formation of 
the methyl ketal using acid in the presence of 1,1’-dimethoxycyclopentanone and MeOH, 3. 
Removal of the TMSE protecting group, 4. Hydrolysis of the ketals, and 5. Reduction of the 
azide (Scheme 3.11). The intermediate made from formation of the methyl ketal could still be 
accessed from AmB to test the final three deprotection steps. 
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Scheme 3.11. Proposed deprotection sequence for the total synthesis. 
 As before, the amine was protected as the Fmoc carbamate followed by ketalization with 
1,1’-dimethoxycyclopentanone in MeOH (Scheme 3.12). TES protection of the remaining 
alcohols followed by formation of the TMSE ester gave fully protected intermediate 3.50 in 35% 
yield over 4 steps. Subsequent Fmoc removal and treatment with imidazole-1-sulfonylazide
27
 
then generated the azide at C3’. Treatment with HF/pyridine then cleaved the TES protecting 
groups providing 3.49, the intermediate that should be accessed in the context of the total 
synthesis. 
 
Scheme 3.12. Synthesis of 3.49. This is the exact intermediate that will be accessed in the proposed deprotection 
sequence for the total synthesis. A 2.5:1 mixture of ketal constitutional isomers was carried through the route.  Only 
the 1,3 ketal is shown for simplicity. 
 
 With this intermediate in hand, deprotections could then be tested. Treatment of 3.49 with 
TBAF to remove the TMSE provided access to 3.52 in 54% yield (Scheme 3.13). Subsequent 
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treatment with HCl in MeCN and water then provided 3.53. During this reaction a series of 
partially deprotected intermediates are isolated. This material is then resubjected to the reaction 
conditions to drive the conversion forward. 3.53 was isolated in 34% after two reaction cycles. 
Finally, treatment of penultimate compound 3.53 with 1,3-propanedithiol and triethylamine in 
MeOH provided AmB.
2d
 Once these steps are fully optimized, valuable time and material will be 
saved when the total synthesis reaches this late stage.  
 
Scheme 3.13. Deprotection of 3.49 to access AmB. YND = yield not determined. 
 
3-6 SUMMARY 
 The complexity of AmB makes it both an interesting as well as challenging target for 
total synthesis. We have proposed a highly modular and efficient way to access this molecule as 
well as its derivatives through the iterative cross-coupling of four key building blocks. It was 
recognized that the late stage steps of this synthesis could actually be tested on a model system 
accessed through semisynthesis from AmB itself. Through degradation, dienyl MIDA boronate 
3.14 was synthesized and tested in the proposed polyene synthesis. This model allowed for 
optimization of the cross-coupling partners and conditions as well as confirmed that this is a 
viable endgame strategy for the total synthesis. Additionally, one of the exact intermediates that 
will be encountered during actual deprotection strategy was synthesized and has been used to 
find conditions for the last three steps of the total synthesis. Semisynthesis has thus proven to be 
a valuable tool when exploring the total synthesis of a molecule as complicated and challenging 
as AmB. As will be shown in the next chapter, the semisynthesis also represents a powerful 
platform for accessing C21-C40 derivatives of AmB. 
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3-7 EXPERIMENTAL SECTION 
Materials.  Commercial reagents were purchased from Sigma-Aldrich, Alfa Aesar, or Strem, 
and were used without further purification unless stated otherwise. Amphotericin B was a 
generous gift from Bristol-Myers Squibb Company.  Iodoform (methanol) and camphorsulfonic 
acid (ethyl acetate) were recrystallized from the indicated solvents prior to use.  All solvents 
were dispensed from a solvent purification system that passes solvents through packed columns 
according to the method of Pangborn and coworkers
28
 (THF, Et2O, CH2Cl2, toluene, dioxane, 
hexanes: dry neutral alumina; DMSO, DMF, CH3OH : activated molecular sieves).  2,6-Lutidine 
and pyridine were freshly distilled under nitrogen from CaH2.   EtOAc and EtOH were freshly 
distilled under nitrogen from activated molecular sieves. Water was doubly distilled or obtained 
from a Millipore MilliQ water purification system. The following compounds were prepared 
according to literature precedent: 1,1-dimethoxycyclopentanone
29
, bisborylated compound 
3.13
4,30
, aldehyde 3.20
4
, monosilylated alcohol 3.32
19
, trienyl iodide 3.7
22
, imidazole-1-sulfuryl 
azide 3.51.
27
 
Reactions. Due to the light and air sensitivity of polyenes, all manipulations of polyenes were 
carried out under low light conditions and compounds were stored under an argon atmosphere. 
All reactions were performed in oven- or flame-dried glassware under an atmosphere of argon 
unless otherwise indicated.  Reactions were monitored by analytical thin layer chromatography 
performed using the indicated solvent on E. Merck silica gel 60 F254 plates (0.25mm).  
Compounds were visualized using a UV (λ254) lamp or stained by an acidic solution of p-
anisaldehyde or KMnO4.  Alternatively, reactions were monitored by RP-HPLC using an Agilent 
1100 series HPLC system equipped with a Symmetry
®
 C18 5 micron 4.6 x 150 mm column 
(Waters Corp. Milford, MA) with UV detection at 406 nm and the indicated eluent and flow rate. 
Purification and Analysis.  Flash chromatography was performed as described by Still and 
coworkers
31
 using the indicated solvent on E. Merck silica gel 60 230-400 mesh.  
1
H NMR 
spectra were recorded at 23 °C on one of the following instruments: Varian Unity 400, Varian 
Unity 500, Varian Unity Inova 500NB.  Chemical shifts (δ) are reported in parts per million 
(ppm) downfield from tetramethylsilane and referenced internally to the residual protium in the 
NMR solvent (CDCl3, = 7.24; (CD3)2CO, = 2.04; DMSO-d6, = 2.49, center line) or to 
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added tetramethylsilane.  Data are reported as follows: chemical shift, multiplicity (s = singlet, d 
= doublet, t = triplet, q = quartet, p = pentet, dd = doublet of doublets, dt = doublet of triplets, m 
= multiplet, app. = apparent), coupling constant (J) in Hertz (Hz) and integration. 
13
C spectra 
were recorded at 23 °C with a Varian Unity 500. Chemical shifts (δ) are reported downfield of 
tetramethylsilane and are referenced to the carbon resonances in the NMR solvent (CDCl3, δ = 
77.0, center line, (CD3)2C(O), δ = 29.8, center line) or to added tetramethylsilane. Carbons 
bearing boron substituents were not reported (quadrapolar relaxation). 
11
B NMR were recorded 
using a General Electric GN300WB instrument and referenced to an external standard of 
BF3∙Et2O. High resolution mass spectra (HRMS) were obtained at the University of Illinois mass 
spectrometry facility. All synthesized compounds gave HRMS within 5 ppm of calculated 
values. Infrared spectra were collected from a thin film on NaCl plates or as a KBr pellet on a 
Mattson Galaxy Series FTIR 5000 spectrometer with internal referencing. Absorption maxima 
(νmax) are reported in wavenumbers (cm
-1
). 
 
Methyl Ketal 3.54 
To phenyl acetic acid (0.662 g, 4.86 mmol, 3 eq) in THF (30 mL) was added trimethyl acetyl 
chloride (0.4 mL, 3.24 mmol, 2 eq). Et3N (0.9 mL, 6.48 mmol, 4 eq) was added dropwise to the 
solution resulting in the formation of a white precipitate. The mixture was stirred at 23 
o
C for 4 
hours then DMSO (30 mL) was added and the solution was cooled to 0 
o
C. Amphotericin B (3.4, 
1.5 g, 1.62 mmol, 1 eq) was added and the reaction was stirred at 0 
o
C for 1.5 hours. The reaction 
mixture was then poured into Et2O (1.8 L) stirring at 0 
o
C. After stirring for 30 minutes the 
resulting yellow precipitate was isolated via Büchner filtration using Whatman 50 filter paper 
and washed with copious amounts of diethyl ether to afford a yellow solid which was analyzed 
by HPLC (Waters Sunfire C18 ODB 5 micron 4.6 x 150 mm column gradient of 5  95% MeCN 
in 1% formic acid over 30 minutes, flow rate = 1.2 mL/min, tR = 17.9 min). The resulting yellow 
solid was placed in a 250-mL round bottom flask and left under vacuum for one hour. To the 
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solid was added THF (30 mL) and MeOH (30 mL) and the slurry was cooled to 0 
o
C.  CSA 
(0.075 g, 0.324 mmol) was added and the reaction was stirred at 0 
o
C for 1 hour over which time 
the mixture went clear. The reaction was then quenched at 0 
o
C with Et3N (0.05 mL, 0.359 
mmol) and concentrated in vacuo until a yellow solid began to precipitate. The resulting solution 
was poured into hexanes: diethyl ether 1:1 (1200 mL) at 0 
o
C and the yellow precipitate was 
collected via Büchner filtration using Whatman 50 filter paper and washed with 50% 
EtOAc/Et2O (250 mL) to yield 3.54 (1.9 g crude, >100% over two steps) as a yellow solid. This 
material was carried forward without further purification.  
 
HPLC 
tR = 17.1 min; flow rate = 1.2 mL/min, Waters Sunfire C18 ODB 5 micron 4.6 x 150 mm 
column gradient of 5 → 95% MeCN in 0.1% formic acid over 30 min. 
 
HRMS (ESI) 
 Calculated for C56H81NO18 (M + Na)
+
:  1078.5351 
 Found:       1078.5310 
 
 
 
 
 
96 
 
 
Methyl Ester 3.55 
To methyl ketal 3.54 (1.9 g, estimated 1.62 mmol) in THF (60 mL) at 0 
o
C was added dropwise 
CH2N2
32
 (9.72 mmol in ~30 mL diethyl ether) over 15 minutes. The reaction was stirred at 0 
o
C 
an additional 45 minutes then was quenched with AcOH (1.05 mL) and allowed to warm to 23 
o
C over 10 minutes. Et3N (4 mL) was added and the reaction was concentrated in vacuo. The 
crude material was purified by flash chromatography (SiO2; 7% → 10% MeOH/CH2Cl2) 
furnishing 3.55 (1.15 g, 1.07 mmol, 66% over 3 steps) as a yellow powder. 
 
TLC (10% MeOH/CH2Cl2) 
 Rf = 0.25, stained by anisaldehyde. 
 
HPLC 
tR = 13.9 min; flow rate = 1.2 mL/min, Waters Sunfire C18 ODB 5 micron 4.6 x 150 mm 
column gradient of 30 → 95% MeCN in water over 30 min. 
 
1
H NMR  (500 MHz, pyridine-d5:CD3OD 10:1) 
 δ 8.95 (d, J = 8.5 Hz, 1H), 7.51 (d, J = 7.0 Hz, 2H), 7.28-7.20 (m, 3H), 6.57-6.30 (m, 
12H), 6.21 (dd, J = 7.0, 14.5 Hz, 1H), 5.72-5.63 (m, 2H), 4.93 (broad t, J = 7.5 Hz, 1H), 
4.87 (s, 1H), 4.81 (dt, J = 4.5, 10.5 Hz, 1H), 4.69-4.60 (m, 2H), 4.46-3.39 (m, 2H), 3.35 
(d, J = 3.5 Hz, 1H), 4.14 (app. t, J = 9.0 Hz, 1H), 4.00-3.96 (m, 2H), 3.86 (d, J = 14.0 Hz, 
1H), 3.82 (d, J = 14.0 Hz, 1H), 3.76-3.65 (m, 2H), 3.73 (s, 3H), 3.54 (app. d, J = 11.0 Hz, 
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1H), 3.24 (s, 3H), 2.89 (dd, J = 4.5, 13.0 Hz, 1H), 2.81 (t, J = 10.5 Hz, 1H), 2.70-2.65 (m, 
2H), 2.51 (dd, J = 8.5, 16.5 Hz, 1H), 2.26 (dd, J = 7.5, 14.0 Hz, 1H), 2.21-2.15 (m, 3H), 
2.07-2.02 (m, 3H), 2.00-1.79 (m, 6H), 1.55 (d, J = 6.0 Hz, 3H), 1.42 (d, J = 6.0 Hz, 3H), 
1.31 (d, J = 6.5 Hz, 3H), 1.23 (d, J = 7.0 Hz, 3H). 
 
13
C NMR (125 MHz, pyridine-d5:CD3OD 10:1) 
 δ 173.9, 172.1, 171.6, 137.6, 137.2, 136.9, 134.5, 134.4, 134.0, 133.9, 133.5, 133.4, 
133.3, 133.2, 132.8, 132.6, 132.2, 130.2, 129.8, 128.9, 127.0, 102.0, 99.1, 77.9, 75.5, 
75.4, 75.1, 74.7, 71.8, 71.1, 70.6, 68.2, 67.5, 67.4, 66.8, 57.4, 56.7, 56.5, 51.9, 46.9, 44.9, 
43.9, 43.8, 43.6, 43.5, 43.3, 41.7, 37.7, 36.3, 30.7, 18.9, 18.6, 17.7, 12.5.  
 
HRMS (ESI) 
 Calculated for C57H83NO18 (M + Na)
+
:   1092.5508 
 Found:       1092.5496 
 
 
Bisketal 3.56. To methyl ester 3.55 (3.34 g, 3.12 mmol, 1 eq) in MeOH (52 mL) and 1,1-
dimethoxy cyclopentanone
29
 (16.4 mL) was added CSA (0.15 g, 0.62 mmol, 0.2 eq). The 
reaction was stirred at 23 
o
C for 1 hour and was then quenched with saturated aqueous NaHCO3 
(50 mL). The resulting mixture was then diluted with EtOAc (200 mL) and the layers were 
separated. The aqueous layer was extracted with EtOAc (2 x 250 mL) and the combined organic 
layers were dried over Na2SO4 and concentrated. The crude material was purified by flash 
chromatography (SiO2; 3% → 7% MeOH/CH2Cl2) furnishing 3.56 (2.79 g, 2.32 mmol, 72%) as 
an orange solid. The product was isolated as a 1:1 mixture of 1,2- and 1,3-ketal constitutional 
isomers. 
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TLC (10% MeOH/CH2Cl2) 
 Rf = 0.39, stained by anisaldehyde. 
 
HPLC 
tR = 25.0 and 26.1 min; flow rate = 1.2 mL/min, Waters Sunfire C18 ODB 5 micron 4.6 x 
150 mm column gradient of 30 → 95% MeCN in water over 30 min. 
 
1
H NMR (500 MHz, acetone-d6) 
 δ 7.35 (d, J = 7.5 Hz, 2H), 7.29 (t, J = 7.0 Hz, 4H), 7.21 (dd, 7.5, 14.5 Hz, 4H), 6.41-6.15 
(m, 24H), 5.93-5.87 (m, 2H), 5.58 (t, J = 15.0 Hz, 1H), 5.56 (t, J = 15.0 Hz, 1H), 5.24 (m, 
1H), 5.18 (m, 1H), 4.64 (broad t, J = 5.5 Hz, 2H), 4.58 (s, 2H), 4.20 (d, J = 3.0 Hz, 1H), 
4.18-4.05 (m, 5H), 4.02 (dd, J = 3.0, 6.0 Hz, 1H), 3.97-3.94 (m, 3H), 3.91-3.85 (m, 4H), 
3.76-3.73 (m, 3H), 3.68-3.58 (m, 4H), 3.66 (s, 3H), 3.65 (s, 3H), 3.51-3.46 (m, 2H), 3.38-
3.24 (m, 5H), 3.09 (s, 3H), 3.03 (s, 3H), 2.43-2.35 (m, 4H), 2.31-2.11 (m, 8H), 1.99-1.73 
(m, 21H), 1.71-1.49 (m, 29H), 1.44-1.29 (m, 8H), 1.21 (d, J = 5.5 Hz, 3H), 1.20 (d, J = 
5.5 Hz, 3H), 1.18 (d, J = 6.5 Hz, 3H), 1.17 (d, J = 6.5 Hz, 3H), 1.10 (d, J = 6.5 Hz, 3H), 
1.09 (d, J = 6.5 Hz, 3H), 1.00 (d, J = 7.0 Hz, 6H). 
 
13
C NMR (125 MHz, acetone-d6) 
 δ 173.7, 173.6, 172.7, 169.9, 169.8, 137.5, 136.9, 136.2, 134.6, 134.4, 134.3, 134.2, 
134.0, 133.9, 133.7, 133.5, 133.2, 132.9, 132.8, 132.6, 132.2, 132.1, 130.0, 129.6, 129.2, 
129.0, 127.2, 118.6, 110.8, 110.7, 110.6, 101.7, 100.9, 98.1, 98.0, 94.9, 94.6, 81.7, 79.9, 
77.9, 77.8, 75.6, 74.7, 74.5, 74.4, 74.0, 73.5, 73.0, 72.6, 71.4, 71.3, 70.8, 70.6, 70.5, 70.0, 
69.8, 69.2, 68.8, 67.6, 67.3, 67.0, 66.9, 66.3, 57.4, 57.3, 56.2, 54.8, 52.0, 48.5, 48.4, 43.3, 
42.7, 42.4, 42.2, 41.9, 41.6, 41.5, 40.9, 40.8, 40.7, 38.1, 38.0, 37.8, 37.7, 37.2, 33.9, 33.8, 
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33.4, 31.8, 31.7, 28.6, 28.3, 24.9, 24.8, 24.0, 23.9, 22.9, 22.8, 18.9, 18.8, 18.2, 17.7, 17.6, 
11.9, 11.8. 
 
HRMS (ESI) 
 Calculated for C67H95NO18 (M + Na)
+
:   1224.6447 
 Found:       1224.6409 
 
 
TBS Ether 3.10 
Prior to the reaction ketal 3.56 was azeotropically dried via coevaporation with acetonitrile (3 x 
25 mL) and was left under vacuum for a minimum of four hours. To the resulting yellow powder 
(2.84 g, 2.36 mmol, 1 eq) was added CH2Cl2 (70 mL) and 2,6-lutidine (3.0 mL, 25.98 mmol, 11 
eq) and the resulting solution was cooled to 0 
o
C.  TBSOTf (4.5 mL, 19.36 mmol, 8.2 eq) was 
added dropwise over 10 minutes and the resulting dark red solution was stirred for 1 hour at 0 
o
C. Additional 2,6-lutidine (3.0 mL, 25.98 mmol, 11 eq) was added followed by additional 
TBSOTf (4.5 mL, 19.36 mmol, 8.2 eq) dropwise over 10 minutes. The reaction was stirred at 0 
o
C for 15 minutes then the ice bath was removed and the reaction was allowed to stir an 
additional 45 minutes. The solution was recooled to 0 
o
C and was quenched with saturated 
aqueous NaHCO3 (70 mL).  Et2O (500 mL) was added and the layers were separated. The 
organic layer was washed with saturated aqueous NaHCO3 (2 x 250 mL) and water (1 x 250 
mL), and the combined aqueous layers were back-extracted with Et2O (100 mL). The combined 
organic layers were then washed with saturated copper(II) sulfate (1 x 750 mL) and the aqueous 
layer was back-extracted with Et2O (200 mL). The combined organic layers were washed with 
water (3 x 200 mL) and brine (1 x 200 mL). The third set of aqueous washes were combined and 
back-extracted with Et2O (200 mL). The combined organic layers were dried over Na2SO4 and 
concentrated in vacuo. The crude material was purified by flash chromatography (SiO2; 5% → 
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15% EtOAc/hexanes) to yield 3.10 (3.25 g, 1.83 mmol, 78%) as a yellow solid. The product was 
isolated as a 1:1 mixture of 1,2- and 1,3-ketal constitutional isomers. 
 
TLC (20% EtOAc/hexanes) 
 Rf = 0.63, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.33-7.28 (m, 8H), 7.24-7.21 (m, 2H), 6.38-6.15 (m, 24H), 6.03 (dd, J = 10.0, 15.5 Hz, 
2H), 5.89 (dd, J = 7.0, 15.5 Hz, 1H), 5.82 (dd, J = 5.5, 15.5 Hz, 1H), 5.67-5.62 (m, 2H), 
4.82 (broad s, 2H), 4.63-4.58 (m, 2H), 4.55 (s, 2H), 4.31-4.23 (m, 2H), 4.17-4.07 (m, 
3H), 4.03 (t, J = 9.5 Hz, 1H), 4.02 (t, J = 9.0 Hz, 1H), 3.97-3.86 (m, 5H), 3.80-3.85 (m, 
2H), 3.70 (s, 3H), 3.69 (s, 3H), 3.62-3.52 (m, 8H), 3.43-3.37 (m, 4H), 3.15 (s, 3H), 3.04 
(s, 3H), 2.44-2.36 (m, 2H), 2.34-2.25 (m, 4H), 2.20-2.12 (m, 2H), 1.99-1.73 (m, 24H), 
1.70-1.46 (m, 32H), 1.40-1.25 (m, 6H), 1.24 (d, J = 6.0 Hz, 3H), 1.23 (d, J = 6.0 Hz, 3H), 
1.18 (d, J = 6.0 Hz, 6H), 1.01 (d, J = 7.5 Hz, 3H), 1.00 (d, J = 7.0 Hz, 3H), 0.96 (d, J = 
7.0 Hz, 3H), 0.95 (d, J = 7.5 Hz, 3H), 0.93-0.84 (m, 90H), 0.16- -0.01 (m, 60H). 
 
13
C NMR (125 MHz, acetone-d6) 
δ 173.6, 173.5, 173.4, 170.3, 170.2, 170.1, 137.0, 136.4, 134.5, 134.4, 134.3, 134.1, 
133.7, 133.6, 133.5, 133.4, 133.0, 132.9, 131.3, 131.0, 130.2, 129.0, 127.4, 118.6, 118.5, 
110.7, 110.6, 110.5, 103.7, 101.8, 101.3, 101.2, 100.9, 100.0, 99.2, 98.7, 81.6, 81.2, 77.8, 
76.7, 76.1, 75.9, 75.5, 75.3, 74.8, 73.5, 73.1, 72.6, 72.5, 72.0, 70.2, 69.5, 68.9, 68.8, 68.2, 
67.5, 67.2, 66.9, 66.7, 57.3, 56.3, 56.2, 52.2, 48.8, 48.5, 44.1, 43.8, 43.5, 41.6, 41.3, 41.2, 
40.8, 40.7, 38.4, 38.2, 36.7, 33.9, 33.7, 32.6, 32.2, 31.7, 31.6, 38.4, 38.2, 37.6, 36.7, 33.9, 
33.7, 32.6, 32.2, 31.7, 31.6, 38.5, 27.9, 26.6, 26.4, 26.3, 26.2, 26.0, 25.5, 25.0, 24.9, 24.2, 
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24.1, 24.0, 23.4, 22.9, 19.6, 18.9, 18.8, 18.7, 18.6, 18.5, 18.4, 18.3, 18.2, 18.1, -3.1, -3.2, -
3.3,  -3.4, -3.5, -3.7, -3.9, -4.1, -4.2, -4.3, -4.7, -4.8, -4.9.  
 
HRMS (ESI) 
 Calculated for C97H165NO18Si5 (M + Na)
+
:  1795.0771 
 Found:       1795.0759 
 
 
Bisvinyl Iodide 3.57 
TBS ether 3.10 (1.12 g, 0.631 mmol, 1 eq) was dissolved in CH2Cl2 (49 mL) and MeOH (2.2 
mL) and was cooled to -78 
o
C.  Ozone was bubbled through the solution until a blue color 
persisted (~10 minutes) and the excess ozone was bubbled out with a stream of nitrogen. 
Dimethyl sulfide (0.7 mL, 9.47 mmol, 15 eq) was added at -78 
o
C with stirring and the cold bath 
was removed. The reaction was stirred at 23 
o
C overnight (~14 h). The mixture was concentrated 
and the residue was dissolved in diethyl ether (100 mL) and washed with saturated aqueous 
NaHCO3 (75 mL). The aqueous layer was extracted with Et2O (3 x 50 mL) and the combined 
organic layers were dried over Na2SO4 and concentrated in vacuo. The resulting white foam was 
azeotropically dried via coevaporation with benzene (3 x 10 mL) and left under vacuum for at 
least 1 hour. In a separate 100 mL round bottom flask equipped with a stir bar and charged with 
CrCl2 (2.40 g, 19.56 mmol, 31 eq) was added THF (14 mL) and dioxane (3.6 mL). To the CrCl2 
slurry was added dropwise a solution of the bisaldehyde intermediate and iodoform (2.03 g, 5.17 
mmol, 8.2 eq) in THF (10.5 mL) and dioxane (7 mL). The resulting dark red slurry was stirred at 
23 
o
C for 2 hours before quenching with saturated aqueous NaHCO3 (30 mL). The resulting 
green slurry was diluted with Et2O (100 mL) and filtered through celite. The filtrate layers were 
separated and the organic layer was washed with saturated aqueous Na2S2O3 (30 mL). The 
combined aqueous layers were extracted with diethyl ether (2 x 75 mL), then the combined 
organic layers were dried over Na2SO4 and concentrated. The crude material was purified by 
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flash chromatography (SiO2; 0% → 10% EtOAc/hexanes) to furnish bisvinyl iodide 3.57 (0.582 
g, 0.307 mmol, 49% over two steps) as a white solid. The product was isolated as a 1:1 mixture 
of 1,2- and 1,3-ketal constitutional isomers. 
 
TLC (20% EtOAc/hexanes) 
 Rf = 0.48, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.33-7.28 (m, 8H), 7.25-7.22 (m, 2H), 6.59-6.47 (m, 6H), 6.37 (d, J = 8.5 Hz, 1H), 6.36 
(d, J = 9.0 Hz, 1H), 6.21 (d, J = 14.5 Hz, 2H), 5.15-5.11 (m, 2H), 4.61 (s, 1H), 4.58 (s, 
1H), 4.37-4.33 (m, 2H), 4.31-4.15 (m, 6H), 4.00 (t, J = 9.0 Hz, 1H), 3.99 (t, J = 9.0 Hz, 
1H), 3.94-3.89 (m, 3H), 3.88-3.82 (m, 2H), 3.74-3.66 (m, 5H), 3.69 (s, 3H), 3.68 (s, 3H), 
3.62-3.54 (m, 8H), 3.38-3.33 (m, 2H), 3.18 (s, 3H), 3.13 (s, 3H), 2.53-2.49 (m, 2H), 2.41 
(d, J = 6.5 Hz, 4H), 2.30-2.04 (m, 6H), 2.00-1.87 (m, 10H), 1.85-1.71 (m, 14H), 1.70-
1.31 (m, 34H), 1.23 (d, J = 6.0 Hz, 3H), 1.22 (d, J = 6.0 Hz, 3H), 1.14 (d, J = 6.5 Hz, 
3H), 1.13 (d, J = 6.5 Hz, 3H), 1.01 (d, J = 6.5 Hz, 6H), 0.94-0.84 (m, 96H), 0.14- -0.01 
(m, 60H). 
 
13
C NMR (125 MHz, acetone-d6) 
δ 173.3, 173.2, 170.2, 151.2, 151.1, 147.5, 136.3, 130.2, 129.1, 127.4, 118.6, 110.9, 
110.8, 101.4, 101.2, 100.2, 100.0, 81.7, 81.4, 80.1, 79.9, 79.5, 79.3, 78.2, 76.7, 76.2, 75.3, 
74.8, 74.6, 73.3, 72.4, 72.2, 71.6, 71.0, 70.5, 68.5, 68.4, 67.5, 67.4, 67.2, 58.1, 58.0, 56.2, 
56.1, 51.9, 48.5, 44.2, 44.0, 43.9, 43.7, 43.6, 43.2, 43.0, 42.3, 42.2, 41.2, 41.0, 39.5, 39.3, 
38.2, 38.1, 37.4, 33.4, 33.2, 32.2, 31.9, 31.8, 28.5, 28.3, 26.5, 26.4, 26.3, 26.2, 26.0, 25.9, 
25.4, 25.1, 25.0, 24.1, 23.9, 23.4, 23.1, 19.7, 18.9, 18.8, 18.6, 18.5, 18.3, 18.2, 16.4, 14.1, 
11.2, -3.3, -3.6, -3.7, -3.8, -3.9, -4.1, -4.2, -4.3, -4.8, -4.9, -5.1.  
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HRMS (ESI) 
 Calculated for C87H155I2NO18Si5 (M + Na)
+
:  1918.8078 
 Found:       1918.8020 
 
 
Methyl Ester 3.11 and Alcohol 3.12 
Prior to the reaction, bisvinyl iodide 3.57 was azeotropically dried via coevaporation with 
benzene (3 x 10 mL) and was left under vacuum for at least eight hours. To bisvinyl iodide 3.57 
(0.580 g, 0.305 mmol, 1 eq) in THF (4.1 mL) and MeOH (4.1 mL) was added NaOMe (0.165 g, 
3.05 mmol, 10 eq) in MeOH (4.1 mL) via cannula. The reaction was stirred at 40 
o
C for 12 hours 
and was then quenched with 0.5 M pH 7 phosphate buffer (10 mL). The mixture was diluted 
with Et2O (20 mL) and the layers were separated. The aqueous layer was extracted with Et2O (3 
x 20 mL) and the combined organic layers were dried over Na2SO4 and concentrated. Flash 
chromatography (SiO2; 0% → 15% EtOAc/hexanes) yielded alcohol 3.12 (0.100 g, 0.251 mmol, 
82%) and methyl ester 3.11 (0.254 g, 0.166 mmol, 54%). 3.11 was isolated as a 1:1 mixture of 
1,2- and 1,3-ketal constitutional isomers. 
 
 
TLC (20% EtOAc/hexanes) 
 Rf = 0.40, stained by anisaldehyde 
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1
H NMR (500 MHz, acetone-d6) 
δ 7.35-7.30 (m, 8H), 7.28-7.24 (m, 2H), 6.60-6.49 (m, 4H), 6.39 (d, J = 9.0 Hz, 1H), 6.38 
(d, J = 8.5 Hz, 1H), 4.63 (s, 1H), 4.60 (s, 1H), 4.39-4.35 (m, 2H), 4.33-4.25 (m, 2H), 
4.25-4.17 (m, 4H), 4.02 (t, J = 9.0 Hz, 1H), 4.01 (t, J = 9.0 Hz, 1H), 3.96-3.29 (m, 3H), 
3.89-3.83 (m, 1H), 3.79-3.68 (m, 4H), 3.71 (s, 3H), 3.70 (s, 3H), 3.66-3.56 (m, 8H), 3.64 
(s, 3H), 3.60 (s, 3H), 3.39-3.52 (m, 2H), 3.20 (s, 3H), 3.15 (s, 3H), 2.44 (d, J = 4.5 Hz, 
4H), 2.31-2.16 (m, 6H), 1.96-1.89 (m, 8H), 1.84-1.72 (m, 10H), 1.71-1.47 (m, 30H), 
1.38-1.29 (m, 4H), 1.25 (d, J = 6.5 Hz, 3H), 1.24 (d, J = 6.5 Hz, 3H), 1.22-1.18 (m, 4H), 
0.94-0.86 (m, 72H), 0.17-0.01 (m, 48H). 
 
13
C NMR (125 MHz, acetone-d6) 
δ 173.3, 173.2, 171.5, 171.4, 170.2, 147.5, 136.3, 130.2, 129.1, 129.0, 127.4, 118.6, 
110.9, 110.8, 101.4, 101.2, 100.2, 100.0, 81.6, 80.0, 79.9, 79.5, 79.4, 78.2, 75.3, 74.8, 
74.6, 74.5, 73.3, 72.3, 72.2, 71.0, 70.5, 68.5, 68.4, 68.3, 67.5, 67.4, 67.2, 58.1, 58.0, 56.2, 
56.1, 51.9, 51.6, 48.5, 44.0, 43.9, 43.7, 43.6, 43.2, 42.2, 41.5, 41.2, 40.8, 39.5, 39.3, 38.1, 
38.0, 37.3, 33.4, 33.2, 32.2, 31.8, 31.7, 28.5, 28.3, 26.5, 26.4, 26.2, 26.0, 25.9, 25.4, 25.0, 
24.9, 24.0, 23.9, 23.3, 23.0, 22.9, 19.7, 18.9, 18.8, 18.6, 18.5, 18.3, 18.2, -3.3, -3.5, -3.6,  
-3.8, -3.9, -4.1, -4.2, -4.3, -4.4, -4.8, -4.9. 
 
HRMS (ESI) 
 Calculated for C73H128INO18Si4 (M + Na)
+
:   1552.7202 
 Found:       1552.7260 
 
 
 
TLC (20% EtOAc/hexanes) 
 Rf = 0.49, stained by anisaldehyde 
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1
H NMR (500 MHz, acetone-d6) 
δ 6.59 (dd, J = 8.0, 14.5 Hz, 1H), 6.16 (dd, J = 1.0 Hz, 14.5 Hz, 1H), 3.89 (t, J = 5.5 Hz, 
1H), 3.80-3.74 (m, 1H), 3.52 (d, J = 4.5 Hz, 1H), 2.56-2.49 (m, 1H), 1.76-1.69 (m, 1H), 
1.09 (d, J = 6.5 Hz, 3H), 1.01 (d, J = 7.0 Hz, 3H), 0.91 (s, 9H), 0.85 (d, J = 7.5 Hz, 3H), 
0.08 (s, 3H), 0.08 (s, 3H). 
 
13
C NMR (125 MHz, acetone-d6) 
δ 152.0, 76.7, 75.4, 68.4, 68.3, 47.0, 46.9, 44.3, 26.4, 21.2, 21.1, 18.8, 15.1, 11.4, -3.9. 
 
HRMS (ESI) 
 Calculated for C15H31O2SiI (M + H)
+
:   399.1216 
 Found:       399.1235 
 
 
 
Dienyl MIDA Boronate 3.14  
A 20 mL I-Chem vial equipped with a stir bar was charged with methyl ester 3.11 (0.173 g, 
0.113 mmol) and bisborylated compound 3.13
4,30
 (0.072 g, 0.237 mmol), sealed under argon, and 
was taken into a glove box. PdCl2dppf∙CH2Cl2 (0.0048 g, 0.0059 mmol) and K3PO4 as a finely 
ground powder (0.0719 g, 0.339 mmol) were added followed by DMSO (3.8 mL). The reaction 
was sealed with a PTFE-lined cap and stirred at 23 
o
C for 24 h. The solution was diluted with 
EtOAc (10 mL) and filtered through a pad of silica gel, washing with EtOAc (100 mL). The 
filtrate was washed with brine (3 x 20 mL) and the combined aqueous layers were back-extracted 
with EtOAc (75 mL). The combined organic layers were dried over Na2SO4 and concentrated in 
vacuo. The crude material was purified via flash chromatography (SiO2; 50% → 100 % 
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EtOAc/hexanes) to furnish dienyl MIDA boronate 3.14 as a white solid (0.128 g, 0.081 mmol, 
71%). The product was isolated as a 1:1 mixture of 1,2- and 1,3-ketal constitutional isomers. 
 
TLC (EtOAc) 
 Rf = 0.50, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.32-7.28 (m, 8H), 7.25-7.22 (m, 2H), 6.61 (dd, J = 10.0, 17.0 Hz, 1H), 6.60 (dd, J = 
10.5, 17.5 Hz, 1H), 6.40 (d, J = 8.5 Hz, 1H), 6.38 (d, J = 7.5 Hz, 1H), 6.33 (dd, J = 10.5, 
15.0 Hz, 1H), 6.32 (dd, J = 10.5, 15.0 Hz, 1H), 5.69 (d, J = 17.5 Hz, 1H), 5.68 (d, J = 
17.5 Hz, 1H), 5.63 (dd, J = 8.0, 15.5 Hz, 1H), 5.62 (dd, J = 8.0, 15.5 Hz, 1H), 4.62 (s, 
1H), 4.61 (s, 1H), 4.39-4.35 (m, 2H), 4.29-4.14 (m, 10H), 4.06-3.98 (m, 6H), 3.94-3.89 
(m, 3H), 3.88-3.81 (m, 1H), 3.79-3.71 (m, 4H), 3.69 (s, 3H), 3.68 (s, 3H), 3.65-3.53 (m, 
8H), 3.61 (s, 3H), 3.56 (s, 3H), 3.40-3.34 (m, 2H), 3.14 (s, 3H), 3.10 (s, 3H), 2.99 (s, 6H), 
2.42 (d, J = 6.0 Hz, 4H), 2.29-2.10 (m, 6H), 1.92-1.89 (m, 8H), 1.85-1.71 (m, 10H), 1.68-
1.46 (m, 32H), 1.37-1.22 (m, 6H), 1.19 (d, J = 7.0 Hz, 3H), 1.18 (d, J = 6.0 Hz, 3H), 
0.92-0.84 (m, 72H), 0.15- -0.02 (m, 48H). 
 
13
C NMR (125 MHz, acetone-d6) 
δ 173.4, 173.3, 171.5, 170.3, 170.2, 169.0, 168.9, 142.7, 142.6, 136.3, 136.1, 135.9, 
135.0, 134.8, 130.2, 129.1, 127.4, 118.5, 110.9, 110.8, 110.5, 101.3, 101.1, 99.8, 99.7, 
81.7, 78.2, 77.7, 77.6, 75.4, 74.8, 74.7, 74.5, 73.4, 71.9, 71.0, 70.5, 68.6, 68.4, 68.3, 67.8, 
67.4, 67.2, 62.4, 62.3, 58.4, 58.3, 56.0, 51.9, 51.6, 48.5, 47.4, 44.1, 43.9, 43.7, 43.6, 43.2, 
42.0, 41.6, 41.2, 40.9, 40.8, 40.3, 38.1, 38.0, 37.3, 33.4, 33.2, 32.2, 31.7, 28.5, 28.4, 26.5, 
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26.4, 26.3, 26.2, 26.0, 25.9, 25.4, 25.2, 25.0, 24.9, 24.0, 23.9, 23.3, 23.0, 22.9, 19.9, 18.9, 
18.8, 18.6, 18.5, 18.3, 18.2, -3.4, -3.5, -3.6, -3.7, -3.8, -3.9, -4.0, -4.2, -4.3, -4.4, -4.8, -4.9. 
 
HRMS (ESI) 
 Calculated for C80H137BN2O21Si4 (M + Na)
+
: 1607.8782 
 Found:       1607.8798 
 
 
Vinyl iodide 3.21 
To a slurry of CrCl2 (10.4 g, 86.25 mmol, 15 eq) in THF (48 mL) was added dropwise via 
cannulation aldehyde 3.20
4
 (1.82 g, 5.75 mmol, 1 eq) and iodoform (11.3 g, 28.75 mmol, 5 eq) in 
dioxane:THF 2:1 (100 mL). After stirring at 23 °C for 5 minutes, the reaction was poured into 
saturated aqueous NaHCO3 (500 mL) and diluted with Et2O (500 mL). The green mixture was 
filtered through celite, washing with Et2O (250 mL) and the filtrate layers were separated. The 
aqueous layer was extracted with Et2O (2 x 250 mL). The combined organic extracts were dried 
over Na2SO4 and concentrated in vacuo. Purification of the crude product by flash 
chromatography (SiO2; 0 → 10% EtOAc/hexanes) provided the title compound 3.21 (2.10 g, 
4.77 mmol, 83%) as a pale yellow oil.  
 
TLC (10% EtOAc/hexanes) 
 Rf = 0.38, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 6.56 (dd, J = 10.5, 18.0 Hz, 1H), 6.22 (dd, J = 1.0, 18.0 Hz, 1H), 5.07 (p, J = 7.0 Hz, 
1H), 3.65 (dd, J = 5.5, 8.0 Hz, 1H), 2.54-2.44 (m, 1H), 1.97 (s, 3H), 1.95-1.86 (m, 1H), 
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1.12 (d, J = 8.0 Hz, 3H), 0.99 (t, J = 9.0 Hz, 9H),  0.96 (d, J = 7.0 Hz, 3H), 0.90 (d, J = 
9.0 Hz, 3H), 0.65 (q, J = 10.5 Hz, 6H). 
 
13
C NMR (100 MHz, acetone-d6) 
δ 170.1, 151.2, 77.3, 76.3, 71.3, 44.2, 42.7, 21.2, 16.1, 13.7, 11.1, 7.3, 6.0.  
 
HRMS (ESI+) 
 Calculated for C17H33O3SiI (M + H)
+
:  441.1332 
 Found:       441.1317 
 
IR (thin film, cm
-1
) 
 2960, 2912, 2877, 2254, 1724, 1460, 1375, 1250, 1082. 1018, 953, 910, 732, 649. 
 
 
Secondary Alcohol 3.22 
To vinyl iodide 3.21 (2.10 g, 4.77 mmol, 1 eq) in DCM (80 mL) at -78 °C was added dropwise 
DIBAL (1M in hexanes, 21 mL, 21 mmol, 4.4 eq). The reaction was stirred at -78 °C for 30 
minutes then MeOH (50 mL) was added and the ice bath was removed. The reaction was 
allowed to warm for 10 minutes then was poured into saturated aqueous potassium sodium 
tartrate (500 mL). The mixture was stirred at 23 °C for 1h and was then extracted with Et2O (3 x 
500 mL), dried over Na2SO4, and concentrated. The crude material was purified via flash 
chromatography (SiO2; 25% EtOAc/hexanes) to yield 3.22 (1.73 g, 4.34 mmol, 91%) as a pale 
yellow oil. 
 
TLC (25% EtOAc/hexanes) 
 Rf = 0.55, stained by anisaldehyde. 
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1
H NMR (400 MHz, acetone-d6) 
δ 6.59 (dd, J = 8.0, 14.4 Hz, 1H), 6.19 (dd, J = 1.2, 14.8 Hz, 1H), 3.84-3.79 (m, 2H), 3.51 
(d, J = 4.0 Hz, 1H), 2.54-2.46 (m, 1H), 1.77-1.68 (m, 1H), 1.07 (d, J = 6.0 Hz, 3H), 1.00 
(d, J = 6.8 Hz, 3H), 0.98 (t, J = 8.0 Hz, 9H), 0.83 (d, J = 7.2 Hz, 3H), 0.63 (q, J = 8.0 Hz, 
6H). 
 
13
C NMR (100 MHz, acetone-d6) 
δ 151.9, 77.4, 75.7, 68.1, 46.5, 44.3, 20.6, 14.5, 11.2, 7.3, 5.9. 
 
HRMS (ESI+) 
 Calculated for C15H31O2SiI (M + H)
+
:  399.1216 
 Found:       399.1223 
 
IR (thin film, cm
-1
) 
 3498, 2962, 2912, 2879, 2254, 1459, 1383, 1242, 1093, 1004, 908, 733. 
 
 
Dienyl MIDA Boronate 3.23 
A 40 mL I-Chem vial equipped with a stir bar was charged with vinyl iodide 3.22 (0.250 g, 0.635 
mmol, 1 eq) and bisborylated compound 3.13
4,30
 (0.174 g, 0.572 mmol, 0.9 eq), sealed under 
argon, and was taken into a glove box. PdCl2dppf∙CH2Cl2 (0.026 g, 0.0318 mmol, 5 mol%) and 
K3PO4 as a finely ground powder (0.405 g, 1.91 mmol, 3 eq) were added, followed by DMSO 
(21 mL). The reaction was sealed with a PTFE-lined cap, removed from the glovebox, and 
stirred at 23 C for 24 hours. The solution was then diluted with EtOAc (10 mL) and filtered 
through a pad of silica gel, washing with EtOAc (70 mL). The filtrate was washed with water (3 
x 50 mL) and brine (1 x 50 mL) and the combined aqueous layers were extracted with EtOAc (3 
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x 50 mL). The combined organic layers were dried over Na2SO4 and concentrated in vacuo. The 
residue was dissolved in acetone (10 mL), celite was added to the solution, and the mixture was 
concentrated in vacuo. The resulting powder was dry-loaded on top of a flash column and 
purified (SiO2; 50% EtOAc/hexanes → EtOAc → 10% MeCN/EtOAc) to yield the desired 
product 3.23 (0.168 g, 0.370 mmol, 65%) as a pale yellow solid. 
 
TLC (EtOAc) 
 Rf = 0.38, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 6.54 (dd, J = 10.0, 17.5 Hz, 1H), 6.12 (dd, J = 10.0, 15.5 Hz, 1H), 5.81 (dd, J = 8.0, 
15.0 Hz, 1H), 5.56 (d, J = 15.5 Hz, 1H), 4.19 (dd, J = 1.5, 17.0 Hz, 2H), 4.00 (dd, J = 1.0, 
17.0 Hz, 2H), 3.84-3.80 (m, 2H), 3.47 (d, J = 4.0 Hz, 1H), 2.98 (s, 3H), 2.49-2.43 (m, 
1H), 1.76-1.69 (m, 1H), 1.05 (d, J = 6.0 Hz, 3H), 1.01 (d, J = 6.5 Hz, 3H), 0.96 (t, J = 8.0 
Hz, 9H), 0.84 (d, J = 7.0 Hz, 3H), 0.62 (q, J = 8.0 Hz, 6H).  
 
13
C NMR (125 MHz, acetone-d6) 
δ 169.1, 169.0, 143.7, 140.6, 132.6, 78.4, 68.3, 62.2, 47.3, 46.7, 40.9, 20.8, 16.0, 11.5, 
7.3, 5.9. 
 
HRMS (ESI+) 
 Calculated for C22H40O6NBSi (M + H)
+
:  454.2796 
 Found:       454.2801 
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Dienyl iodide 3.24 
To dienyl MIDA boronate 3.23 (25 mg, 0.0551 mmol, 1 eq) in THF (0.280 mL) was added 3 M 
NaOH (0.092 mL, 0.275 mmol, 5 eq). The reaction was stirred at 23 C for 10 minutes then 
cooled to 0 C over 5 minutes. A solution of I2 (0.2M in THF, 0.290 mL, 0.058 mmol, 1.05 eq) 
was added dropwise over 5 minutes. The reaction was stirred at 0 C for 15 minutes and was 
then quenched with saturated aqueous Na2S2O3 (2 mL) and diluted with Et2O (10 mL). The 
layers were separated and the aqueous layer was extracted with Et2O (2 x 5 mL) and the 
combined organic layers were dried over Na2SO4 and concentrated. The residue was pushed 
through a plug of silica gel with Et2O to give dienyl iodide 3.24 (22.5 mg, 0.0530 mmol, 96%) as 
a pale yellow oil. 
 
TLC (20% EtOAc/hexanes) 
 Rf = 0.48, stained by anisaldehyde. 
 
1
H NMR (400 MHz, acetone-d6) 
δ 7.05 (dd, J = 10.4, 14.4 Hz, 1H), 6.38 (d, J = 14.4 Hz, 1H), 6.08 (dd, J = 10.8, 15.6 Hz, 
1H), 5.86 (dd, J = 8.0, 15.2 Hz, 1H), 3.85-3.76 (m, 2H), 3.46 (d, J = 5.5 Hz, 1H), 2.49-
2.40 (m, 1H), 1.76-1.68 (m, 1H), 1.06 (d, J = 6.0 Hz, 3H), 1.01 (d, J = 6.8 Hz, 3H), 0.96 
(t, J = 8.0 Hz, 9H), 0.84 (d, J = 7.2 Hz, 3H), 0.62 (q, J = 7.6 Hz, 6H). 
 
HRMS (ESI+) 
 Calculated for C17H33O2SiI (M + H)
+
:  425.1373 
 Found:       425.1376 
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Acylated alcohol 3.32  
To monosilylated alcohol 3.32
19
 (0.875 g, 2.39 mmol, 1 eq) in pyridine (24 mL) at 0 
°
C was 
added DMAP (0.029g, 0.239 mmol, 0.1 eq) and acetic anhydride (0.45 mL, 4.77 mmol, 2 eq). 
The reaction was stirred at 23 °C for 6 hours and then concentrated in vacuo. The crude material 
was purified via flash chromatography (SiO2; 10% EtOAc/hexanes) to yield the title compound 
3.29 as a colorless oil (0.924 g, 2.26 mmol, 95%). 
 
TLC (25% EtOAc/hexanes) 
Rf = 0.56, stained by anisaldehyde. 
 
1
H NMR (500 MHz, CDCl3) 
 7.35-7.27 (m, 5H), 4.96 (p, J = 6.5 Hz, 1H), 4.47 (d, J = 11.5 Hz, 1H), 4.42 (d, J = 12 
Hz, 1H), 3.91 (dd, J = 2.0, 6.0 Hz, 1H), 3.33 (app t, J = 8.5 Hz, 1H), 3.20 (dd, J = 6.0, 8.5 
Hz, 1H), 1.96-1.86 (m, 2H), 1.88 (s, 3H), 1.16 (d, J = 6.0 Hz, 3H), 0.89 (s, 9H), 0.88 (d, J 
= 7.0 Hz, 3H), 0.85 (d, J = 7.0 Hz, 3H), 0.08 (s, 3H), 0.03 (s, 3H). 
 
13
C NMR (125 MHz, CDCl3) 
 170.5, 138.6, 128.3, 127.7, 127.4, 73.7, 72.8, 71.9, 71.2, 43.1, 35.2, 26.0, 21.2, 18.3, 
16.8, 11.3, 11.1, -4.0, -4.5. 
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HRMS (ESI+) 
calculated for C23H40O4Si (M+H)
+
:     409.2774 
found:                                                     409.2780 
 
IR (thin film, cm
-1
) 
2254, 1724, 1471, 1379, 1254, 1095, 1045, 908, 735, 650. 
 
Primary alcohol 3.58 
To acylated alcohol 3.29 (0.920 g, 2.25 mmol, 1 eq) in THF (23 mL) was added palladium on 
activated carbon (5 wt. % dry basis, wet, Degussa type E101 NO/W) (480 mg, 0.113 mmol Pd, 
0.05 eq). The flask was purged with H2 and the reaction was stirred at 23 °C under H2 balloon 
pressure for 1h. The reaction was filtered through a pad of silica gel with EtOAc and 
concentrated in vacuo. The crude material was purified by flash chromatography (SiO2; 50% 
EtOAc/hexanes) to provide primary alcohol 3.58 as a colorless oil (0.715 g, 2.24 mmol, 100%).  
 
TLC (25% EtOAc/hexanes) 
Rf = 0.27, stained by anisaldehyde. 
 
1
H NMR (500 MHz, CDCl3) 
 5.00 (p, J = 7.0 Hz, 1H), 3.88 (dd, J = 2.0, 5.5 Hz, 1H), 3.45 (d, J = 7.0 Hz, 2H), 2.03 
(s, 3H), 1.93 (app sext, J = 6.0 Hz, 1H), 1.81 (d sext, J = 2.0, 7.0 Hz, 1H), 1.17 (d, J = 6.5 
Hz, 3H), 0.91 (d, J = 7.0 Hz, 3H), 0.90 (s, 9H), 0.85 (d, J = 7.0 Hz, 3H), 0.09 (s, 3H), 
0.07 (s, 3H). 
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13
C NMR (100 MHz, CDCl3) 
 170.8, 71.8, 71.4, 66.2, 43.3, 37.8, 26.0, 21.4, 18.3, 17.0, 11.4, 11.2, -4.1, -4.5. 
 
HRMS (ESI+) 
calculated for C16H34O4Si (M+Na)
+
:    341.2124 
found:                                                     341.2125 
 
IR (thin film, cm
-1
) 
 3475, 2956, 2931, 2887, 2858, 1736, 1716, 1471, 1375, 1252, 1092, 1045, 837, 773. 
 
Aldehyde 3.58 
To primary alcohol 3.58 (0.715 g, 2.24 mmol, 1 eq) in CH2Cl2 (32 mL) was added Dess-Martin 
periodinane (1.43 g, 3.37 mmol, 1.5 eq) and water (0.012 mL, 0.67 mmol, 0.3 eq). The reaction 
was stirred at 23 °C for 30 minutes. Saturated aqueous NaHCO3 (80 mL) and saturated aqueous 
Na2S2O3 (40 mL) were added, and the reaction was stirred an additional 30 minutes.  The layers 
were separated and the aqueous layer was extracted with Et2O (3 x 50 mL). The combined 
organic extracts were dried over Na2SO4 and concentrated in vacuo to yield aldehyde 3.33 (0.665 
g, 2.10 mmol, 94%), which was used without further purification. 
 
TLC (25% EtOAc/hexanes) 
Rf = 0.42, stained by anisaldehyde. 
 
 
 
115 
 
1
H NMR (400 MHz, acetone-d6) 
 9.68 (s, 1H), 5.03 (p, J = 8.0 Hz, 1H), 4.38 (dd, J = 2.8, 6.8 Hz, 1H), 2.55 (dq, J = 2.8, 
7.2 Hz, 1H), 2.03-1.94 (m, 1H), 1.98 (s, 3H), 1.17 (d, J = 6.4 Hz, 3H), 1.09 (d, J = 7.2 
Hz, 3H), 0.94 (d, J = 7.2 Hz, 3H), 0.87 (s, 9H), 0.12 (s, 3H), 0.00 (s, 3H). 
 
13
C NMR (100 MHz, acetone-d6) 
 204.9, 170.3, 71.6, 71.4, 49.9, 43.5, 26.3, 21.1, 18.8, 16.2, 11.1, 8.0, -4.0, -4.2. 
 
HRMS (ESI+) 
calculated for C16H32O4Si (M+Na)
+
:     339.1968 
found:                                                      339.1966 
 
IR (thin film, cm
-1
) 
 2956, 2931, 2887, 2858, 2710, 1732, 1464, 1373, 1244, 1090, 1030, 949, 839, 775, 673. 
 
Vinyl iodide 3.34. To a slurry of CrCl2 (3.81 g, 31.5 mmol, 15 eq) in THF (19 mL) was added 
dropwise via cannulation aldehyde 3.33 (0.665 g, 2.10 mmol, 1 eq) and iodoform (4.14 g, 10.5 
mmol, 5 eq) in dioxane:THF 2:1 (36 mL). After stirring at 23 °C for 5 minutes, the reaction was 
poured into saturated aqueous NaHCO3 (250 mL) and diluted with Et2O (250 mL). The green 
mixture was filtered through celite, washing with Et2O (100 mL) and the filtrate layers were 
separated. The aqueous layer was extracted with Et2O (2 x 100 mL). The combined organic 
extracts were dried over Na2SO4 and concentrated in vacuo. Purification of the crude product by 
flash chromatography (SiO2; 0 → 10% EtOAc/hexanes) provided the title compound 3.34 as a 
pale yellow oil (0.450 g, 1.02 mmol, 49%).  
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TLC (25% EtOAc/hexanes) 
Rf = 0.60, stained by anisaldehyde. 
 
1
H NMR (400 MHz, acetone-d6) 
 6.56 (dd, J = 7.6, 14.4 Hz, 1H), 6.20 (d, J = 14.4 Hz, 1H), 5.07 (p, J = 6.4 Hz, 1H), 3.67 
(dd, J = 4.4, 6.0 Hz, 1H), 2.54-2.45 (m, 1H), 1.97 (s, 3H), 1.96-1.87 (m, 1H), 1.13 (d, J = 
6.4 Hz, 3H), 1.01 (d, J = 6.8 Hz, 3H), 0.92 (s, 9H), 0.91 (d, J = 6.8 Hz, 3H), 0.11 (s, 3H), 
0.10 (s, 3H). 
 
13
C NMR (100 MHz, acetone-d6) 
 170.2, 151.3, 76.7, 76.0, 71.5, 44.2, 43.2, 26.5, 21.2, 18.9, 16.5, 14.2, 11.2, -3.7, -3.9. 
 
HRMS (ESI+) 
calculated for C17H33O3SiI (M+Na)
+
:     463.1141 
found:                                                      463.1142 
 
IR (thin film, cm
-1
) 
 2956, 2931, 2885, 2858, 1732, 1705, 1462, 1373, 1246, 1063, 951, 837, 775, 669. 
 
 
Secondary alcohol 3.35 
To vinyl iodide 3.34 (0.450 g, 1.02 mmol, 1 eq) in MeOH:THF 2:1 (27 mL) was added K2CO3 
(1.41 g, 10.2 mmol, 10 eq). The reaction was stirred at 40 C for 2.5 hours and then the reaction 
was poured into water (200 mL) and diluted with Et2O (200 mL). The layers were separated and 
the aqueous layer was extracted with Et2O (2 x 200 mL). The combined organic extracts were 
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dried over Na2SO4 and concentrated. The crude material was purified by flash chromatography 
(SiO2; 10% EtOAc/hexanes) to provide secondary alcohol 3.35 (0.350 g, 0.879 mmol, 86%).  
 
TLC (25% EtOAc/hexanes) 
Rf = 0.50, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
 6.59 (dd, J = 8.5, 14.0 Hz, 1H), 6.16 (dd, J = 1.0, 14.0 Hz, 1H), 3.89 (app t, J = 5.0 Hz, 
1H), 3.80-3.73 (m, 1H), 3.52 (d, J = 4.5 Hz, 1H), 2.56-2.49 (m, 1H), 1.76-1.69 (m, 1H), 
1.09 (d, J = 6.5 Hz, 3H), 1.01 (d, J = 6.5 Hz, 3H), 0.91 (s, 9H), 0.85 (d, J = 7.0 Hz, 3H), 
0.08 (s, 6H). 
 
13
C NMR (100 MHz, acetone-d6) 
 151.8, 76.6, 75.3, 68.3, 46.8, 44.2, 26.4, 21.2, 18.7, 15.1, 11.5, -3.9. 
 
HRMS (ESI+) 
calculated for C15H31O2SiI (M+H)
+
:     399.1216 
found:                                                      399.1235 
 
IR (thin film, cm
-1
) 
3431, 1958, 2929, 2885, 2858, 1605, 1462, 1383, 1255, 1188, 1082, 1022, 955, 837, 775, 
669. 
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Dienyl MIDA boronate 3.36 
A 40 mL I-Chem vial equipped with a stir bar was charged with vinyl iodide 3.35 (0.350 g, 0.879 
mmol, 1 eq) and bisborylated compound 3.13
4,30
 (0.241 g, 0.791 mmol, 0.9 eq), sealed under 
argon, and was taken into a glove box. PdCl2dppf∙CH2Cl2 (0.037 g, 0.046 mmol, 5 mol%) and 
K3PO4 as a finely ground powder (0.560 g, 2.64 mmol, 3 eq) were added, followed by DMSO 
(29 mL). The reaction was sealed with a PTFE-lined cap, removed from the glovebox, and 
stirred at 23 C for 24 hours. The solution was then diluted with EtOAc (10 mL) and filtered 
through a pad of silica gel, washing with EtOAc (70 mL). The filtrate was washed with water (3 
x 50 mL) and brine (1 x 50 mL) and the combined aqueous layers were extracted with EtOAc (3 
x 50 mL). The combined organic layers were dried over Na2SO4 and concentrated in vacuo. The 
residue was dissolved in acetone (10 mL), celite was added to the solution, and the mixture was 
concentrated in vacuo. The resulting powder was dry-loaded on top of a flash column and 
purified (SiO2; 50% EtOAc/hexanes → EtOAc → 10% MeCN:EtOAc) to yield the desired 
product 3.36 (0.293 g, 0.646 mmol, 82%) as a pale yellow solid. 
 
TLC (EtOAc) 
Rf = 0.30, stained by KMnO4. 
 
1
H NMR (500 MHz, acetone-d6) 
 6.53 (dd, J = 10.0, 17.0 Hz, 1H), 6.11 (dd, J = 10.5, 15.5 Hz, 1H), 5.81 (dd, J = 8.0, 
15.5 Hz, 1H), 5.55 (d, J = 17.0 Hz, 1H), 4.20 (dd, J = 2.0, 17.0 Hz, 2H), 4.00 (d, J = 16.5 
Hz, 2H), 3.88 (t, J = 5.5 Hz, 1H), 3.81-3.75 (m, 1H), 3.47 (d, J = 4.0 Hz, 1H), 2.98 (s, 
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3H), 2.52-2.45 (m, 1H), 1.76-1.69 (m, 1H), 1.06 (d, J = 6.0 Hz, 3H), 1.02 (d, J = 6.5 Hz, 
3H), 0.91 (s, 9H), 0.85 (d, J = 7.0 Hz, 3H), 0.07 (s, 3H), 0.06 (s, 3H). 
 
13
C NMR (100 MHz, acetone-d6) 
 169.1, 143.8, 140.7, 132.4, 77.7, 68.4, 62.2, 47.3, 47.1, 40.9, 26.4, 21.3, 18.8, 16.6, 
11.7, -3.8, -3.9. 
 
11
B NMR (128 MHz, acetone-d6) 
 δ 11.3. 
 
HRMS (EI+) 
calculated for C22H40O6NSiB (M)
+
:     453.27180 
found:                                                      453.27235 
 
IR (thin film, cm
-1
) 
3502, 2960, 2931, 2894, 2858, 1764, 1701, 1645, 1604, 1462, 1338, 1292, 1251, 1120, 
1084, 1006, 837, 775. 
 
 
Dienyl iodide 3.8 
To dienyl MIDA boronate 3.36 (10 mg, 0.0221 mmol, 1 eq) in THF (0.060 mL) was added 3 M 
aqueous NaOH (0.037 mL, 0.110 mmol, 5 eq). The reaction was stirred at 23 
o
C for 10 minutes, 
then I2 (11.2 mg, 0.044 mmol, 2 eq) in THF (0.220 mL) was added dropwise over 5 minutes. The 
reaction was stirred at 23 
o
C for 2 hours and then was quenched with 0.5 M pH 7 phosphate 
buffer (1 mL) and diluted with Et2O (5 mL). The layers were separated and the aqueous layer 
was extracted with Et2O (2 x 10 mL). The combined organic layers were washed with saturated 
Na2S2O3 (10 mL). The aqueous layer was back-extracted with Et2O (10 mL) and the combined 
organic layers were dried over Na2SO4 and concentrated. The residue was pushed through a plug 
120 
 
of silica gel with 20% EtOAc/hexanes to give dienyl iodide 3.8 (8.4 mg, 0.0198 mmol, 90 %) as 
a pale yellow oil. 
 
 
TLC (25% EtOAc/hexanes) 
Rf = 0.72, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
 δ 7.04 (dd, J = 10.5, 14.5 Hz, 1H), 6.37 (d, J = 14.5 Hz, 1H), 6.07 (dd, J = 10.5, 15.5 Hz, 
1H), 5.86 (dd, J = 8.0, 15.5 Hz, 1H), 3.88 (t, J = 5.0 Hz, 1H), 3.78-3.74 (m, 1H), 3.44 (d, 
J = 4.5 Hz, 1H), 2.46 (app. sextet, J = 7.0 Hz, 1H), 1.74-1.69 (m, 1H), 1.07 (d, J = 6.0 
Hz, 3H), 1.01 (d, J = 7.0 Hz, 3H), 0.91 (s, 9H), 0.85 (d, J = 7.0, 3H), 0.07 (s, 3H), 0.06 (s, 
3H). 
 
 
13
C NMR (125 MHz, acetone-d6) 
 146.7, 141.4, 130.1, 77.4, 77.3, 68.5, 47.2, 40.8, 26.4, 26.3, 21.4, 18.8, 16.4, 11.7, -3.8, 
-3.9. 
 
HRMS (ESI+)  
calculated for C17H33O2SiI (M+Na)
+
:     447.1192 
found:                                                      447.1172 
 
IR (thin film, cm
-1
) 
 3452, 2956, 2929, 2856, 1639, 1462, 1381, 1362, 1254, 1064, 1004, 983, 837, 775. 
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Dienyl pinacolboronic ester 3.40 
A 20-mL I-Chem vial was charged with dienyl MIDA boronate 3.14 (0.050 g, 0.0315 mmol, 1 
eq), pinacol (4.5 mg, 0.0378 mmol, 1.2 eq), solid NaHCO3 (13.2 mg, 0.158 mmol, 5 eq) and 
MeOH (0.630 mL) was then added. The reaction was stirred at 45 C for 3 hours and then was 
concentrated in vacuo and finely ground anhydrous CaCl2 (7.0 mg, 0.063 mmol, 2 eq), solid 
NaHCO3 (5.3 mg, 0.063 mmol, 2 eq), and toluene (0.925 mL) were added to the resulting 
residue. The mixture was stirred at 23 C for 45 minutes, filtered through a pad of celite with 
toluene (25 mL) and concentrated to yield 3.40 (0.046 g, 0.0295 mmol, 93%) as a white solid. 
The product was used directly in the next reaction without further purification. The product was 
isolated as a 1:1 mixture of 1,2- and 1,3-ketal constitutional isomers. 
 
TLC (EtOAc) 
Rf = 0.80, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
 δ 7.35-7.11 (m, 10H), 6.96 (dd, J = 9.5, 17.5 Hz, 1H), 6.95 (dd, J = 10.0, 17.5 Hz, 1H), 
6.39-6.33 (m, 2H), 5.82 (dd, J = 7.5, 15.5 Hz, 2H), 5.49 (dd, J = 3.5, 17.5 Hz, 2H), 4.64 
(s, 1H), 4.62 (s, 1H), 4.42-4.38 (m, 2H), 4.28-4.14 (m, 4H), 4.02-3.98 (m, 2H), 3.96-3.89 
(m, 2H), 3.80-3.72 (m, 4H), 3.69 (s, 3H), 3.68 (s, 3H), 3.67-3.56 (m, 10H), 3.61 (s, 3H), 
3.57 (s, 3H), 3.37 (q, J = 7.0 Hz, 2H), 3.15 (s, 3H), 3.11 (s, 3H), 2.42-2.38 (m, 4H), 2.26-
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2.14 (m, 6H), 1.98-1.89 (m, 8H), 1.84-1.49 (m, 44H), 1.36-1.33 (m, 8H), 1.24 (s, 12H), 
1.19 (d, J = 6.5 Hz, 6H), 1.16 (s, 12H), 0.93-0.84 (m, 72H), 0.15-0.00 (m, 48H).  
 
Pentaenyl MIDA Boronate 3.17 
A 7 mL Wheaton vial equipped with a stir bar was charged with pinacolboronic ester 3.40 (0.014 
g, 0.00899 mmol, 1 eq) and trienyl iodide 3.7
22
 (4.9 mg, 0.0135 mmol, 1.5 eq), sealed under 
argon, and taken into a glove box. PdCl2dppf∙CH2Cl2 (1.5 mg, 0.00179 mmol, 20 mol%) and 
K3PO4 as a finely ground powder (11.4 mg, 0.0539 mmol, 6 eq) were added, followed by DMSO 
(0.450 mL). The reaction was sealed with a PTFE-lined cap, removed from the glove box and 
stirred at 45 C for 12.5 hours. The solution was diluted with EtOAc (5 mL) and filtered through 
a pad of silica gel, washing with EtOAc (25 mL). The filtrate was washed with water (3 x 25 
mL) and brine (25 mL).  The combined aqueous layers were back-extracted with EtOAc (1 x 50 
mL). The combined organic extracts were dried over Na2SO4 and concentrated in vacuo. The 
crude material was purified via flash chromatography (SiO2; 50% → 100% EtOAc/hexanes) to 
furnish pentenyl MIDA boronate 3.17 (7.6 mg, 0.00457 mmol, 51%) as a white solid. The 
product was isolated as a 1:1 mixture of 1,2- and 1,3-ketal constitutional isomers. 
 
TLC (EtOAc) 
 Rf = 0.31, stained by anisaldehyde. 
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1
H NMR (500 MHz, acetone-d6) 
δ 7.32-7.28 (m, 8H), 7.25-7.22 (m, 2H), 6.62 (dd, J = 10.0, 17.5 Hz, 2H), 6.40-6.34 (m, 
16H), 5.72 (d, J = 17.0 Hz, 2H), 5.69-5.61 (m, 2H), 4.62 (s, 1H), 4.60 (s, 1H), 4.40-4.36 
(m, 2H), 4.27-4.14 (m, 10H), 4.07-3.98 (m, 6H), 3.94-3.91 (m, 3H), 3.88-3.81 (m, 1H), 
3.80-3.71 (m, 4H), 3.69 (s, 3H), 3.73 (s, 3H), 3.64-3.54 (m, 8H), 3.61 (s, 3H), 3.56 (s, 
3H), 3.38-3.34 (m, 2H), 3.15 (s, 3H), 3.10 (s, 3H), 2.99 (s, 6H), 2.42 (d, J = 7.0 Hz, 4H), 
2.28-2.12 (m, 6H), 1.98-1.89 (m, 8H), 1.85-1.71 (m, 10H), 1.69-1.48 (m, 32H), 1.40-1.25 
(m, 6H), 1.19 (d, J = 7.0 Hz, 3H), 1.18 (d, J = 6.0 Hz, 3H), 0.92-0.84 (m, 72H), 0.15- -
0.02 (m, 48H). 
 
HRMS (ESI) 
 Calculated for C86H143BN2O21Si4 (M + Na)
+
: 1685.9251 
 Found:       1685.9270 
 
 
Amphotericin B Macrolactone 3.38 
 A solution of the palladium catalyst was prepared as follows: To a 1.5 mL vial equipped with a 
stir bar and containing 2-dicyclohexylphosphino-2’,4’,6’-tri-i-propyl-1,1’-biphenyl ligand (1.3 
mg, 0.0027 mmol) was added a solution of Pd(OAc)2 in toluene (0.0073 M , 0.188 mL, 0.0014 
mmol). The vial was sealed with a PTFE-lined cap and maintained at 23 
o
C with stirring for 15 
minutes. 
This catalyst solution was then utilized in the following procedure: To pentaenyl MIDA boronate 
3.17 (6.0 mg, 0.0036 mmol, 1.5 eq) and dienyl iodide 3.8 (1.0 mg, 0.0024 mmol, 1.5 eq) was 
added the catalyst stock solution described above (0.033 mL, 0.00024 mmol Pd, 10 mol%). The 
resulting mixture was sealed with a teflon-lined septum cap and 1M aqueous NaOH (0.024 mL, 
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0.024 mmol, 10 eq) was added.  The reaction was stirred at 23 
o
C for 30 minutes then at 45 
o
C 
for 4 hours. The reaction was diluted with EtOAc (10 mL), filtered through a short plug of silica 
gel with EtOAc, and concentrated. The residue was taken up in THF:MeOH:H2O 3:1:1 (0.370 
mL), LiOH (7.8 mg, 0.186 mmol, 78 eq) was added and the vial was sealed under argon. The 
reaction was stirred at 35 
o
C for 1 hour and was then diluted with EtOAc (10 mL) and was 
poured into water (10 mL). The aqueous layer was extracted with EtOAc (5 x 10 mL). The 
combined organic layers were dried over Na2SO4 and concentrated. The residue was dissolved in 
CH2Cl2 (0.6 mL) and was added dropwise over 4 hours to a solution of MNBA (1.1 mg, 0.0032 
mmol, 1.3 eq) and DMAP (0.8 mg, 0.0064 mmol, 2.6 eq) in CH2Cl2 (0.97 mL). The reaction was 
stirred an additional 1.5 hours, cooled to 0 
o
C, and quenched with saturated aqueous NaHCO3 
(10 mL). The layers were separated and the aqueous layer was extracted with Et2O (3 x 10 mL) 
and the combined organic layers were dried over Na2SO4 and concentrated. The crude material 
was purified by flash chromatography (SiO2; 5% → 15% EtOAc/hexanes) to yield macrolactone 
3.38 (1.3 mg, 0.00073 mmol, 31% over 3 steps) as a yellow solid.  The product was isolated as a 
1:1 mixture of 1,2- and 1,3-ketal constitutional isomers. 
 
1
H NMR and HRMS analysis of 3.38 were fully consistent with the data reported above from the 
global protection of amphotericin B (3.10). 
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Bisketal 3.56 
To macrolactone 3.38 (20 mg, 0.0112 mmol, 1 eq) in MeOH (0.165 mL) at 0 °C was added 
0.122 mL of HF∙4 pyridine complex (prepared by adding 0.342 mL 70% HF.pyridine complex to 
2 mL pyridine at 0 
o
C). The resulting reaction mixture was heated to 40 
o
C and stirred for 33 
hours. The reaction was poured into saturated aqueous NaHCO3 (5 mL), extracted with EtOAc (3 
x 10 mL), and dried over Na2SO4. The solution was concentrated and purified by flash 
chromatography (SiO2; 2% → 10% MeOH/DCM) to furnish 3.56 (4.0 mg, 0.00336 mmol, 30%) 
as a yellow solid. HPLC analysis (Waters Sunfire C18 ODB 5 micron 4.6 x 150 mm column 
gradient of 5  95% MeCN in water over 30 minutes) of the reaction mixture matched the 
known product standard.  
 
 
1
H NMR, HPLC, and MS analysis of 3.56 were fully consistent with the data reported above 
from the ketalization of amphotericin B. 
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Methyl Ketal 3.55 
To bisketal 3.56 (2.0 mg, 0.00166 mmol, 1 eq) in MeOH (0.170 mL) at 0 °C was added CSA 
(0.8 mg, 0.00344 mmol, 2 eq). The reaction was stirred at 0 °C for 3 hours and quenched with 
Et3N (0.050 mL) and analyzed by analytical HPLC (Waters Sunfire C18 ODB 5 micron 4.6 x 150 
mm column gradient of 30  95% MeCN in water over 30 minutes).  
 
HPLC analysis of the reaction mixture matched known product standard 3.55 from above. 
 
 
N-phenylacyl AmB 3.59 
To methyl ketal 3.55 (10.0 mg, 0.00934 mmol, 1 eq) in THF:H2O 2:1 (0.9 mL) was added CSA 
(0.5 mg, 0.00233 mmol, 0.25 eq). The reaction was stirred at 23 °C for 16 hours and quenched 
with the addition of solid NaHCO3 (10 mg). The mixture was filtered through celite, 
concentrated in vacuo, and analyzed by analytical HPLC (Waters Sunfire C18 ODB 5 micron 4.6 
x 150 mm column gradient of 5  95% MeCN in water over 30 minutes, tR = 22.1 min). The 
material was taken into the next reaction without purification. To the crude material (~0.00934 
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mmol, 1 eq) in THF:H2O 2:1 (0.315 mL) at 0 °C was added 1M aqueous LiOH (0.094 mL, 0.094 
mmol, 10 eq) and the reaction was allowed to warm to 23 °C. The reaction was stirred at 23 °C 
for 2 hours, concentrated, filtered through celite with MeOH, and analyzed by analytical HPLC 
(Waters Sunfire C18 ODB 5 micron 4.6 x 150 mm column gradient of 5  95% MeCN in 1% 
formic acid over 30 minutes).  
 
HPLC analysis of the reaction mixture matched the known product standard (see procedure for 
formation of 3.54 above). 
 
Purification of Penicillin G Amidase 
Penicillin G amidase (PGA) was purchased from Clea Technologies (Delft, The Netherlands) as 
a crude solution and was purified within one month of use using the following procedure. 2.5 mL 
of the crude PGA solution and 1.6 mL of saturated aqueous ammonium sulfate were each added 
to twelve individual 15 mL centrifuge tubes. The tubes were inverted several times to mix and 
were then left to stand for 5 minutes. Subsequently, the PGA/(NH4)2SO4 solutions were 
centrifuged at 4500xg for 20 minutes at 23 °C and after centrifugation the supernatants were 
transferred to fresh 15 mL centrifuge tubes and the brown pellets were discarded. To each 
supernatant was added 6 mL of saturated (NH4)2SO4 and the tubes were inverted several times to 
mix and then let stand for 5 minutes. Next, the samples were again centrifuged at 4500xg for 20 
minutes at 23 °C. The supernatants were discarded and the pellets were dissolved in 1.1M 
(NH4)2SO4 50 mM TRIS (pH 7.5). The samples were then purified using a 15 x 5 cm phenyl 
sepharose 6 (Sigma-Aldrich, St. Louis, MO) gel column. The sepharose column was pre-
equilibrated with 2 column volumes of 1.1M (NH4)2SO4 50 mM TRIS (pH 7.5) and the samples 
were then loaded. The protein was then eluted with one column volume each of 50 mM TRIS 
(pH 7.5) buffer of decreasing ionic strength in the order: 1.1M (NH4)2SO4, 0.9M (NH4)2SO4, 
0.7M (NH4)2SO4, 0.45M (NH4)2SO4, 0.25M (NH4)2SO4 and then two column volumes of MilliQ 
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H2O. Fractions were collected beginning with the 0.25M (NH4)2SO4 eluent and were analyzed 
for the presence of PGA using SDS-PAGE.  
 The loading buffer was prepared by dissolving 20 mg of dithiothreitol in 500 L 
Laemmli sample buffer (Bio-Rad, Hercules, CA). Then, 15 L of each fraction and 15 L of the 
loading buffer were added to individual 0.6 mL microcentrifuge tubes, mixed and then incubated 
at 95 °C for 5 minutes. The samples were cooled by incubating at 23 °C for 15 minutes and then 
12.5 L of each sample was loaded onto precast Mini-PROTEAN TGX (Bio-Rad) gels. The gels 
were run at 190V for 35 minutes using TRIS/glycine running buffer (125mM TRIS, 1.92M 
glycine, 0.5% SDS, pH 8.3). The gels were then stained with Brillant Blue staining solution 
(Sigma-Aldrich) for 30 minutes with gentle shaking. The stain was decanted and the gels were 
destained by three successive 30 minute destaining cycles using H2O:MeOH:AcOH (45:45:10, 
v/v/v).  Fractions containing PGA were then concentrated using Amicon Ultra centrifugal filter 
units (Sigma-Aldrich). PGA containing fractions were added to the filter units and centrifuged at 
4500xg for 20 minutes at 4 °C. Once all the samples had been concentrated, the collected PGA 
was suspended in 12 mL MilliQ H2O and stored at 4 °C. 
 
 
AmB (3.4) 
To N-phenylacyl AmB 3.59 (1.0 mg, 0.000959 mmol) was added freshly purified PGA solution 
(1 mL). The reaction was stirred at 37 °C for 72 hours then analyzed directly by analytical HPLC 
(Waters Sunfire C18 ODB 5 micron 4.6 x 150 mm column gradient of 5  95% MeCN in 25 
mM ammonium acetate over 30 minutes). The reaction had reached 80% conversion at 72 hours 
and the chromatogram matched the known AmB standard. 
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HPLC 
tR = 20.4 min; flow rate = 1.2 mL/min, Waters Sunfire C18 ODB 5 micron 4.6 x 150 mm 
column gradient of 5 → 65% MeCN in 25 mM ammonium acetate over 30 min. 
Coinjection of the reaction and AmB showed a single product peak. 
 
Bisketal 3.43 
A round bottom flask was charged with amphotericin B (1.5 g, ~55% pure, ca. 0.891 mmol, 1 
eq) and Fmoc-succinimide (0.840 g, 2.48 mmol, 2.8 eq) which were dissolved in a mixture of 
DMF:MeOH 2:1 (105 mL) at 23 °C. Pyridine (0.84 mL, 10.22 mmol, 11.5 eq) was subsequently 
added and the reaction stirred for 12 hours. The reaction mixture was then poured into Et2O (1.8 
L) stirring at 23 
o
C. After stirring for 15 minutes the resulting yellow precipitate was isolated via 
Büchner filtration using Whatman 50 filter paper to afford a yellow solid. Two 1.5 g batches 
were combined and the yellow powder was suspended in MeOH (50 mL) and 1,1’ 
dimethoxycyclopentanone
29
 (15 mL). CSA (0.140 g, 0.605 mmol, 0.2 eq) was added and the 
reaction was stirred at 23 °C for 1 hour. Et3N (0.200 mL, 1.43 mmol, 0.47 eq) was added and the 
reaction concentrated. The crude material was purified via flash chromatography (SiO2; 1% → 
10% MeOH/DCM/0.1% AcOH) to yield 3.43 (2.27g, 1.76 mmol, 60%) as a 2.5:1 mixture of 
ketal constitutional isomers. Only the major isomer characterization is reported. 
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TLC (10% MeOH/DCM/0.1% AcOH) 
 Rf = 0.39, stained by anisaldehyde. 
 
1
H NMR (400 MHz, acetone-d6) 
δ 7.86 (d, J = 7.2 Hz, 2H), 7.74 (d, J = 7.2 Hz, 2H), 7.41 (t, J = 7.2 Hz, 2H), 7.32 (t, J = 
7.6 Hz, 2H), 6.39-6.20 (m, 12H), 5.98-5.89 (m, 1H), 5.61-5.52 (m, 1H), 5.28-5.20 (m, 
1H), 4.72-4.66 (m, 1H), 4.64 (s, 1H), 4.33-4.29 (m, 2H), 4.25-4.09 (m, 4H), 3.97-3.83 
(m, 4H), 3.66-3.58 (m, 3H), 3.37-3.25 (m, 5H), 3.05 (s, 3H), 2.42-2.35 (m, 2H), 2.24-
2.09 (m, 4H), 1.98-1.75 (m, 9H), 1.71-1.53 (m, 14H), 1.43-1.32 (m, 4H), 1.24 (d, J = 5.6 
Hz, 3H), 1.18 (d, J = 6.4 Hz, 3H), 1.09 (d, J = 6.4 Hz, 3H), 1.00 (d, J = 7.2 Hz, 3H).  
 
HRMS (ESI) 
 Calculated for C73H97NO19 (M + Na)
+
:  1314.6553 
 Found:       1314.6534 
 
 
TES ether 3.60 
To 3.43 (1.33 g, 1.03 mmol, 1 eq) in DCM (52 mL) and 2,6-lutidine (3.1 mL, 26.77 mmol, 26 
eq) at 0 °C was added dropwise TESOTf (4.7 mL, 20.59 mmol, 20 eq). The reaction was stirred 
at 0 °C for 1 hour and was quenched with saturated aqueous NaHCO3 (50 mL) for 10 minutes at 
0 °C. The mixture was extracted with Et2O (1 x 250 mL) and the organic layer was washed with 
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saturated aqueous NaHCO3 (1 x 100 mL) and water (1 x 100 mL). The combined aqueous layers 
were extracted with Et2O (1 x 100 mL). The combined organic layers were washed with 
saturated aqueous Cu(II)SO4 (1 x 250 mL). The aqueous layer was extracted with Et2O (1 x 100 
mL). The combined organic layers were washed with water (2 x 100 mL) and brine (1 x 100 
mL), dried over Na2SO4, and concentrated in vacuo. The yellow residue was purified via flash 
chromatography (SiO2; 0% → 20% EtOAc/hexanes) to yield 3.60 (1.31 g, 0.703 mmol, 68%) as 
a yellow solid. The product was isolated as a 2.5:1 mixture of ketal constitutional isomers. Only 
the major isomer characterization is reported. 
 
TLC (20% EtOAc/hexanes) 
 Rf = 0.30, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.87 (d, J = 7.5 Hz, 2H), 7.68 (d, J = 7.0 Hz, 2H), 7.42 (t, J = 7.5 Hz, 2H), 7.33 (t, J = 
7.5 Hz, 2H), 6.38-6.15 (m, 12H), 5.85 (dd, J = 5.5, 15.5 Hz, 1H), 5.63 (dd, J = 9.5, 14.5 
Hz, 1H), 5.38 (d, J = 10.0 Hz, 1H), 4.90 (broad s, 1H), 4.69 (s, 1H), 4.56-4.47 (m, 3H), 
4.35-4.28 (m, 2H), 4.24 (t, J = 6.0 Hz, 1H), 4.12-4.05 (m, 2H), 3.94-3.86 (m, 2H), 3.78-
3.73 (m, 2H), 3.60-3.52 (m, 4H), 3.44 (t, J = 9.0 Hz, 1H), 3.32-3.26 (m, 1H), 3.05 (s, 
3H), 2.41-2.10 (m, 6H), 1.98-1.80 (m, 8H), 1.71-1.41 (m, 16H), 1.37-1.28 (m, 3H), 1.23 
(d, J = 6.0 Hz, 3H), 1.18 (d, J = 6.0 Hz, 3H), 1.05-0.84 (m, 51H), 0.70-0.52 (m, 30H). 
 
HRMS (ESI) 
 Calculated for C102H167NO19Si5 (M + Na)
+
:  1885.0876 
 Found:       1885.0833 
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TMSE ester 3.50 
To 3.60 (1.31 g, 0.703 mmol, 1 eq) in THF (35 mL) at 0 °C was added PPh3 (0.461 g, 1.76 
mmol, 2.5 eq), 2-(trimethylsilyl)ethanol (0.30 mL, 2.11 mmol, 3 eq ), and DIAD (0.30 mL, 1.54 
mmol, 2.2 eq). The reaction was stirred at 45 °C for 2 hours and was concentrated in vacuo. The 
residue was stirred with hexanes (25 mL) for 15 minutes and was filtered. The filtrate was 
concentrated and purified by flash chromatography (SiO2; 0% → 15% EtOAc/hexanes) to 
provide 3.50 (1.19 g, 0.606 mmol, 87%) as a yellow solid. The product was isolated as a 2.5:1 
mixture of ketal constitutional isomers. Only the major isomer characterization is reported. 
 
 
TLC (20% EtOAc/hexanes) 
 Rf = 0.55, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.87 (d, J = 7.5 Hz, 2H), 7.68 (d, J = 7.5 Hz, 2H), 7.42 (t, J = 7.5 Hz, 2H), 7.33 (t, J = 
7.5 Hz, 2H), 6.41-6.06 (m, 12H), 5.86 (dd, J = 5.5, 15.0 Hz, 1H), 5.64 (dd, J = 9.0, 14.5 
Hz, 1H), 5.36 (d, J = 9.5 Hz, 1H), 4.90 (broad s, 1H), 4.64 (t, J = 6.0 Hz, 1H), 4.52 (s, 
1H), 4.47 (dd, J = 6.0, 10.0 Hz, 1H), 4.35-4.17 (m, 6H), 4.11-4.08 (m, 1H), 3.93-3.86 (m, 
3H), 3.76-3.73 (m, 1H), 3.66-3.59 (m, 3H), 3.48-3.41 (m, 2H), 3.32-3.27 (m, 2H), 3.06 
(s, 3H), 2.40-2.13 (m, 6H), 1.99-1.79 (m, 8H), 1.72-1.41 (m, 16H), 1.37-1.26 (m, 5H), 
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1.23 (d, J = 5.5 Hz, 3H), 1.18 (d, J = 6.5 Hz, 3H), 1.05-0.84 (m, 51H), 0.71-0.54 (m, 
30H), 0.08 (s, 9H).  
 
HRMS (ESI) 
 Calculated for C108H179NO19Si6 (M + Na)
+
:  1985.1585 
 Found:       1985.1624 
 
 
Amine 3.61 
To 3.50 (1.19 g, 0.606 mmol, 1 eq) in THF (30 mL) was added piperidine (6.00 mL, 6.06 mmol, 
100 eq). The reaction was stirred at 45 °C for 3 hours. The mixture was poured into water (100 
mL) and extracted with Et2O (3 x 100 mL). The combined organic layers were dried over 
Na2SO4 and concentrated in vacuo. The crude material was purified by flash chromatography 
(SiO2; 0% → 15% EtOAc/hexanes) to yield 3.61 (0.958 g, 0.551 mmol, 92%) as a yellow solid. 
The product was isolated as a 2.5:1 mixture of ketal constitutional isomers. Only the major 
isomer characterization is reported. 
 
TLC (20% EtOAc/hexanes) 
 Rf = 0.07, stained by anisaldehyde. 
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1
H NMR (500 MHz, acetone-d6) 
δ 6.41-6.15 (m, 11H), 6.08 (dd, J = 10.0, 15.0 Hz, 1H), 5.86 (dd, J = 5.5, 15.5 Hz, 1H), 
5.64 (dd, J = 9.0, 14.5 Hz, 1H), 4.89 (broad s, 1H), 4.66-4.60 (m, 1H), 4.40 (s, 1H), 4.32-
4.22 (m, 2H), 4.16-4.08 (m, 2H), 3.93-3.86 (m, 2H), 3.79-3.74 (m, 3H), 3.62-3.51 (m, 
3H), 3.28 (t, J = 9.0 Hz, 1H), 3.06 (s, 3H), 2.43-2.13 (m, 6H), 2.01-1.77 (m, 9H), 1.74-
1.41 (m, 16H), 1.34-1.25 (m, 6H), 1.21 (d, J = 6.0 Hz, 3H), 1.18 (d, J = 6.5 Hz, 3H), 
1.05-0.91 (m, 51H), 0.73-0.54 (m, 30H), 0.08 (s, 9H). 
 
HRMS (ESI) 
 Calculated for C93H169NO17Si6 (M + H)
+
:  1741.1085 
 Found:       1741.1091 
 
Azide 3.62 
To 3.61 (0.239 g, 0.137 mmol, 1 eq) in THF (0.685 mL) and MeOH (0.685 mL) was added 
K2CO3 (0.076 g, 0.549 mmol, 4 eq), Cu(II)SO4∙5 H2O (1.4 mg, 0.00549 mmol, 0.04 eq), and 
imidazole-1-sulfuryl azide 3.51
27
 (0.069 g, 0.329 mmol, 2.4 eq). The reaction was stirred at 23 
°C for 3 hours then was poured into brine (50 mL) and extracted with Et2O (3 x 75 mL). The 
combined organic layers were dried over Na2SO4 and concentrated in vacuo. The crude material 
was purified by flash chromatography (SiO2; 0% → 5% EtOAc/hexanes) to give 3.62 (0.121 g, 
0.068 mmol, 50%) as a yellow solid. The product was isolated as a 2.5:1 mixture of ketal 
constitutional isomers. Only the major isomer characterization is reported. 
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TLC (20% EtOAc/hexanes) 
 Rf = 0.23, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 6.42-6.15 (m, 11H), 6.08 (dd, J = 10.0, 14.5 Hz, 1H), 5.84 (dd, J = 5.5, 15.5 Hz, 1H), 
5.64 (dd, J = 9.0, 14.5 Hz, 1H), 4.90 (broad s, 1H), 4.62 (t, J = 6.0 Hz, 1H), 4.48 (s, 1H), 
4.35-4.14 (m, 5H), 4.11-4.07 (m, 1H), 3.93-3.86 (m, 2H), 3.78-4.73 (m, 2H), 3.62-3.51 
(m, 3H), 3.34-3.25 (m, 2H), 3.05 (s, 3H), 2.40-2.12 (m, 6H), 2.01-1.79 (m, 9H), 1.73-
1.44 (m, 17H), 1.40-1.26 (m, 4H), 1.24 (d, J = 6.5 Hz, 3H), 1.18 (d, J = 6.0 Hz, 3H), 
1.03-0.92 (m, 51H), 0.74-0.54 (m, 30H), 0.08 (s, 9H). 
 
HRMS (ESI) 
 Calculated for C93H167N3O17Si6 (M + Na)
+
:  1789.0809 
 Found:       1789.0801 
 
 
Bisketal 3.49 
To 3.62 (0.055 g, 0.0311 mmol, 1 eq) in THF (3.75 mL) and pyridine (2.5 mL) at 0 °C was 
added dropwise 70% HF/pyridine (0.280 mL, 10.88 mmol, 350 eq). The reaction was allowed to 
warm to 23 °C and stirred for 6 hours. TMSOMe (2 mL) was added and the reaction stirred at 23 
°C an additional 30 minutes. The reaction was concentrated in vacuo and purified by flash 
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chromatography (SiO2; 5% MeOH/DCM) to yield 3.49 (0.029 g, 0.0223 mmol, 72%) as a yellow 
solid. The product was isolated as a 2.5:1 mixture of ketal constitutional isomers. Only the major 
isomer characterization is reported. 
 
TLC (10% MeOH/DCM) 
 Rf = 0.46, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 6.39-6.14 (m, 12H), 5.90 (dd, J = 5.0, 15.0 Hz, 1H), 5.55 (dd, J = 4.5, 15.5 Hz, 1H), 
5.25-5.21 (m, 1H), 4.67-4.63 (m, 2H), 4.56 (s, 1H), 4.26-4.07 (m, 4H), 4.03-3.85 (m, 
4H), 3.67-3.59 (m, 3H), 3.33-3.26 (m, 3H), 3.05 (s, 3H), 2.47-2.13 (m, 5H), 2.00-1.73 
(m, 10H), 1.68-1.49 (m, 16H), 1.44-1.31 (m, 5H), 1.26 (d, J = 6.0 Hz, 3H), 1.18 (d, J = 
6.5 Hz, 3H), 1.09 (d, J = 6.5 Hz, 3H), 1.00 (d, J = 7.5 Hz, 3H), 0.07 (s, 9H). 
 
HRMS (ESI) 
 Calculated for C63H97N3O17Si (M + Na)
+
:  1218.6485 
 Found:       1218.6462 
 
 
Carboxylic Acid 3.52 
To 3.49 (0.022 g, 0.0184 mmol, 1 eq) in THF (2.1 mL) was added TBAF (1M in THF, 0.063 
mL, 0.063 mmol, 3 eq). The reaction was stirred at 23 °C for 2 hours then MeOH (10 mL), 
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CaCO3 (0.200 g), and DOWEX 50WX8-400 (triturated with MeOH 3 x 2 mL, 0.600 g). The 
reaction was stirred at 23 °C for an additional 30 minutes and filtered through celite. The 
solution was concentrated and purified by preparative RP-HPLC (Waters Sunfire prep C18 ODB 
5 micron 30 x 150 mm; 25 mL/min flow rate; gradient of 5  95% MeCN in 25 mM aqueous 
ammonium acetate over 23 min) to furnish 3.52 (0.011 g, 0.010 mmol, 54%) as a yellow solid. 
The product formed as a 2.5:1 mixture of ketal constitutional isomers. Only the major isomer 
characterization is reported. 
 
HPLC 
tR = 18.3 and 19.1 min; flow rate = 25 mL/min, Waters Sunfire prep C18 ODB 5 micron 
30 x 150 mm column gradient of 5 → 95% MeCN in 25 mM ammonium acetate over 23 
min. 
 
 
1
H NMR (500 MHz, acetone-d6) 
δ 6.41-6.15 (m, 12H), 5.92 (dd, J = 5.0, 15.0 Hz, 1H), 5.54 (dd, J = 9.5, 15.0 Hz, 1H), 
5.26-5.22 (m, 1H), 4.67 (s, 1H), 4.68-4.64 (m, 1H), 4.10-4.06 (m, 2H), 3.97 (d, J = 2.5 
Hz, 1H), 3.93-3.86 (m, 2H), 3.65-3.57 (m, 4H), 3.43-3.32 (m, 3H), 3.26-3.09 (m, 4H), 
3.05 (s, 3H), 2.42-2.37 (m, 3H), 2.25-2.12 (m, 4H), 1.93-1.88 (m, 3H), 1.85-1.76 (m, 
6H), 1.70-1.64 (m, 5H), 1.61-1.52 (m, 7H), 1.42-1.30 (m, 3H), 1.26 (d, J = 6.5 Hz, 3H), 
1.18 (d, J = 6.5 Hz, 3H), 1.09 (d, J = 6.5 Hz, 3H), 1.00 (d, J = 7.0 Hz, 3H). 
 
HRMS (ESI) 
 Calculated for C58H85N3O17 (M + Na)
+
:  1118.5777 
 Found:       1118.5758 
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Azide 3.53 
Prior to the reaction, acetyl chloride was freshly distilled from quinoline (20% v/v) and used 
immediately. The distillation apparatus was set up immediately before the distillation and was 
used only once per reaction. A 20 mL I-Chem vial was charged with acetonitrile (10 mL), water 
(400 L) and acetyl chloride (100 L). The vial was enclosed with a PTFE-lined cap and was 
stirred for 30 minutes at 23 C and then was cooled to 0 C and stirred for an additional 15 
minutes. Subsequently, the cooled acetonitrile:water solution (7 mL) was added to a 40 mL I-
Chem vial containing 3.52 (6.7 mg, 0.00611 mmol, 1eq). The vial was enclosed with a PTFE-
lined cap and stirred at 0 C for 30 min. The reaction was quenched with triethylamine (300 L) 
and the resulting hazy solution was solubilized with the minimal amount of methanol. The crude 
was immediately purified by preparative RP-HPLC (Waters Sunfire prep C18 ODB 5 micron 30 x 
150 mm 25 mL/min flow rate MeCN:25 mM aqueous ammonium acetate 5%  95% over 23 
minutes) to yield the title compound 3.53 (2.0 mg, 0.00211 mmol, 34% over 2 cycles) as a 
yellow solid.  
 
HPLC 
tR = 14.5 min; flow rate = 25 mL/min, Waters Sunfire prep C18 ODB 5 micron 30 x 150 
mm column gradient of 5 → 95% MeCN in 25 mM ammonium acetate over 23 min. 
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1
H NMR (500 MHz, CD3OD) 
δ 6.48-6.10 (m, 12H), 6.02 (dd, J = 8.5, 15.5 Hz, 1H), 5.38-5.31 (m, 2H), 4.54 (s, 1H), 
4.46-4.43 (m, 1H), 4.39-4.33 (m, 1H), 4.27-4.21 (m, 1H), 4.17 (tt, J = 3.5, 9.5 Hz, 1H), 
3.97 (s, 1H), 3.71 (t, J = 5.5 Hz, 1H), 3.62 (d, J = 6.0 Hz, 1H), 3.49-3.44 (m, 1H), 3.20-
3.15 (m, 3H), 2.40-2.35 (m, 1H), 2.31-2.13 (m, 3H), 2.08-1.95 (m, 3H), 1.92 (s, 1H), 
1.81-1.68 (m, 5H), 1.59-1.53 (m, 2H), 1.51-1.31 (m, 6H), 1.26 (d, J = 6.0 Hz, 3H), 1.18 
(d, J = 6.0 Hz, 3H), 1.10 (d, J = 6.5 Hz, 3H), 1.00 (d, J = 7.0 Hz, 3H). 
 
HRMS (ESI) 
 Calculated for C47H71N3O17 (M + Na)
+
:  972.4681 
 Found:       972.4682 
 
 
AmB (3.4) 
To 1,3-propanedithiol (0.050 mL) in MeOH (2.65 mL) was added Et3N (0.075 mL). 0.055 mL of 
this stock solution was added to azide 3.53 (0.5 mg, 0.000326 mmol, 1 eq). The reaction was 
stirred at 23 °C for 42 hours then analyzed directly by analytical HPLC (Agilent Zorbax C18 
XDB 3.5 micron 4.6 x 75 mm column gradient of 5  95% MeCN in 25 mM ammonium acetate 
over 8 minutes).The reaction had reached 35% conversion at 42 hours and the chromatogram 
matched the known AmB standard. 
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HPLC 
tR = 4.7 min; flow rate = 1.2 mL/min, Agilent Zorbax C18 XDB 3.5 micron 4.6 x 75 mm 
column gradient of 5 → 95% MeCN in 25 mM ammonium acetate over 8 min. 
Coinjection of the reaction and AmB showed a single product peak. 
 
HRMS (ESI) 
 Calculated for C47H73NO17 (M + H)
+
:  924.4957 
 Found:       924.5069 
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CHAPTER 4 
SEMISYNTHESIS OF C35-DEOXY AMPHOTERICIN B    
 
 The ultimate goal of the total synthesis of AmB is not only to access the natural product, 
but to enable modular and flexible synthetic access to any of its targeted derivatives, including 
those lacking specific functional groups. In the previous chapter, a degradation of the natural 
product was described that allowed for a modeling of the endgame strategy of the total synthesis. 
We recognized that in this route, the western half of the molecule that contains the C35 hydroxyl 
group is removed allowing for the possibility of a semisynthesis of C35-deoxy amphotericin B 
(C35deOAmB). This chapter details the development of a synthesis of C35deOAmB in 
milligram quantities from the natural product AmB. While many different strategies were tried, 
in the end, the iterative SM cross-coupling strategy was the most effective route to this 
derivative. Ultimately, the main challenge of this synthesis was the development of a protecting 
group strategy that is compatible with the highly sensitive nature of the deoxygenated core of 
C35deOAmB. The discoveries made in the context of this synthesis have helped to inform the 
protecting group strategy for the total synthesis and will hopefully enable the synthesis of all ten 
deoxygenated derivatives of this interesting natural product. Dan Palacios contributed to the 
work in this chapter by synthesizing large quantities of 4.45 as well as optimizing the final two 
deprotection steps in scheme 4.11. Brice Uno synthesized building block 4.41. Ian Dailey also 
made building block 4.41 and helped make large amounts of advanced intermediate 4.46. 
Finally, Matt Endo and Brandon Wilcock processed material to intermediate 4.45.  
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4-1 BACKGROUND 
 The leading model for the AmB ion channel, supported primarily by extensive computer 
modeling studies,
1
 involves self-assembly into C8-symmetric pores which allow for efflux of 
ions. The proposed interactions include a ring of stabilization formed by polar interactions 
between the C41 carboxylate and C3’ amine and a hydrogen bond between the C8 and C9 
hydroxyls (Figure 4.1). Additionally, AmB is approximately half the length of the lipid bilayer. 
In some models the C35 hydroxyl group is predicted to be crucial for a tail-to-tail dimerization 
between two pore complexes in order to span the bilayer.
2
 In other models, AmB is proposed to 
form a single barrel channel, dimpling the membrane in order to span across it.
2
 Following the 
deletion strategy used previously by Palacios et al. to test the salt bridge hypothesis,
3
 removal of 
the C35 hydroxyl group would allow for a probe of its role in the mechanism of action of AmB. 
 
Figure 4.1. (A) The proposed critical interactions involved in AmB channel formation. (B) The double-barrel model 
of AmB channel formation. (C) The single-barrel model of channel formation. 
A doubly modified derivative of AmB, C35-deoxy amphotericin B methyl ester, was 
synthesized by Carreira and coworkers in 2008.
4
 It was found that this derivative was 
substantially less active than AmB methyl ester against yeast. This derivative also demonstrated 
a diminished ability to induce permeability in a liposome assay. We pursued the preparation of a 
singly modified derivative, C35deOAmB, to enable head-to-head studies against other singly 
modified derivatives of AmB in biological and biophysical assays as part of a systematic effort 
to probe its mechanism of action in atomistic detail. 
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4-2 SYNTHESIS VIA TRADITIONAL METHODS   
To help simplify some of the challenges of synthesizing such a complex derivative as 
C35-deoxy amphotericin B, a hybrid bottom-up/top-down synthesis was employed (Figure 4.2).  
Rychnovsky
5
 and Murata
6
 have shown that a hybrid synthesis could be utilized to modify the 
C22-C37 fragment of amphotericin B. In particular, Murata and coworkers were able to use 
semisynthesis to access complex intermediate 4.2, then using cross-coupling chemistry and 
Horner-Wadsworth-Emmons olefination they were able to rebuild the polyene with a fluorine 
label.
6a
  Modifying this route to include a C35-deoxygenated building block (4.5) as one of the 
cross-coupling partners could theoretically yield C35deOAmB.  The power of this hybrid 
approach is that the densely packed stereochemistry of the polyol and mycosamine is obtained 
from the natural product, leaving only the polyene and C34-C37 fragments to be set by total 
synthesis. 
 
Figure 4.2. Retrosynthesis of C35deOAmB using traditional chemistry. 
Initial efforts focused on the synthesis of C35-deoxygenated building block 4.5. The key 
to a short and effective route to 4.5 (Scheme 4.1) was recognizing that all the desired 
stereochemistry as well as the correct protecting group strategy was contained in previously 
reported intermediate 4.6 derived from (S)-2-methyl-3-hydroxypropionate in five steps.
7
 4.6 was 
treated with thiocarbonyl diimidazole to install a thiocarbamate at C35, which was then subjected 
to Barton-McCombie deoxygenation conditions
8
 providing C35-deoxygenated 4.7 in 56% yield 
over two steps. Subsequent debenzylation and Dess-Martin oxidation
9
 generated aldehyde 4.9 in 
excellent yields. Finally, exposure to Takai olefination conditions
10
 provided the desired vinyl 
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iodide 4.5. The synthesis proceeded in a net 30% yield over five steps from known intermediate 
4.6. 
 
Scheme 4.1. Synthesis of C35-deoxygenated building block 4.5. 
The polyol and mycosamine-containing building block of amphotericin B was prepared 
via Murata’s top-down degradation of the natural product (Scheme 4.2).6a  The route began with 
protection of the amine and carboxylic acid as an Fmoc carbamate and a methyl ester, 
respectively.
11
  Subsequent treatment of the polyol with 1,1’-dimethoxycyclopentanone and CSA 
in MeOH yielded the bis-ketal with concomitant conversion of the hemiketal at C13 to a methyl 
ketal.  This reaction yielded a 1:1 mixture of the C8/C9 and C9/C11 protected diols that were 
inseparable by flash chromatography and this mixture was carried through the synthesis. The five 
remaining hydroxyl groups were then protected as TBS ethers yielding fully protected   
amphotericin B (4.12).   The heptaene was then excised by exhaustive ozonolysis to provide the 
corresponding bis-aldehyde.
12
 A double Takai olefination then provided bis-vinyl iodide 4.13.
5
  
Lithium hydroxide-promoted cleavage of the C32-C37 fragment in the presence of the C41 
methyl ester proceeded with concomitant cleavage of Fmoc.  The Fmoc protecting group was 
then reinstalled to yield polyol building block 4.2
6a
 as a mixture of ketal constitutional isomers. 
147 
 
 
Scheme 4.2. Route to polyol building block 4.2.  A 1:1 mixture of the 1,2 and 1,3 ketal protected diol at C8-C11 
was carried through the route.  Only the 1,3 ketal is shown for simplicity. 
With 4.2 and 4.5 in hand, reconstruction of the amphotericin B core commenced with a 
Stille coupling between diene 4.4
13
 and vinyl iodide 4.5 affording triene 4.14 in excellent yield 
(Scheme 4.3).  Subsequent Dess-Martin oxidation cleanly provided the conjugated aldehyde in 
81% yield. However, serious challenges were encountered following the oxidation.  Phosphonate 
4.3
13
 was made following literature procedures; however, it could only be isolated in a 30% yield 
over two steps. (The yield reported in the literature is 43%.) Horner-Wadsworth-Emmons 
reaction of the conjugated aldehyde with phosphonate 4.3 gave hexaene 4.15 as a mixture of 
isomers in low yield.  Completion of the synthesis of C35deOAmB via this route required 
coupling of hexaene 4.15 with polyol building block 4.2.  Screening of standard Stille coupling 
conditions including Pd2dba3∙CHCl3, Pd(PPh3)4, Pd(OAc)2, and PdCl2(MeCN)2 as palladium 
sources with additives such as Ph3As, iPr2NEt, and CuI failed to yield any desired product and 
these reactions exhausted the supply of coupling partner 4.15.
6a,14
 Given the drawbacks of these 
conventional polyene synthesis methods (e.g. mixtures of stereoisomers, the use of toxic 
organotin reagents, and the apparent inefficiencies of the key Stille coupling) as well as the lack 
of material, we switched our efforts to developing a route based on the iterative SM cross-
coupling strategy described in chapters 2 and 3.
15,16
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Scheme 4.3. Proposed route to C35deOAmB (4.1).  Low yields, poor stereoselectivities and an inefficient Stille 
coupling between 4.15 and 4.2 led to the abandonment of this approach. 
 
4-3 EARLY DEVELOPMENT OF THE ITERATIVE CROSS-COUPLING ROUTE 
 Given the success of the SM cross-coupling route for testing the endgame strategy of the 
total synthesis described in the previous chapter, we decided to try the same system for accessing 
the targeted deoxygentated derivative. In fact, since the C35 alcohol is installed late stage in the 
synthesis, the exact same route could be used to access pentaenyl MIDA boronate 4.20 (Scheme 
4.5, see chapter 3 for its synthesis) leaving only the synthesis of deoxygenated building block 
4.19 to be developed.  
 Beginning with vinyl iodide 4.5 from the original route, deacylation using potassium 
carbonate in methanol followed by SM coupling with pinacolboronic ester 4.17
16
 provided 4.18 
in 83% yield (Scheme 4.4). One pot deprotection and iodine exchange then gave dienyl iodide 
4.19 which was ready to be used in the coupling reaction with pentaenyl MIDA boronate 
4.20.
17,18
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Scheme 4.4. Synthesis of C35-deoxygenated building block 4.19. 
SM coupling of 4.19 to pentaenyl MIDA boronate 4.20, selective deprotection of the 
methyl ester at C1, and macrolactonization
6
 provided the core structure of C35deOAmB (4.23) 
in 54% over 3 steps which is an average of 81% yield per step (Scheme 4.5). Up to this point the 
synthesis had gone smoothly; however, the deprotections proved to be extremely challenging. 
Treatment with TBAF was able to provide low yields of desilylated product however, it was 
difficult to purify and was not reproducible. Subsequent attempts to cleave the cyclopentylidene 
ketals resulted in low conversion and large amounts of decomposition. The C35-deoxygenated 
core of AmB proved to be much more sensitive than its oxygenated counterpart to a wide variety 
of conditions. This observation made it clear that this protecting group strategy would not allow 
access to C35deOAmB in large enough quantities to test. 
 
Scheme 4.5. Synthesis of the macrolactone of C35deOAmB (4.23). Attempts at deprotecting this intermediate were 
unsuccessful, giving large amounts of decomposition. A 1:1 mixture of the 1,2 and 1,3 ketal protected diol at C8-
C11 was carried through the route.  Only the 1,3 ketal is shown for simplicity. 
4-4 TOP DOWN SYNTHESIS STRATEGY 
 Before altering the protecting group strategy for the iterative cross-coupling strategy, we 
decided to explore if there were other, more efficient, routes to this particular derivative. In the 
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context of studying the TBS deprotection of AmB in the previous chapter, it was noted that the 
C35 alcohol is the last and most difficult alcohol to deprotect. Given its selective reactivity we 
decided to explore the possibility of performing a selective protecting group manipulation to 
isolate the C35 hydroxyl from the top down and a subsequent deoxygenation on AmB to remove 
it.  
 Given the difficulty of removing TBS groups from AmB, we first explored whether TES 
protecting groups would have the same type of deprotection selectivity. Treatment of fully 
protected intermediate 4.24 with TBAF in THF provided C35 monosilylated intermediate 4.25 in 
20% yield with a large amount of fully desilylated material (4.26) recovered (Scheme 4.6). By 
switching to a mixed solvent system of 3:1 MeCN:THF, the yield of 4.25 was increased to 79%.  
 
Scheme 4.6. Selective desilylation of 4.24. Use of TBAF in THF gave fully desilylated 4.26 as the major product. 
By switching to 3:1 MeCN:THF, 4.25 was isolated in 79% yield. 
 With a selective silylation sequence targeting the C35 alcohol in place, an orthogonal 
protecting group for the remaining alcohols needed to be found. A simple acyl group was ideal 
given its compatibility with silyl groups and the wide variety of deprotection conditions 
available. To test whether or not it was compatible with AmB, we synthesized peracylated 
derivative 4.27 and explored its ability to be deacylated (Scheme 4.7). Treatment with potassium 
cyanide in MeOH produced three products. The major product was monoacylated 4.28 and 
minor amounts of open chain 4.29 and 4.30 were observed. Given the steric hinderance at the 
C35 alcohol, the macrolactone appears to open before this encumbered center can be 
deprotected. Despite these interesting results, the acyl protecting group could be used given that 
the C35 hydroxyl would be missing in this particular derivative of AmB. 
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Scheme 4.7. Model deprotection of fully acylated AmB (4.27). 
 Starting from fully protected 4.24, treatment with TBAF followed by acylation of the 
remaining alcohols provided the fully protected intermediate in 49% yield over 2 steps (Scheme 
4.8). Subsequent removal of the C35 TES protecting group with HF/pyridine gave 4.31. With 
this alcohol effectively isolated we then needed to find conditions to remove this group. 
Attempts to convert the alcohol to an iodide,
19
 as well as activate it as a mesylate or tosylate, 
resulted in only recovery of starting material. However, treatment with phenyl 
chlorothionoformate (4.32) provided 4.33 in 53% yield but only about 75% purity. All attempts 
to deoxygenate this material either led to no conversion or massive amounts of decomposition.
8
 
For this reason, we decided to return to the iterative cross-coupling strategy for accessing this 
derivative. In the future, intermediate 4.31 could be useful for accessing other types of AmB 
derivatives. 
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Scheme 4.8. Proposed route to 4.34 through deoxygenation on AmB. All attempts to deoxygenate the C35-alcohol 
either gave no conversion or large amounts of decomposition. 
 
4-5 DEVELOPMENT OF A PROTECTING GROUP STRATEGY 
 While the SM coupling strategy allowed access to the C35deOAmB macrolactone, the 
protecting groups described above proved to be challenging to remove. Given the harsh 
conditions required to remove TBS groups from the AmB core, the use of TES groups as a 
replacement was explored (Scheme 4.9). Global protection of AmB gave 4.35 in five steps from 
the natural product. Ozonolysis
12
 followed by Takai olefination
10
 then provided 4.36 in good 
yield. However, transesterification conditions to cleave the western half of the molecule resulted 
in only the isolation of 4.38. The TES groups were too labile to survive this step and resulted in 
decomposition of the desired product. 
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Scheme 4.9. Use of TES ethers in the degradation of AmB. Attemps to cleave the western half of the molecule led 
to undesired desilylation. A 1:1 mixture of the 1,2 and 1,3 ketal protected diol at C8-C11 was carried through the 
route.  Only the 1,3 ketal is shown for simplicity. 
 An alternate protecting group strategy was then proposed involving global TBS 
protection, negating the need for the difficult to remove cyclopentylidene ketals (Scheme 4.10). 
Ozonolysis
12
 followed by Takai olefination
10
 of globally protected intermediate proceeded 
smoothly. Transesterification to cleave the western half took much longer than with the ketals 
present and gave only a 36% yield. This was hypothesized to be due to the larger steric hindrance 
and lack of ability to direct the nucleophile to the ester.
20
 SM cross-coupling with bisborylated 
4.17
16
 then gave 4.40 in 48% yield. MIDA boronate deprotection followed by coupling to trienyl 
iodide 4.41
21
 provided pentaenyl MIDA boronate 4.43. Cross-coupling with 4.19 went smoothly; 
however, saponification of the C1 methyl ester required extended reaction times to get full 
conversion. Final macrolactonization then needed increased reaction temperature to proceed. 
These results suggested that the ketals provided some rigidity to the polyol portion of the 
molecule, helping to promote macrolactonization. While we were able to make a small amount 
of macrolactone 4.44, the yields in this sequence were not satisfactory to scale this route up. 
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Scheme 4.10. Route to 4.44 using globally TBS protected AmB. 4.44 was observed, but it was isolated in low yield 
and purity. Additionally, many of the other steps proceeded slowly and in low yields so the decision was made to 
move away from this protecting group strategy. YND = yield not determined. 
 While these two protecting group strategies did not end up providing C35deOAmB, they 
did give insight as to what the ultimate strategy should be. Since TES groups were too labile to 
the transesterification conditions, the alcohols needed to be protected with TBS groups. 
Additionally, ketals were found to be important for allowing nucleophilic cleavage at the C1 
position as well as promoting macrolactonization. Due to the difficulties in cleaving the 
cyclopentylidene ketals at a late stage, they were replaced with more labile p-methoxyphenyl 
(PMP) acetals. We had also noted a dramatically increased sensitivity of the C35deOAmB core 
to a wide variety of reagents and were therefore concerned about the nucleophilic cleavage of the 
methyl ester. Consistent with these concerns, in the context of synthesizing C35deOAmB methyl 
ester, Carreira and coworkers found that this derivative is not stable to the hydroxide conditions 
necessary to cleave the methyl ester.
4
 To address this issue, the methyl ester was exchanged for a 
2-(trimethylsilyl)ethyl (TMSE) ester
22
 which can be cleaved with nucleophilic fluoride.  
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4-6 COMPLETION OF THE SEMISYNTHESIS OF C35-DEOXY AMPHOTERICIN B 
 As before, the C3’ amine of AmB was protected as a benzyl amide and the hemiketal 
exchanged for a methyl ketal (Scheme 4.11). Subsequent ketalization with para-methoxyphenyl 
(PMP) acetals formed a single constitutional isomer with protection of only the 1,3 diols.
6b
 
Protection of the remaining alcohols as TBS ethers and the acid as a TMSE ester generated 4.45. 
Ozonolysis exhaustively cleaved the polyene,
12
 although the initial conditions proceeded in low 
yield. We hypothesized that the reduced yield stemmed from the choice of quench. In order to 
quench the ozonide, the reaction was stirred overnight with dimethyl sulfide. Over this time, the 
solution became acidic enough to cleave the more labile PMP acetals. In order to account for 
this, the dimethyl sulfide quench was exchanged for tributylphosphine, which can destroy the 
ozonide in 30 minutes versus overnight.
23
 With this change, the acetals remained stable and the 
bisaldehyde was isolated in 67% yield. Takai olefination,
10
 transesterification, and SM cross-
coupling then gave dienyl MIDA boronate 4.46. The MIDA boronate was exchanged for a 
pinacolboronic ester
24
 and was then coupled to trienyl iodide 4.41
21
 giving 4.47 in 56% yield. 
The three step macrolactonization sequence subsequently provided the fully protected 
macrolactone of C35deOAmB (4.48). 
 Desilylation and ester deprotection of 4.48 was attempted with extended treatment with 
TBAF. Initially, it appeared that this reaction generated a mixture of a monosilylated product and 
the desired product; however, there were inconsistencies with this reaction. During the course of 
the reaction p-anisaldehyde was observed, consistent with the loss of a PMP acetal, and the 
NMR of the product showed a single TBS group remained. Upon closer examination of the 
spectrum it was determined that what was thought to be desired product was actually 4.49, the 
product of the elimination of the PMP acetal at C3/C5 (Figure 4.49). Since this product only 
started to appear with longer reaction times, the reaction time in the presence of TBAF was 
reduced and the remaining silyl groups were cleaved with HF/pyridine. Subsequent acid 
hydrolysis with HCl and enzyme mediated deacylation
25
 of the amine completed the synthesis of 
C35deOAmB. 
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Scheme 4.11. Synthesis of C35deOAmB. 
 
Figure 4.3. Elimination by product observed on treatment with TBAF. 
 
4-7 THESIS SUMMARY 
 This dissertation describes the development of strategies and methods targeting the 
synthesis of polyene natural products, in particular AmB and its derivatives. Toward this end, the 
application of iterative SM cross-coupling via bifunctional MIDA boronates needed to be 
extended to use in polyene synthesis. A series of small polyene building blocks, including 
bifunctional building blocks with one, two, or three olefins were generated. These three 
bifunctional molecules were then used in the efficient syntheses of all-trans-retinal, β-parinaric 
acid, and one half of AmB. 
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 With the ultimate goal of using this iterative cross-coupling strategy to complete the total 
synthesis of AmB and its derivatives, a better model of this endgame strategy was sought. It was 
realized that almost the exact model for the polyol and mycosamine containing intermediate 
targeted in our synthesis could be accessed via degradation of the natural product. With the 
dienyl MIDA boronate in hand, the iterative cross-coupling endgame strategy was tested. This 
model allowed for the discovery that replacing the vinyl chloride cross-coupling partners with 
vinyl iodides greatly enhances the yields of the SM reactions. Additionally, transesterifying the 
dienyl MIDA boronate to a dienyl pinacolboronic acid instead of deprotecting to the boronic acid 
improved the stability of this intermediate as well as its yield in the coupling reaction. These 
optimizations allowed for the development of an effective endgame strategy for reaching the 
natural product from the dienyl MIDA boronate intermediate.  
 Finally, the semisynthesis strategy used to access the model system for the total synthesis 
was recognized to provide a useful intermediate to make one of the deoxygenated derivatives, 
C35deOAmB. It was found, however, that simply deleting this one functional group makes the 
polyene macrolide core extremely sensitive to certain deprotection sequences. With this in mind, 
a series of protecting group strategies and manipulations was explored to access this interesting 
derivative. While many of these routes were not successful, they were extremely informative and 
eventually led to a strategy that provided the complete synthesis of C35deOAmB. It is 
anticipated that the strategies and methods developed herein will contribute strongly to the 
synthesis-enabled understanding of this fascinating natural product. 
 
4-8 EXPERIMENTAL SECTION 
Materials.  
Commercially available materials were purchased from Sigma-Aldrich, Alfa Aesar, Strem, or 
Fisher Scientific, and were used without further purification unless stated otherwise. 
Amphotericin B was a generous gift from Bristol-Myers Squibb Company.  Iodoform 
(methanol), camphorsulfonic acid (ethyl acetate), and triphenylphosphine (hexanes) were 
recrystallized from the indicated solvents prior to use.  All solvents were dispensed from a 
solvent purification system that passes solvents through packed columns according to the method 
of Pangborn and coworkers
26
 (THF, Et2O, CH2Cl2, toluene, dioxane, hexanes : dry neutral 
alumina; DMSO, DMF, CH3OH : activated molecular sieves).  2,6-Lutidine and pyridine were 
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freshly distilled under nitrogen from CaH2. EtOAc and EtOH were freshly distilled under 
nitrogen from activated molecular sieves. Water was doubly distilled or obtained from a 
Millipore MilliQ water purification system. Ozone was generated using an ozone solutions ozone 
generator. The following compounds were prepared according to literature precedent: alcohol 
4.6
16
, Diene 4.4
13
, phosphonate 4.3
13
, bisborylated compound 4.17
16,27
, triene 4.41
21
 
 
Reactions.  
Due to the light and air sensitivity of polyenes, all manipulations of polyenes were carried out 
under low light conditions and compounds were stored under an argon atmosphere. All reactions 
were performed in oven- or flame-dried glassware under an atmosphere of argon unless 
otherwise indicated.  Reactions were monitored by analytical thin layer chromatography 
performed using the indicated solvent on E. Merck silica gel 60 F254 plates (0.25mm).  
Compounds were visualized using a UV (λ254) lamp or stained by an acidic solution of p-
anisaldehyde or KMnO4.  Alternatively, reactions were monitored by RP-HPLC using an Agilent 
1100 series HPLC system equipped with a Symmetry
®
 C18 5 micron 4.6 x 150 mm column 
(Waters Corp. Milford, MA) with UV detection at 406 nm and the indicated eluent and flow rate. 
 
Purification and Analysis.   
Flash chromatography was performed as described by Still and coworkers
28
 using the indicated 
solvent on E. Merck silica gel 60 230-400 mesh.  
1
H NMR spectra were recorded at 23 °C on one 
of the following instruments: Varian Unity 400, Varian Unity 500, Varian Unity Inova 500NB.  
Chemical shifts (δ) are reported in parts per million (ppm) downfield from tetramethylsilane and 
referenced internally to the residual protium in the NMR solvent (CHCl3, δ = 7.26, 
CD3C(O)CHD2, δ = 2.04, center line) or to added tetramethylsilane.  Data are reported as 
follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, 
sext = sextet, sept = septet, dd = doublet of doublets, ddd = doublet of doublet of doublets, td = 
triplet of doublets, m = multiplet, b = broad, app. = apparent), coupling constant (J) in hertz (Hz) 
and integration. 
13C spectra were recorded at 23 °C with a Varian Unity 500. Chemical shifts (δ) 
are reported downfield of tetramethylsilane and are referenced to the carbon resonances in the 
NMR solvent (CDCl3, δ = 77.0, center line, CD3C(O)CD3, δ = 29.8, center line) or to added 
tetramethylsilane. Carbons bearing boron substituents were not reported (quadrapolar 
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relaxation). 
11
B NMR were recorded using a General Electric GN300WB instrument and 
referenced to an external standard of BF3∙Et2O. High resolution mass spectra (HRMS) were 
obtained at the University of Illinois mass spectrometry facility. All synthesized compounds 
gave HRMS within 5 ppm of calculated values. Infrared spectra were collected from a thin film 
on NaCl plates or as a KBr pellet on a Mattson Galaxy Series FTIR 5000 spectrometer with 
internal referencing. Absorption maxima (νmax) are reported in wavenumbers (cm
-1
). 
 
Thiocarbamate 4.50 
To a stirred solution of alcohol 4.6
16
 (3.32 g, 11.3 mmol, 1 eq) in CH2Cl2 (16.6 mL) in a 25 mL 
round-bottomed flask was added thiocarbonyl diimidizole (3.02 g, 16.95 mmol, 1.5 eq).  The 
resulting yellow solution was stirred for 60 hours at 23 
o
C.  The reaction mixture was poured into 
a mixture of water (60 mL) and CH2Cl2 (60 mL) and the layers were separated.   The aqueous 
layer was extracted with CH2Cl2 (3 x 60 mL).  The combined organic layers were washed with 
1N HCl (100 mL), saturated aqueous NaHCO3 (100 mL), and brine (100 mL), dried over 
Na2SO4, and concentrated in vacuo.  Purification by flash chromatography (SiO2; 25%  50% 
EtOAc/hexanes) furnished the desired product 4.50 (3.06 g, 7.57 mmol, 67%) as a yellow oil. 
 
 
TLC (1:1 hexanes : EtOAc) 
 Rf = 0.40, stained by anisaldehyde 
 
1
H NMR (500 MHz, CDCl3) 
  8.35 (s, 1H), 7.63 (t, J = 1Hz, 1H), 7.34-7.26 (m, 5H), 7.03 (t, J = 1Hz, 1H), 5.91 (dd, J  
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= 2.5, 9Hz, 1H), 4.92 (dq, J = 4.5, 6.4Hz, 1H), 4.46 (d, J = 11.5Hz, 1H), 4.37 (d, J = 
11.5Hz, 1H), 3.40-3.30 (m, 2H), 2.44-2.34 (m, 1H), 2.32-2.22 (m, 1H), 1.97 (s, 3H), 1.22 
(d, J = 6.5Hz, 3H), 1.04 (d, J = 7Hz, 3H), 0.99 (d, J = 7Hz, 3H). 
13
C NMR (125 MHz, CDCl3) 
  184.4, 170.3, 138.0, 137.1, 130.9, 128.3, 127.7, 127.6, 117.8, 84.8, 73.3, 72.4, 70.3,  
38.9, 35.7, 21.2, 15.4, 11.0, 10.8. 
 
HRMS (CI+) 
 Calculated for C21H29N2O4S (M+H)
+
:     405.1848 
 Found:                                                     405.1850 
 
 
C35-Deoxy Intermediate 4.7  
A 250 mL 2-neck round-bottomed flask equipped with a condenser was charged with 
thiocarbambate 4.50 (2.60 g, 6.43 mmol, 1 eq), Bu3SnH (3.44 mL, 12.79 mmol, 2 eq), AIBN 
(0.53 g, 3.23 mmol, 0.5 eq), and toluene (122 mL). The reaction mixture was stirred at 90 
o
C for 
2 hours and concentrated in vacuo. The resulting crude product was purified by flash 
chromatography (SiO2; 5%  10% EtOAc/hexanes) to yield 4.7 (1.39 g, 4.99 mmol, 83%) as a 
clear colorless oil. 
 
TLC (3:1 hexanes : EtOAc) 
 Rf = 0.71, stained by anisaldehyde 
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1
H NMR (500 MHz, CDCl3) 
 7.36-7.26 (m, 5H), 4.78 (app. p, J = 6.5Hz, 1H), 4.52 (d, J = 12.5Hz, 1H), 4.49 (d, J =  
12.5Hz, 1H), 3.30 (dd, J = 6, 9Hz, 1H), 3.26 (dd, J = 6, 9Hz, 1H), 2.03 (s, 3H), 1.84 (dpd, 
J = 4, 6.5, 10.5Hz, 1H), 1.80-1.72 (m, 1H), 1.28-1.20 (m, 1H), 1.4 (d, J = 6.5Hz, 3H), 
1.14-1.10 (m, 1H), 0.90 (d, J = 6.5Hz, 3H), 0.87 (d, J = 7Hz, 3H). 
 
13
C NMR (125 MHz, CDCl3) 
  170.7, 138.7, 128.3, 127.5, 127.4, 76.5, 74.7, 72.9, 36.1, 34.4, 30.8, 21.4, 16.5, 16.0,  
14.4. 
 
HRMS (EI+) 
 Calculated for C17H26O3 (M)
+
:     278.1882 
 Found:                                278.1883        
 
 
Primary Alcohol 4.8 
A 250 mL 3-neck round-bottomed flask was charged with Pd black (0.429 g, 1.03 mmol, 0.22 
eq).  A solution of 4.7 (1.29 g, 4.63 mmol, 1 eq) in 2:1 EtOH : EtOAc (75 mL) was cannulated 
into this flask and the argon atmosphere was blown off with hydrogen gas.  The reaction was 
stirred under a balloon of hydrogen gas at 23 
o
C for 4 hours.  The reaction was filtered through 
celite making sure to keep the Pd black under solvent at all times. The filtrate was concentrated 
yielding primary alcohol 4.8 (0.860 g, 4.57 mmol, 98%) as a colorless oil (0.860 g, 4.57 mmol, 
98%). 
 
TLC (3:1 hexanes : EtOAc) 
 Rf = 0.31, stained by anisaldehyde 
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1
H NMR (500 MHz, CDCl3) 
 4.79 (app. p, J = 6.5 Hz, 1H), 3.50-3.43 (m, 2H), 2.04 (s, 3H), 1.81-1.74 (m, 1H), 1.74-
1.66 (m, 1H), 1.22-1.08 (m, 1H), 1.24-1.18 (m, 1H), 1.16-1.10 (m, 1H), 1.15 (d, J = 6.5 
Hz, 3H), 0.89 (d, J = 6.5 Hz, 3H), 0.88 (d, J = 6.0 Hz, 3H).  
 
13
C NMR (125 MHz, CDCl3) 
  170.8, 74.6, 68.8, 35.8, 34.4, 33.0, 21.3, 15.9, 15.8, 14.4. 
 
HRMS (CI+) 
 Calculated for C10H21O3 (M + H)
+
:   189.1491 
 Found:       189.1486 
   
 
Aldehyde 4.9 
To a 25 mL round-bottomed flask with a solution of 4.8 (81 mg, 0.43 mmol, 1 eq) in CH2Cl2 (6.1 
mL) was added Dess-Martin periodinane (273 mg, 0.64 mmol, 1.5 eq). The reaction was stirred 
at 23 
o
C for 2 hours. To the solution was added saturated aqueous NaHCO3 (4 mL) and saturated 
aqueous Na2S2O3 (2 mL) and the reaction was stirred an additional 30 min.  The layers were 
separated and the aqueous layer was extracted with Et2O (3 x 10 mL). The combined organic 
extracts were dried over Na2SO4 and concentrated in vacuo to yield aldehyde 4.9 (76 mg, 0.41 
mmol, 96%) which was used without further purification. 
 
TLC (1:1 hexanes : EtOAc) 
 Rf = 0.61, stained by anisaldehyde 
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1
H NMR (500 MHz, acetone-d6) 
 9.64 (d, J = 1.5 Hz, 1H), 4.77 (app. p, J = 6.5 Hz, 1H), 2.49-2.42 (m, 1H), 2.00 (s, 3H), 
1.83-1.77 (m, 1H), 1.59 (ddd, J = 5.0, 10.0, 13.5 Hz, 1H), 1.36 (ddd, J = 4.5, 9.5, 14.0 
Hz, 1H), 1.16 (d, J = 6.5 Hz, 3H), 1.06 (d, J = 6.0 Hz, 3H), 0.92 (d, J = 7.0 Hz, 3H). 
 
13
C NMR (125 MHz, acetone-d6) 
 204.9, 170.4, 74.5, 44.5, 35.5, 33.3, 21.1, 16.5, 14.8, 13.2.  
 
HRMS (ESI) 
 Calculated for C10H18O3Na (M+Na)
+
 :  209.1154 
 Found:       209.1158 
 
IR (thin film, cm
-1
) 
 2977, 2938, 2879, 2814, 2712, 1736, 1459, 1373, 1247, 1104, 1047, 1020, 949. 
  
 
Vinyl Iodide 4.5 
To a suspension of CrCl2 (740 mg, 6.1 mmol, 15 eq) in THF (2.2 mL) in a 25 mL round-
bottomed flask was added dropwise a solution of aldehyde 4.9 (76 mg, 0.41 mmol, 1 eq) and 
iodoform (803 mg, 2.04 mmol, 5 eq) in dioxane : THF 2:1 (7.0 mL). After stirring for 15 
minutes, the reaction was poured into saturated aqueous NaHCO3 (40 mL) and diluted with Et2O 
(50 mL). The green mixture was filtered through celite with Et2O (100mL) and the filtrate layers 
were separated. The aqueous layer was extracted with Et2O (2 x 20 mL). The combined organic 
layers were dried over Na2SO4 and concentrated in vacuo. Purification of the crude product by 
column chromatography (SiO2; 0%  10% EtOAc/hexanes) provided title compound 4.5 (72 
mg, 0.23 mmol, 57%) as a pale yellow oil.  
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TLC (1:1 hexanes : EtOAc) 
 Rf = 0.75, stained by anisaldehyde 
 
1
H NMR (500 MHz, acetone-d6) 
 6.47 (dd, J = 8.5, 14.5 Hz, 1H), 6.18 (dd, J = 0.5, 14.5 Hz, 1H), 4.76 (app. p, J = 6.5, 
1H), 2.38-2.29 (m, 1H), 1.96 (s, 3H), 1.78-1.70 (m, 1H), 1.35 (ddd, J = 5.5, 8.0, 14.0 Hz, 
1H), 1.17 (ddd, J = 7.0, 8.5, 14.0 Hz, 1H), 1.10 (d, J = 6.5 Hz, 3H), 0.97 (d, J = 6.5 Hz, 
3H), 0.87 (d, J = 7.0 Hz, 3H).   
 
13
C NMR (125 MHz, acetone-d6) 
 170.4, 153.2, 74.5, 74.1, 39.6, 38.9, 35.4, 30.3, 21.1, 19.3, 15.8, 15.1. 
 
HRMS (ESI+) 
 Calculated for C11H19O2I (M+Na)
+
:     333.0328 
Found:                  333.0335 
 
IR (thin film, cm
-1
) 
 2965, 2966, 2874, 1732, 1456, 1372, 1247, 1187, 1106, 1044, 1018, 949. 
 
 
Triene 4.14 
Diene 4.4 was prepared by the literature procedure.
13
  A 10 mL round-bottomed flask was 
charged with vinyl iodide 4.5 (36 mg, 0.12 mmol, 1 eq), diene 4.4 (48 mg, 0.13 mmol, 1.05 eq) 
and DMF (3.4 mL). The solution was cooled to 0 
o
C and PdCl2(MeCN)2 (1.5 mg, 0.0058 mmol, 
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5 mol%) in DMF (0.4 mL) was added in five portions over 2 hours.  The reaction was warmed to 
23 
o
C and stirred for 1 hour.  The reaction was poured into water (5 mL) and Et2O (5 mL) and 
the layers were separated.  The aqueous layer was extracted with Et2O (3 x 5 mL).  The 
combined organic extracts were washed with brine (5 mL), dried over Na2SO4, and concentrated 
in vacuo. The resulting crude product was purified by flash chromatography (SiO2; 15% 
EtOAc/hexanes) to yield 4.14 (25 mg, 0.095 mmol, 82%) as a yellow oil. 
 
TLC (3:1 hexanes : EtOAc) 
 Rf = 0.14, visualized by UV 
 
1
H NMR (500 MHz, CDCl3) 
 6.26 (dd, J = 10.0, 15.0 Hz, 1H), 6.22-6.12 (m, 2H), 6.06 (dd, J = 9.5, 14.5 Hz, 1H), 
5.81 (td, J = 6.0, 15.0 Hz, 1H), 5.63 (dd, J = 7.5, 15.0 Hz, 1H), 4.81 (app. p, J = 6.0 Hz, 
1H), 4.19 (t, J = 5.5 Hz, 2H), 2.30-2.23 (m, 1H), 2.03 (s, 3H), 1.76-1.68 (m, 1H), 1.34-
1.22 (m, 3H), 1.13 (d, J = 6.5 Hz, 3H), 0.97 (d, J = 7.0 Hz, 3H), 0.87 (d, J = 7.0 Hz, 3H). 
 
HRMS (ESI+) 
 Calculated for C16H26O3 (M+Na)
+
:     289.1780 
Found:              289.1765 
 
 
Aldehyde 4.51 
To a 7 mL vial with a solution of 4.14 (8 mg, 0.029 mmol, 1 eq) in CH2Cl2 (0.5 mL) was added 
Dess-Martin periodinane (19 mg, 0.044 mmol, 1.5 eq). The reaction was stirred at room 
temperature for 10 minutes. To the solution was added saturated aqueous NaHCO3 (0.4 mL) and 
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saturated aqueous Na2S2O3 (0.2 mL) and the reaction was stirred an additional 30 minutes.  The 
layers were separated and the aqueous layer was extracted with Et2O (3 x 3 mL). The combined 
organic extracts were dried over Na2SO4 and concentrated in vacuo to yield clean aldehyde 4.51 
(6 mg, 0.023 mmol, 81%). 
 
TLC (1:1 hexanes : EtOAc) 
 Rf = 0.58, visualized by UV. 
 
1
H NMR (500 MHz, acetone-d6) 
 9.55 (d, J = 8.0 Hz, 1H), 7.30 (dd, J = 11.0, 14.5 Hz, 1H), 6.78 (dd, J = 10.5, 14.5 Hz, 
1H), 6.49 (dd, J = 11.0, 14.5 Hz, 1H), 6.29 (dd, J = 10.5, 15.0 Hz, 1H), 6.11 (dd, J = 8.0, 
15.5 Hz, 1H), 6.00 (dd, J = 8.0, 15.5 Hz, 1H), 4.81-4.76 (m, 1H), 2.42-2.35 (m, 1H), 
1.80-1.73 (m, 1H), 1.42-1.36 (m, 1H), 1.24-1.16 (m, 1H), 1.10 (d, J = 6.5 Hz, 3H), 1.00 
(d, J = 6.5 Hz, 3H), 0.88 (d, J = 7.0 Hz, 3H). 
 
 
Hexaene 4.15 
To a 7 mL vial charged with NaH washed with pentane (1.5 mg, 0.059 mmol, 3 eq) in THF (0.5 
mL) and cooled to –78 oC was added dropwise a solution of phosphonate 4.313 (27 mg, 0.059 
mmol, 3 eq) in THF (0.25 mL).  The solution was warmed to 0 
o
C for 30 minutes then cooled to -
40 
o
C.  A solution of aldehyde 4.51 (5.2 mg, 0.02 mmol, 1 eq) in THF (0.25 mL) was added 
dropwise and the solution was stirred at -40 
o
C for 36 hours. The reaction was quenched with 
saturates aqueous NaHCO3 (0.5 mL) and extracted with Et2O (3 x 2 mL).  The combined organic 
layers were concentrated in vacuo and the crude material purified by flash chromatography 
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(SiO2; 0%  8% EtOAc/hexanes) to yield 4.15 (4 mg, 0.0063 mmol, 32%) as an inseparable 
mixture of E and Z isomers. 
 
 
TLC (1:1 hexanes : EtOAc) 
 Rf = 0.77, visualized by UV. 
 
1
H NMR (500 MHz, acetone-d6) 
 6.46-6.20 (m, 8H), 6.14 (dd, J = 10.5, 15.0 Hz, 1H), 5.67 (dd, 7.5, 15.0 Hz, 1H), 5.21 
(d, J = 16.5 Hz, 1H), 5.06 (d, J = 10 Hz, 1H), 4.77 (app. p, J = 6.0 Hz, 1H), 2.34-2.26 (m, 
1H), 1.96 (s, 3H), 1.78-1.70 (m, 1H), 1.40-1.20 (m, 7H), 1.20-1.10 (m, 7H), 1.00-0.92 
(m, 6H), 0.91-0.82 (m, 9H). 
 
LRMS (ESI) 
 Calculated for C33H56O2SnNa (M + Na)
+
:   627.3 
 Found:       627.3 
 
 
Secondary alcohol 4.52 
K2CO3 (390 mg, 2.81 mmol, 10 eq) was added to vinyl iodide 4.5 (87.3 mg, 0.281 mmol, 1 eq) 
in MeOH:THF 2:1 (11.2 mL). The reaction was stirred at 40 C for 2 hours and then the reaction 
was poured into water (15 mL) and diluted with Et2O (20 mL). The layers were separated and the 
aqueous layer was extracted with Et2O (2 x 20 mL). The combined organic extracts were dried 
over Na2SO4 and concentrated. The crude material was purified by flash chromatography (SiO2; 
10% → 50% EtOAc/hexanes) to provide alcohol 4.52 (54.2 mg, 0.202 mmol, 85%).  
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TLC (50% EtOAc/hexanes) 
 Rf = 0.52, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
 δ 6.48 (dd, J = 8.0, 14.5 Hz, 1H), 6.14 (d, J = 14.5 Hz, 1H), 3.57 (app. sext, J = 6.0 Hz, 
1H), 3.42 (d, J = 4.5 Hz, 1H), 2.33 (app. sept, J = 7.0 Hz, 1H), 1.58-1.51 (m, 1H), 1.44 
(ddd, J = 5.0, 8.5, 13.5 Hz, 1H), 1.12 (ddd, J = 6.0, 8.5, 13.5 Hz, 1H), 1.04 (d, J = 6.5 Hz, 
3H), 0.95 (d, J = 6.5 Hz, 3H), 0.83 (d, J = 6.5 Hz, 3H). 
 
13
C NMR (125 MHz, acetone-d6) 
 δ 153.9, 73.8, 71.1, 40.0, 39.1, 38.1, 19.6, 19.3, 15.2. 
 
HRMS (EI) 
 calculated for C9H17OI (M)
+
:    268.0325 
 found:       268.0328 
 
IR (thin film, cm
-1
) 
3370, 2968, 2926, 2881, 1713, 1603, 1455, 1379, 1281, 1185, 1096, 1053, 951, 926, 672. 
 
 
Dienyl MIDA boronate 4.18 
A 20 mL I-Chem vial equipped with a stir bar was charged with vinyl iodide 4.52 (52.1 mg, 
0.194 mmol, 1 eq) and bisborylated compound 4.17
16,27
 (46.6 mg, 0.153 mmol, 0.8 eq.), sealed 
under argon, and was taken into a glove box. PdCl2dppf∙CH2Cl2 (8.3 mg, 0.010 mmol, 5 mol%) 
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and K3PO4 as a finely ground powder (124 mg, 0.583 mmol, 3 eq) were added, followed by 
DMSO (6.5 mL). The reaction was sealed with a PTFE-lined cap, removed from the glovebox, 
and stirred at 23 C for 24 hours. The solution was then diluted with EtOAc (10 mL) and filtered 
through a pad of silica gel, washing with EtOAc (70 mL). Celite was added to the filtrate and the 
mixture was concentrated in vacuo. The resulting powder was dry-loaded on top of a flash 
column and purified (SiO2; 50% EtOAc/hexanes → EtOAc → 10% MeCN:EtOAc) to yield the 
desired product 4.18 (40.8 mg, 0.126 mmol, 83%) as a pale yellow solid. 
 
TLC (EtOAc) 
 Rf = 0.19, stained by KMnO4. 
 
1
H NMR (500 MHz, acetone-d6) 
 δ 6.52 (dd, J = 10.0, 17.5 Hz, 1H), 6.10 (dd, J = 10.5, 15.5 Hz, 1H), 5.69 (dd, J = 8.0, 
15.0 Hz, 1H), 5.54 (d, J = 18.0 Hz, 1H), 4.19 (d, J = 17.0 Hz, 2H), 3.41 (d, J = 17.0 Hz, 
2H), 3.59 (app. p, J = 5.5 Hz, 1H), 2.98 (s, 3H), 2.30-2.25 (m, 1H), 1.61-1.53 (m, 1H), 
1.43 (ddd, J = 4.5, 8.0, 13.5 Hz, 1H), 1.12 (ddd, J = 6.0, 8.5, 13.5 Hz, 1H), 1.04 (d, J = 
6.5 Hz, 3H), 0.95 (d, J = 7.0 Hz, 3H), 0.84 (d, J = 6.5 Hz, 3H). 
 
13
C NMR (125 MHz, acetone-d6) 
 δ 169.0, 143.9, 143.1, 131.2, 71.1, 62.2, 47.3, 40.8, 38.2, 35.0, 20.1, 19.5, 15.1. 
 
11
B NMR (128 MHz, acetone-d6) 
 δ 11.5. 
 
HRMS (EI) 
 Calculated for C16H26O5NB (M)
+
:   323.1904 
Found:       323.1903 
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IR (thin film, cm
-1
) 
3420, 2963, 2899, 1742, 1642, 1604, 1453, 1337, 1287, 1249, 1154, 1084, 1004, 957, 
890. 
 
 
Dienyl iodide 4.19 
3 M NaOH (0.258 mL, 0.773 mmol, 5 eq) was added to dienyl MIDA boronate 4.18 (50 mg, 
0.16 mmol, 1 eq) in THF (0.775 mL). The reaction was stirred at 23 C for 10 minutes then 
cooled to 0 C over 5 minutes. I2 (41.2 mg, 0.162 mmol, 1.2 eq) in THF (0.810 mL) was added 
dropwise over 5 minutes. The reaction was stirred at 0 C for 15 minutes and was then quenched 
with saturated aqueous Na2S2O3 (5 mL) and diluted with Et2O (5 mL). The layers were separated 
and the aqueous layer was extracted with Et2O (2 x 10 mL) and the combined organic layers 
were dried over Na2SO4 and concentrated. The residue was pushed through a plug of silica gel 
with Et2O to give dienyl iodide 4.19 (42.4 mg, 0.144 mmol, 93 %) as a pale yellow oil. 
 
TLC (1:1 EtOAc/hexanes) 
 Rf = 0.54, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
 δ 7.03 (dd, J = 10.5, 14.0 Hz, 1H), 6.34 (d, J = 14.5 Hz, 1H), 6.05 (dd, J = 10.5, 15.5 Hz, 
1H), 5.73 (dd, J = 8.0, 15.5 Hz, 1H), 3.58-3.54 (m, 1H), 3.38 (d, J = 4.5 Hz, 1H), 2.28-
2.20 (m, 1H), 1.58-1.51 (m, 1H), 1.42 (ddd, J = 5.5, 9.0, 13.5 Hz, 1H), 1.09 (ddd, J = 6.5, 
9.0, 14.0 Hz, 1H), 1.03 (d, J = 6.0 Hz, 3H), 0.94 (d, J = 7.0 Hz, 3H), 0.82 (d, J = 7.0 Hz, 
3H). 
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13
C NMR (125 MHz, acetone-d6) 
 δ 146.8, 143.6, 129.0, 76.9, 71.1, 40.6, 38.3, 35.0, 19.9, 19.6, 15.2. 
 
HRMS (CI+) 
 Calculated for C11H19OI (M+H)
+
:   295.0559 
Found:       295.0562 
 
IR (thin film, cm
-1
) 
3360, 2961, 2921, 2851, 1729, 1452, 1378, 1322, 1261, 1097, 980, 796. 
 
 
Macrolactone 4.22 
A solution of the palladium catalyst was prepared as follows: A 20 mL Wheaton vial equipped 
with a magnetic stir bar was charged with Pd(OAc)2 (2.2 mg, 0.0098 mmol) and 2-
cyclohexylphosphino-2’,4’,6’-isopropyl-1,1’-biphenyl (X-Phos, 9.3 mg, 0.0196 mmol). Toluene 
(1.35 mL) was added and the vial was sealed with a PTFE lined cap. The resulting mixture was 
stirred at 23 C for 15 minutes resulting in a yellow catalyst stock solution (0.00725 M in Pd). 
This catalyst solution was then utilized in the following procedure: To pentaenyl MIDA boronate 
4.20
29
 (92.0 mg, 0.0553 mmol, 1 eq) and dienyl iodide 4.19 (15.4 mg, 0.0525 mmol, 0.95 eq) in 
THF (2.8 mL) was added the catalyst stock solution described above (0.381 mL, 0.00276 mmol 
Pd, 5 mol% Pd). The resulting mixture was sealed with a teflon-lined septum cap and 1 M NaOH 
(0.276 mL, 0.276 mmol, 5 eq) was added.  The reaction was stirred at 23 
o
C for 30 minutes then 
at 45 
o
C for 4 hours. The reaction was diluted Et2O (50 mL) and was quenched with 0.5 M pH 7 
phosphate buffer (50 mL). The layers were separated and the aqueous layer was extracted with 
Et2O (2 x 25 mL). The combined organic layers were filtered through a short plug of silica gel 
with Et2O and concentrated. The residue was taken up in THF:MeOH:H2O 3:1:1 (5.4 mL), LiOH 
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(113 mg, 2.686 mmol, 50 eq) was added and the vial was sealed under argon. The reaction was 
stirred at 35 
o
C for 1 h and was then diluted with EtOAc (50 mL) and was poured into water (50 
mL). The aqueous layer was extracted with EtOAc (5 x 25 mL). The combined organic layers 
were dried over Na2SO4 and concentrated. The residue was dissolved in CH2Cl2 (13.1 mL) and 
was added dropwise over 15 hours to a solution of MNBA (22 mg, 0.0628 mmol, 1.2 eq) and 
DMAP (15 mg, 0.126 mmol, 2.4 eq) in CH2Cl2 (21 mL). The reaction was stirred an additional 
45 min, cooled to 0 
o
C, and quenched with saturated NaHCO3 (50 mL). The layers were 
separated and the aqueous layer was extracted with Et2O (3 x 50 mL) and the combined organic 
layers were dried over Na2SO4 and concentrated. The crude material was purified by flash 
chromatography (SiO2; 5% → 10% EtOAc/hexanes) to yield macrolactone 4.22 (44.9 mg, 
0.0273 mmol, 52% over 3 steps) as a 1:1 mixture of ketal constitutional isomers. 
 
TLC (20% EtOAc/hexanes) 
 Rf = 0.52, stained by anisaldehyde. 
 
1
H NMR 
δ 7.33-7.21 (m, 8H), 7.24-7.21 (m, 2H), 6.41 (m, 26H), 5.99 (dd, J = 7.5, 14.0 Hz, 1H), 
5.86 (dd, J = 6.5, 14.0 Hz, 1H), 5.43-5.34 (m, 2H), 5.15 (dd, J = 4.5, 6.5 Hz, 1H), 5.10 
(dd, J = 4.5, 6.5 Hz, 1H), 4.61-4.57 (m, 2H), 4.53 (s, 2H), 4.31-4.23 (m, 2H), 4.21-4.10 
(m, 3H), 4.05-3.96 (m, 2H), 3.93-3.86 (m, 5H), 3.72-3.66 (m, 2H), 3.70 (s, 3H), 3.69 (s, 
3H), 3.64-3.50 (m, 10H), 3.40-3.35 (m, 2H), 3.22 (s, 3H), 3.08 (s, 3H), 2.48-2.42 (m, 
2H), 2.33-2.20 (m, 6H), 1.98-1.48 (m, 66H), 1.23 (d, J = 6.0 Hz, 3H), 1.22 (d, J = 6.0 Hz, 
3H), 1.06 (d, J = 6.5 Hz, 3H), 1.05 (d, J = 6.0 Hz, 3H), 0.98 (d, J = 6.5 Hz, 6H), 0.92-
0.84 (m, 78H), 0.16- -0.01 (m, 48H). 
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HRMS (ESI) 
 Calculated for C91H152NO17Si4 (M + H)
+
:  1643.0137 
 Found:       1643.0071 
 
 
Per-Acylated 4.27 
To methyl ester 4.53
29
 (50 mg, 0.0467 mmol, 1 eq) in pyridine (4.7 mL) was added DMAP (5.7 
mg, 0.0467 mmol, 1 eq) and acetic anhydride (0.22 mL, 2.33 mmol, 50 eq). The reaction was 
stirred at 23 
o
C for 15 hours then was poured into saturated aqueous NaHCO3 (10 mL) and Et2O 
(20 mL). The layers were separated and the aqueous layer was extracted with Et2O (2 x 10 mL). 
The combined organic layers were dried over Na2SO4 and concentrated in vacuo. The crude 
material was purified by silica gel chromatography (50% → 100% EtOAc/hexanes) to yield 4.27 
(60.5 mg, 0.0418 mmol, 89%) as a yellow solid. 
 
TLC (EtOAc) 
 Rf = 0.73, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.29-7.19 (m, 4H), 7.07 (d, J = 9.5 Hz, 1H), 6.64-6.09 (m, 13H), 5.53 (dd, J = 9.0, 15.0 
Hz, 1H), 5.34-5.25 (m, 3H), 5.22-5.09 (m, 2H), 5.07-4.92 (m, 5H), 4.81-4.75 (m, 2H), 
4.68 (t, J = 9.5 Hz, 1H), 4.50 (t, J = 6.0 Hz, 1H), 4.36-4.31 (m, 1H), 4.10-3.99 (m, 3H), 
3.67 (s, 3H), 3.56 (dd, J = 6.0, 9.5 Hz, 1H), 3.42 (q, J = 15.0 Hz, 2H), 3.17 (s, 3H), 2.59-
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2.45 (m, 4H), 2.29 (t, J = 10.5 Hz, 1H), 2.19-2.16 (m, 1H), 2.09-1.92 (m, 24H), 1.86-1.81 
(m, 2H), 1.79 (s, 3H), 1.65-1.55 (m, 3H), 1.49-1.28 (m, 5H), 1.14 (d, J = 6.5 Hz, 3H), 
1.10 (d, J = 6.0 Hz, 3H), 0.93 (d, J = 6.5 Hz, 3H), 0.87 (d, J = 7.0 Hz, 3H). 
 
Monoacylated 4.28 
To per-acylated 4.27 (10 mg, 0.0069 mmol, 1 eq), in MeOH:THF 2:1 (0.69 mL) at 0 
o
C was 
added KCN (2 mg, 0.0138 mmol, 2 eq). The reaction was allowed to warm to 23 
o
C and was 
stirred for 21 hours. The reaction was quenched with saturated aqueous NaHCO3 (5 mL) and was 
extracted with 20% MeOH/DCM (3 x 5 mL). The combined organic layers were dried over 
Na2SO4 and concentrated in vacuo. The crude material was purified via flash chromatography 
(SiO2; 5% → 8% MeOH/DCM) to yield 4.28 (1.9 mg, 0.00177 mmol, 25%). 
 
TLC (10% MeOH/DCM) 
 Rf = 0.37, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.36-7.20 (m, 5H), 6.47-6.16 (m, 12H), 5.87 (dd, J = 6.5, 14.5 Hz, 1H), 5.57 (dd, J = 
9.5, 15.5 Hz, 1H), 5.26-5.24 (m, 1H), 4.83-4.76 (m, 2H), 4.63-4.58 (m, 2H), 4.21-4.14 
(m, 3H), 4.04-3.92 (m, 5H), 3.87-3.80 (m, 2H), 3.78-3.68 (m, 2H), 3.67 (s, 3H), 3.63-
3.52 (m, 2H), 3.17 (s, 3H), 2.51 (s, 3H), 2.34-2.24 (m, 3H), 1.99-1.93 (m, 2H), 1.87-1.81 
(m, 2H), 1.62-1.40 (m, 10H), 1.20 (d, J = 5.5 Hz, 3H), 1.17 (d, J = 6.5 Hz, 3H), 0.95 (d, J 
= 6.5 Hz, 3H), 0.90 (d, J = 7.0 Hz, 3H). 
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HRMS (ESI) 
 Calculated for C59H85NO19S (M + Na)
+
:  1134.5614 
 Found:       1134.5607 
 
TES Protected 4.24 
To methyl ester 4.53
29
 (0.450 g, 0.420 mmol, 1 eq) in hexanes (21 mL) and 2,6-lutidine (1.27 
mL, 10.93 mmol, 26 eq) at 0 °C was added dropwise TESOTf (1.9 mL, 8.41 mmol, 20 eq). The 
reaction was stirred at 0 °C for 2h then more 2,6-lutidine (0.32 mL, 2.73 mmol, 6.5 eq) and 
TESOTf (0.48 mL, 2.10 mmol, 5 eq) was added. The reaction was stirred at 0 °C for an 
additional 15 minutes then more 2,6-lutidine (0.32 mL, 2.73 mmol, 6.5 eq) and TESOTf (0.48 
mL, 2.10 mmol, 5 eq) was added. The reaction was stirred an additional 1 hour then quenched 
with saturated aqueous NaHCO3.  The biphasic mixture was transferred to a separatory funnel 
and was diluted with diethyl ether (300 mL). The layers were separated and the organic phase 
was washed with saturated aqueous NaHCO3 (1 x 100 mL) and water (1 x 100 mL). The 
combined aqueous washings were back-extracted with diethyl ether (1 x 50 mL) and the 
combined organic extracts were washed with saturated aqueous copper sulfate (1 x 100 mL). The 
combined copper sulfate washings were back-extracted with diethyl ether (1 x 100 mL) and the 
combined organic extracts were washed with water (1 x 100 mL) and brine (1 x 100 mL), dried 
over Na2SO4 and concentrated in vacuo. The crude material was purified by flash 
chromatography (SiO2; 5% → 10% EtOAc/hexanes) to give 4.24 (0.686 g, 0.327 mmol, 78%) as 
a yellow solid. 
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TLC (20% EtOAc/hexanes) 
 Rf = 0.47, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.37-7.25 (m, 5H), 6.58-6.10 (m, 12H), 5.92 (dd, J = 5.5, 15.5 Hz, 1H), 5.48 (dd, J = 
9.5, 15.0 Hz, 1H), 4.67-4.60 (m, 2H), 4.48 (s, 1H), 4.42 (dt, J = 4.5, 10.0, 1H), 4.25-4.19 
(m, 1H), 4.12 (t, J = 8.0 Hz, 1H), 4.03-3.93 (m, 3H), 3.86-3.83 (m, 2H), 3.71 (s, 3H), 
3.70-3.67 (m, 2H), 3.64-3.56 (m, 3H), 3.50 (t, J = 4.5 Hz, 1H), 3.33 (dd, J = 6.5, 8.5 Hz, 
1H), 3.11 (s, 3H), 2.56 (d, J = 7.0 Hz, 1H), 2.48-2.40 (m, 2H), 2.33 (t, J = 10.0 Hz, 1H), 
2.01-1.49 (m, 15H), 1.23 (d, J = 6.0 Hz, 3H), 1.17 (d, J = 6.5 Hz, 3H), 1.05-0.89 (m, 
87H), 0.77-0.51 (m, 54H). 
 
 
Acyl alcohol 4.54 
To 4.24 (0.635 g, 0.303 mmol, 1 eq) in MeCN:THF 3:1 (16 mL) at 0 °C was added dropwise 
TBAF (1M in THF, 2.42 mL, 2.42 mmol, 8 eq). The reaction was stirred at 0 °C for 1.5 hours 
then was poured into saturated aqueous NaHCO3 (50 mL) and extracted with 20% MeOH/DCM 
(3 x 75 mL). The combined organic layers were dried over Na2SO4 and concentrated in vacuo. 
The crude material was pushed through a plug of silica gel with 10% MeOH/DCM and taken 
into the next step without further purification. To the semi-crude material in pyridine (42 mL) 
was added DMAP (0.051 g, 0.418 mmol, 1.4 eq) and acetic anhydride (2.0 mL, 2.08 mmol, 69 
eq). The reaction was stirred at 23 °C for 12 hours then partitioned between saturated aqueous 
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NaHCO3:H2O 1:1 (250 mL) and Et2O (500  mL). The organic layer was washed with water (1 x 
200 mL). The combined aqueous layers were extracted with Et2O (2 x 150 mL). The combined 
organic layers were washed with brine (1 x 250 mL), dried over Na2SO4, and concentrated in 
vacuo. The crude material was purified by flash chromatography (SiO2; 50% → 75% 
EtOAc/hexanes) to yield 4.54 (0.228 g, 0.150 mmol, 49% over 2 steps) as a yellow solid. 
 
TLC (50% EtOAc/hexanes) 
 Rf = 0.20, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.29-7.19 (m, 5H), 1.07 (d, J = 9.5 Hz, 1H), 6.64-6.04 (m, 13H), 5.62 (dd, J = 9.0, 14.5 
Hz, 1H), 5.53 (dd, J = 9.5, 15.0 Hz, 1H), 5.35-5.28 (m, 4H), 5.19-5.12 (m, 2H), 5.06-4.92 
(m, 8H), 4.82 (s, 1H), 4.81-4.76 (m, 1H), 4.69 (t, J = 9.5 Hz, 1H), 4.53 (t, J = 6.5 Hz, 
1H), 4.37-4.32 (m, 1H), 4.06 (t, J = 10.5 Hz, 1H), 3.67 (s, 3H), 3.61-3.53 (m, 2H), 3.47-
3.39 (m, 4H), 3.16 (d, J = 2.5 Hz, 1H), 3.14 (s, 3H), 2.56-2.50 (m, 2H), 2.48-2.38 (m, 
3H), 2.29 (t, J = 6.0 Hz, 2H), 2.08 (s, 3H), 2.07 (s, 3H), 2.06 (s, 3H), 2.00 (s, 3H), 1.98-
1.93 (m, 1H), 1.96 (s, 3H), 1.93 (s, 3H), 1.91 (s, 3H), 1.79 (s, 3H), 1.50-1.45 (m, 1H), 
1.14 (d, J = 6.0 Hz, 3H), 1.11 (d, J = 6.0 Hz, 3H), 1.05 (d, J = 6.5 Hz, 3H), 0.99 (t, J = 
8.0 Hz, 9H), 0.96 (d, J = 7.0 Hz, 3H), 0.65 (q, J = 8.0 Hz, 6H). 
 
HRMS (ESI) 
 Calculated for C79H113NO26Si (M + Na)
+
:  1542.7218 
 Found:       1542.7177 
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C35 Alcohol 4.31 
To pyridine (31 mL) at 0 °C was added cautiously HF/pyridine (3.58 mL) and was stirred for 10 
minutes. This solution was added to 4.54 (0.599 g, 0.394 mmol, 1 eq) in THF (47 mL) at 0 °C. 
The reaction was allowed to warm to 23 °C and was stirred for 14 hours. The reaction was 
recooled to 0 °C and was quenched slowly with NaHCO3 (100 mL). The mixture was extracted 
with Et2O (3 x 150 mL) and the combined organic layers were washed with water (1 x 100 mL) 
and brine (1 x 100 mL). The organic layers were dried over Na2SO4 and concentrated in vacuo.  
The residue was purified by flash chromatography (SiO2; 50% → 75% EtOAc/hexanes) to give 
4.31 (0.437 g, 0.311 mmol, 79%) as a yellow solid. 
 
TLC (75% EtOAc/hexanes) 
 Rf = 0.29, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.29-7.19 (m, 4H), 7.06 (d, J = 9.0 Hz, 1H), 6.64-6.10 (m, 13H), 5.50 (dd, J = 9.5, 14.0 
Hz, 1H), 5.33-5.28 (m, 3H), 5.21-5.15 (m, 1H), 5.09-4.93 (m, 4H), 4.80 (s, 1H), 4.68 (t, J 
= 10.0 Hz, 1H), 4.50 (t, J = 6.0 Hz, 1H), 4.36-4.32 (m, 1H), 4.10-4.00 (m, 2H), 3.95 (d, J 
= 5.5 Hz, 1H), 3.67 (s, 3H), 3.57 (dd, J = 6.0, 9.0 Hz, 1H), 3.42 (q, J = 9.5 Hz, 2H), 3.27-
3.25 (m, 2H), 3.17 (s, 3H), 2.53-2.38 (m, 4H), 2.29 (t, J = 11.0 Hz, 1H), 2.07-1.79 (m, 
28H), 1.65-1.55 (m, 3H), 1.49-1.40 (m, 2H), 1.16 (d, J = 7.0 Hz, 3H), 1.10 (d, J = 6.0 Hz, 
3H), 1.09 (d, J = 6.0 Hz, 3H), 0.98 (d, J = 7.0 Hz, 3H). 
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Thiocarbonate 4.33 
To 4.31 (20 mg, 0.0142 mmol, 1 eq) in pyridine (1.42 mL) was added phenyl 
chlorothionoformate (0.019 mL, 0.142 mmol, 10 eq). The reaction was stirred at 40 °C for 3 
hours then quenched with saturated aqueous NaHCO3 (5 mL). The mixture was extracted with 
Et2O (3 x 10 mL), dried over Na2SO4, and concentrated in vacuo. The residue was purified by 
flash chromatography (SiO2; 50% → 70% EtOAc/hexanes) to yield 4.33 (12.2 mg, 0.00790 
mmol, 56%) in only ~70% purity. 
 
TLC (75% EtOAc/hexanes) 
 Rf = 0.47, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.48-7.42 (m, 2H), 7.32-7.06 (m, 8H), 6.64-6.08 (m, 14H), 5.50 (dd, J = 9.5, 14.5 Hz, 
1H), 5.32-5.28 (m, 3H), 5.22-5.18 (m, 2H), 5.08-4.93 (m, 4H), 4.80 (s, 1H), 4.68 (t, J = 
11.0 Hz, 2H), 4.50 (d, J = 7.0 Hz, 1H), 4.34 (t, J = 6.0 Hz, 1H), 4.08 (t, J = 5.5 Hz, 1H), 
4.00 (t, J = 6.5 Hz, 1H), 3.67 (s, 3H), 3.60-3.55 (m, 1H), 3.42 (q, J = 11.0 Hz, 2H), 3.17 
(s, 3H), 2.59-2.27 (m, 6H), 2.13-1.78 (m, 24H), 1.65-1.40 (m, 8H), 1.34-1.25 (m, 4H), 
1.19-0.97 (m, 12H).  
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LRMS (ESI) 
 Calculated for C80H103NO27S (M + Na)
+
:  1564.6 
 Found:       1564.5 
 
TES Protected 4.35 
To bisketal 4.55
29
 (0.100 g, 0.0.0832 mmol, 1 eq) in hexanes (4.2 mL) and 2,6-lutidine (0.140 
mL, 1.198 mmol, 14.4 eq) at 0 °C was added dropwise TESOTf (0.209 mL, 0.924 mmol, 11.1 
eq). The reaction was stirred at 0 °C for 2h then more 2,6-lutidine (0.035 mL, 0.299 mmol, 3.6 
eq) and TESOTf (0.050 mL, 0.224 mmol, 2.7 eq) was added. The reaction was stirred at 0 °C for 
an additional 15 minutes then more 2,6-lutidine (0.035 mL, 0.299 mmol, 3.6 eq) and TESOTf 
(0.050 mL, 0.224 mmol, 2.7 eq) was added. The reaction was stirred an additional 1 hour then 
quenched with saturated aqueous NaHCO3.  The biphasic mixture was transferred to a separatory 
funnel and was diluted with diethyl ether (100 mL). The layers were separated and the organic 
phase was washed with saturated aqueous NaHCO3 (1 x 50 mL) and water (1 x 50 mL). The 
combined aqueous washings were back-extracted with diethyl ether (1 x 50 mL) and the 
combined organic extracts were washed with saturated aqueous copper sulfate (1 x 50 mL). The 
combined copper sulfate washings were back-extracted with diethyl ether (1 x 50 mL) and the 
combined organic extracts were washed with water (1 x 50 mL) and brine (1 x 50 mL), dried 
over Na2SO4 and concentrated in vacuo. The crude material was purified by flash 
chromatography (SiO2; 0% → 15% EtOAc/hexanes) to give 4.35 (0.084 g, 0.474 mmol, 57%) as 
a yellow solid. The product was isolated as a 1:1 mixture of ketal constitutional isomers. 
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TLC (20% EtOAc/hexanes) 
 Rf = 0.30, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.36-7.25 (m, 10H), 6.38 (m, 20H), 6.07 (dd, J = 10.0, 14.5 Hz, 2H), 5.89 (dd, J = 5.5, 
14.5 Hz, 1H), 5.83 (dd, J = 5.5, 15.0 Hz, 1H), 5.65-5.60 (m, 2H), 4.94-4.87 (m, 2H), 
4.63-4.58 (m, 2H), 4.50 (s, 2H), 4.34-4.26 (m, 2H), 4.19-4.13 (m, 2H), 4.11-4.06 (m, 
2H), 4.01-3.97 (m, 2H), 3.95-3.85 (m, 4H), 3.84-3.82 (m, 2H), 3.77-3.73 (m, 2H), 3.71 
(s, 3H), 3.68 (s, 3H), 3.58-3.44 (m, 12H), 3.36-3.30 (m, 2H), 3.14 (s, 3H), 3.04 (s, 3H), 
2.41-2.13 (m, 10H), 2.00-1.91 (m, 8H), 1.90-1.76 (m, 10H), 1.72-1.56 (m, 22H), 1.55-
1.43 (m, 14H), 1.36-1.25 (m, 6H), 1.21 (d, J = 6.5 Hz, 6H), 1.18 (d, J = 6.5 Hz, 3H), 1.17 
(d, J = 6.5 Hz, 3H), 1.04-0.90 (m, 102H), 0.70-0.53 (m, 60H). 
 
Bisvinyl Iodide 4.36 
TES ether 4.35 (0.300 g, 0.169 mmol, 1 eq) was dissolved in CH2Cl2 (13 mL) and MeOH (0.590 
mL) and was cooled to -78 
o
C.  Ozone was bubbled through the solution until a blue color 
persisted (~10 minutes) and the excess ozone was bubbled out with a stream of nitrogen. 
Dimethyl sulfide (0.124 mL, 1.691 mmol, 10 eq) was added at -78 
o
C with stirring and the cold 
bath was removed. The reaction was stirred at 23 
o
C overnight (~14 h). The mixture was 
concentrated and the residue was dissolved in diethyl ether (100 mL) and washed with saturated 
NaHCO3 (75 mL). The aqueous layer was extracted with Et2O (3 x 50 mL) and the combined 
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organic layers were dried over Na2SO4 and concentrated in vacuo. The resulting white foam was 
azeotropically dried via coevaporation with benzene (3 x 10 mL) and left under vacuum for at 
least 1 hour. In a separate round bottom flask equipped with a stir bar and charged with CrCl2 
(0.650 g, 5.29 mmol, 31 eq) was added THF (3.8 mL) and dioxane (0.96 mL). To the CrCl2 
slurry was added dropwise a solution of the bisaldehyde intermediate and iodoform (0.551 g, 
1.399 mmol, 8.2) in THF (2.9 mL) and dioxane (1.9 mL). The resulting dark red slurry was 
stirred at 23 
o
C for 1.5 hours before quenching with saturated NaHCO3 (30 mL). The resulting 
green slurry was diluted with Et2O (100 mL) and filtered through celite. The filtrate layers were 
separated and the organic layer was washed with saturated Na2S2O3 (30 mL). The combined 
aqueous layers were extracted with diethyl ether (2 x 50 mL), then combined organic layers were 
dried over Na2SO4 and concentrated. The crude material was purified by flash chromatography 
(SiO2; 0% → 15% EtOAc/hexanes) to furnish bisvinyl iodide 4.36 (0.151 g, 0.0796 mmol, 47% 
over two steps) as a white solid. The product was isolated as a 1:1 mixture of ketal constitutional 
isomers. 
 
TLC (20% EtOAc/hexanes) 
 Rf = 0.33, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.36-7.25 (m, 10H), 6.59-6.49 (m, 4H), 6.28 (d, J = 9.0 Hz, 2H), 6.23 (d, J = 14.5 Hz, 
2H), 5.13 (p, J = 6.5 Hz, 2H), 4.57 (s, 1H), 4.55 (s, 1H), 4.38-4.27 (m, 4H), 4.24-4.16 (m, 
4H), 3.97-3.90 (m, 4H), 3.83 (s, 2H), 3.69 (s, 3H), 3.68 (s, 3H), 3.66-3.56 (m, 12H), 3.47 
(t, J = 4.5 Hz, 2H), 3.32-3.27 (m, 2H), 3.17 (s, 3H), 3.13 (s, 3H), 2.54-2.47 (m, 2H), 2.43-
2.38 (m, 4H), 2.31-2.14 (m, 6H), 2.00-1.84 (m, 12H), 1.75-1.41 (m, 42H), 1.36-1.28 (m, 
6H), 1.23 (d, J = 6.5 Hz, 3H), 1.21 (d, J = 6.5 Hz, 3H), 1.14 (d, J = 6.5 Hz, 6H), 1.01-
0.88 (m, 102H), 0.69-0.53 (m, 60H). 
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TBS ether 4.39 
To methyl ester 4.53
29
 (0.250 g, 0.234 mmol, 1 eq) in DCM (11.7 mL) and 2,6-lutidine (0.707 
mL, 6.07 mmol, 26 eq) at 0 °C was added dropwise TBSOTf (1.07 mL, 4.67 mmol, 20 eq). The 
reaction was stirred at 0 °C for 1 hour then quenched with saturated aqueous NaHCO3.  The 
biphasic mixture was transferred to a separatory funnel and was diluted with diethyl ether (100 
mL). The layers were separated and the organic phase was washed with saturated aqueous 
NaHCO3 (1 x 50 mL) and water (1 x 50 mL). The combined aqueous washings were back-
extracted with diethyl ether (1 x 50 mL) and the combined organic extracts were washed with 
saturated aqueous copper sulfate (1 x 50 mL). The combined copper sulfate washings were back-
extracted with diethyl ether (1 x 50 mL) and the combined organic extracts were washed with 
water (1 x 50 mL) and brine (1 x 50 mL), dried over Na2SO4 and concentrated in vacuo. The 
crude material was purified by flash chromatography (SiO2; 0% → 5% EtOAc/hexanes) to give 
4.39 (0.248 g, 0.118 mmol, 50%) as a yellow solid. 
 
TLC (15% EtOAc/hexanes) 
 Rf = 0.50, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.34-7.20 (m, 5H), 6.69-6.57 (m, 3H), 6.42-6.10 (m, 9H), 5.95 (dd, J = 4.5, 15.5 Hz, 
1H), 5.45 (dd, J = 10.0, 15.0 Hz, 1H), 4.63 (broad s, 1H), 4.49 (s, 1H), 4.49-4.46 (m, 1H), 
4.41 (dt, J = 4.5, 9.5 Hz, 1H), 4.13-4.10 (m, 2H), 4.07-4.01 (m, 3H), 3.92-3.88 (m, 2H), 
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3.71-3.68 (m, 1H), 3.70 (s, 3H), 3.59-3.55 (m, 4H), 3.40-3.37 (m, 1H), 3.09 (s, 3H), 2.65-
2.55 (m, 2H), 2.48-2.40 (m, 1H), 2.34 (t, J = 10.0 Hz, 1H), 2.21 (t, J = 9.0 Hz, 1H), 1.97-
1.87 (m, 5H), 1.84-1.61 (m, 7H), 1.58-1.47 (m, 3H), 1.24 (d, J = 6.0 Hz, 3H), 1.14 (d, J = 
5.5 Hz, 3H), 0.99-0.84 (m, 87H), 0.26-0.00 (m, 54H).  
 
Bisvinyl Iodide 4.56 
TBS ether 4.39 (1.12 g, 0.534 mmol, 1 eq) was dissolved in CH2Cl2 (49 mL) and MeOH (2.2 
mL) and was cooled to -78 
o
C.  Ozone was bubbled through the solution until a blue color 
persisted (~10 minutes) and the excess ozone was bubbled out with a stream of nitrogen. 
Dimethyl sulfide (0.124 mL, 1.691 mmol, 10 eq) was added at -78 
o
C with stirring and the cold 
bath was removed. The reaction was stirred at 23 
o
C overnight (~14 h). The mixture was 
concentrated and the residue was dissolved in diethyl ether (300 mL) and washed with saturated 
NaHCO3 (150 mL). The aqueous layer was extracted with Et2O (3 x 100 mL) and the combined 
organic layers were dried over Na2SO4 and concentrated in vacuo. The resulting white foam was 
azeotropically dried via coevaporation with benzene (3 x 10 mL) and left under vacuum for at 
least 1 hour. In a separate round bottom flask equipped with a stir bar and charged with CrCl2 
(2.03 g, 16.55 mmol, 31 eq) was added THF (11.8 mL) and dioxane (3.0 mL). To the CrCl2 
slurry was added dropwise a solution of the bisaldehyde intermediate and iodoform (1.72 g, 4.38 
mmol, 8.2) in THF (8.9 mL) and dioxane (5.9 mL). The resulting dark red slurry was stirred at 
23 
o
C for 1.5 hours before quenching with saturated NaHCO3 (100 mL). The resulting green 
slurry was diluted with Et2O (300 mL) and filtered through celite. The filtrate layers were 
separated and the organic layer was washed with saturated Na2S2O3 (50 mL). The combined 
aqueous layers were extracted with diethyl ether (2 x 100 mL), then combined organic layers 
were dried over Na2SO4 and concentrated. The crude material was purified by flash 
chromatography (SiO2; 0% → 10% EtOAc/hexanes) to furnish bisvinyl iodide 4.56 (0.578 g, 
0.260 mmol, 49% over two steps) as a white solid. 
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TLC (15% EtOAc/hexanes) 
 Rf = 0.52, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.31-7.22 (m, 5H), 5.59 (dd, J = 7.5, 14.5 Hz, 1H), 6.47 (dd, J = 7.5, 14.5 Hz, 1H), 6.35 
(d, J = 8.5 Hz, 1H), 6.20 (d, J = 14.5 Hz, 1H), 5.17-5.14 (m, 1H), 4.57 (s, 1H), 4.33-4.26 
(m, 2H), 4.06-3.98 (m, 2H), 3.90-3.84 (m, 2H), 3.70 (s, 3H), 3.67-3.54 (m, 4H), 3.37-
3.34 (m, 1H), 3.19 (s, 3H), 2.56-2.49 (m, 2H), 2.41 (dd, J = 8.0, 15.0 Hz, 1H), 2.24 (t, J = 
10.5 Hz, 1H), 1.99-1.93 (m, 4H), 1.85-1.46 (m, 16H), 1.24 (d, J = 6.5 Hz, 3H), 1.17 (d, J 
= 6.5 Hz, 3H), 1.02 (d, J = 6.5 Hz, 3H), 0.96-0.85 (m, 84H), 0.18-0.00 (m, 54H). 
 
 
Methyl Ester 4.57 
To bisvinyl iodide 4.56 (0.575 g, 0.259 mmol, 1 eq) in MeOH:THF 1:1 (7 mL) was added 
NaOMe (0.140 g, 2.59 mmol, 10 eq) in MeOH (3.5 mL) via cannula. The reaction was stirred at 
50 
o
C for 3 hours then more NaOMe (0.140 g, 2.59 mmol, 10 eq) was added as a solid. After 22 
hours at 50 
o
C the reaction was cooled to 0 
o
C then quenched with 0.5 M pH 7 phosphate buffer 
(10 mL). The mixture was diluted with Et2O (100 mL) and the layers were separated. The 
aqueous layer was extracted with Et2O (2 x 100 mL) and the combined organic layers were dried 
over Na2SO4 and concentrated. Flash chromatography (SiO2; 0% → 10% EtOAc/hexanes) 
yielded 4.57 (0.172 g, 0.093 mmol, 36%) as a colorless solid. 
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TLC (15% EtOAc/hexanes) 
 Rf = 0.44, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.33-7.22 (m, 5H), 6.56 (d, J = 14.5 Hz, 1H), 6.47 (dd, J = 7.5, 14.5 Hz, 1H), 6.36 (d, J 
= 9.0 Hz, 1H), 4.57 (s, 1H), 4.32 (m, 3H), 4.05-3.97 (m, 2H), 3.89 (d, J = 2.5 Hz, 1H), 
3.88-3.83 (m, 1H), 3.69 (s, 3H), 3.62 (s, 3H), 3.57-3.52 (m, 7H), 3.37-3.33 (m, 1H), 3.19 
(s, 3H), 2.59 (dd, J = 6.0, 15.0 Hz, 1H), 2.37 (dd, J = 8.0, 15.0 Hz, 1H), 2.24 (t, J = 10.5 
Hz, 1H), 2.15-2.11 (m, 1H), 1.98-1.91 (m, 1H), 1.82-1.51 (m, 14H), 1.44-1.39 (m, 2H), 
1.30-1.26 (m, 1H), 1.23 (d, J = 6.5 Hz, 3H), 0.95-0.84 (m, 72H), 0.18-0.00 (m, 48H). 
 
Dienyl MIDA Boronate 4.40 
 A 20 mL I-Chem vial equipped with a stir bar was charged with methyl ester 4.57 (0.170 g, 
0.0916 mmol, 1 eq) and bisborylated compound 4.17
16,27
 (0.056 g, 0.183 mmol, 2 eq), sealed 
under argon, and was taken into a glove box. PdCl2dppf∙CH2Cl2 (0.015 g, 0.0183 mmol, 20 
mol%) and K3PO4 as a finely ground powder (0.117 g, 0.549 mmol, 6 eq) were added followed 
by DMSO (4.6 mL). The reaction was sealed with a PTFE-lined cap and stirred at 23 
o
C for 24 h. 
The solution was diluted with EtOAc (10 mL) and filtered through a pad of silica gel, washing 
with EtOAc (100 mL). The filtrate was washed with brine (3 x 20 mL) and the combined 
aqueous layers were back-extracted with EtOAc (75 mL). The combined organic layers were 
dried over Na2SO4 and concentrated in vacuo. The crude material was purified via flash 
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chromatography (SiO2; 50% → 70% EtOAc/hexanes) to furnish dienyl MIDA boronate 4.40 
(0.083 g, 0.043 mmol, 48%) as a white solid. 
 
TLC (EtOAc) 
 Rf = 0.73, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.30-7.22 (m, 5H), 6.61 (dd, J = 10.5, 17.5 Hz, 1H), 6.40 (d, J = 9.0 Hz, 1H), 6.32 (dd, 
10.5, 15.5 Hz, 1H), 5.68 (d, J = 17.5 Hz, 1H), 5.59 (dd, J = 8.5, 15.0 Hz, 1H), 4.59 (s, 
1H), 4.38-4.32 (m, 1H), 4.29-4.20 (m, 2H), 4.08-3.99 (m, 2H), 3.90 (d, J = 2.5 Hz, 1H), 
3.69 (s, 3H), 3.62 (s, 3H), 3.58-3.54 (m, 1H), 3.38-3.35 (m, 1H), 3.14 (s, 3H), 3.00 (s, 
3H), 2.62-2.57 (m, 1H), 2.40-2.34 (m, 1H), 2.23 (t, J = 10.0 Hz, 1H), 2.13 (s, 1H), 1.81-
1.65 (m, 9H), 1.57-1.48 (m, 4H), 1.43-1.32 (m, 3H), 1.19 (d, J = 6.0 Hz, 3H), 0.95-0.84 
(m, 72H), 0.18--0.02 (m, 48H). 
 
Pentaenyl MIDA Boronate 4.43 
MIDA boronate 4.43 was converted to a boronic acid via the following procedure: To a stirred 
solution of dienyl MIDA boronate 4.43 (80 mg, 0.0419 mmol, 1 eq) in THF (4.2 mL) at 23 ˚C 
was added 1 M aq. NaOH (1.3 mL, 1.3 mmol, 30 eq) and the resulting mixture was stirred for 10 
min. The reaction was then quenched with the addition of 0.5 M pH 7 phosphate buffer (10 mL) 
and diluted with Et2O (10 mL). The layers were separated and the aq. layer was extracted with 
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Et2O (3 x 5 mL).  The combined organic layers were dried over Na2SO4 and concentrated in 
vacuo until a small amount of THF (~0.6 mL) remained, yielding a solution of boronic acid.  
A solution of the palladium catalyst was prepared as follows: To a 1.5 mL vial equipped with a 
stir bar and containing 2-dicyclohexylphosphino-2’,6’-dimethoxy-1,1’-biphenyl ligand (S-Phos, 
6.8 mg, 0.0167 mmol) was added a solution of Pd(OAc)2 in toluene (0.0145 M , 0.580 mL, 
0.00836 mmol). The vial was sealed with a PTFE-lined cap and maintained at 23 
o
C with stirring 
for 30 min. 
This catalyst solution was then utilized in the following procedure: To a 7-mL vial equipped with 
a stir bar and containing triene 4.41
21
 (13.6 mg, 0.0376 mmol, 0.9 eq) was added the boronic acid 
as a solution in THF (estimated 0.6 mL, 0.0419 mmol, 1 eq), anhydrous Cs2CO3 (81.8 mg, 0.251 
mmol, 6 eq), and the catalyst stock solution described above (0.290 mL, 0.00418 mmol Pd, 10 
mol% Pd).  The resulting mixture was sealed with a PTFE-lined cap and stirred at 45 ˚C for 3.5 
hours. The reaction was then diluted with EtOAc (2 mL) and filtered throught a short pad of 
silica gel with copious amounts of EtOAc.  The filtrate was concentrated in vacuo and purified 
by silica gel chromatography (50% → 75% EtOAc/hexanes) to yield pentaenyl MIDA boronate 
4.43 (12.8 mg, 0.00644 mmol, 17%) as a pale yellow solid.  
 
TLC (75% EtOAc/hexanes) 
 Rf = 0.43, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.31-7.20 (m, 5H), 6.41-6.28 (m, 8H), 6.15-6.07 (m, 1H), 5.79-5.58 (m, 2H), 4.59 (s, 
1H), 4.40-4.24 (m, 3H), 4.21 (d, J = 21.0 Hz, 2H), 4.03 (d, J = 21.5 Hz, 2H), 3.90-3.83 
(m, 2H), 3.69 (s, 3H), 3.62 (s, 3H), 3.56-3.54 (m, 1H), 3.29 (d, J = 6.0 Hz, 1H), 3.15 (s, 
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3H), 2.99 (s, 3H), 2.26-2.21 (m, 2H), 1.82-1.63 (m, 13H), 1.60-1.49 (m, 2H), 1.48-1.39 
(m, 2H), 1.30-1.11 (m, 13H), 0.95-0.84 (m, 72H), 0.18--0.02 (m, 48H). 
 
Macrolactone 4.44  
A solution of the palladium catalyst was prepared as follows: To a 1.5 mL vial equipped with a 
stir bar and containing 2-dicyclohexylphosphino-2’,4’,6’-tri-i-propyl-1,1’-biphenyl ligand (1.5 
mg, 0.0031 mmol) was added a solution of Pd(OAc)2 in toluene (0.0073 M , 0.676 mL, 0.00057 
mmol). The vial was sealed with a PTFE-lined cap and maintained at 23 
o
C with stirring for 15 
min. 
This catalyst solution was then utilized in the following procedure: To pentaenyl MIDA boronate 
4.44 (12.8 mg, 0.00643 mmol, 1 eq) and dienyl iodide 4.19 (1.8 mg, 0.00611 mmol, 0.95 eq) was 
added the catalyst stock solution described above (0.045 mL, 0.000321 mmol Pd, 5 mol% Pd). 
The resulting mixture was sealed with a teflon-lined septum cap and 1 M NaOH (0.032 mL, 
0.032 mmol, 5 eq) was added.  The reaction was stirred at 23 
o
C for 30 min then at 45 
o
C for 2 
hours. The reaction was diluted Et2O (10 mL) and was quenched with 0.5 M pH 7 phosphate 
buffer (5 mL). The layers were separated and the aqueous layer was extracted with Et2O (2 x 5 
mL). The combined organic layers were filtered through a short plug of silica gel with Et2O and 
concentrated. The residue was taken up in THF:MeOH:H2O 3:1:1 (0.7 mL), LiOH (14.7 mg, 
0.349 mmol, 50 eq) was added, and the vial was sealed under argon. The reaction was stirred at 
35 
o
C for 1 h and then heated to 45 
o
C for 3 hours. The reaction was then diluted with EtOAc (10 
mL) and was poured into water (10 mL). The aqueous layer was extracted with EtOAc (5 x 10 
mL). The combined organic layers were dried over Na2SO4 and concentrated. The residue was 
dissolved in CH2Cl2 (1.5 mL) and was added dropwise over 5 h to a solution of MNBA (2.4 mg, 
0.0070 mmol, 1.2 eq) and DMAP (1.7 mg, 0.0140 mmol, 2.4 eq) in CH2Cl2 (2.4 mL). The 
reaction was stirred an additional 10 hours and was then heated to 45 
o
C and stirred for 1 hour. 
The reaction was cooled to 0 
o
C and quenched with saturated NaHCO3 (10 mL). The layers were 
190 
 
separated and the aqueous layer was extracted with Et2O (3 x 10 mL) and the combined organic 
layers were dried over Na2SO4 and concentrated. The crude material was purified by flash 
chromatography (SiO2; 5% → 10% EtOAc/hexanes) to provide macrolactone 4.44 (5.1 mg, 
0.00259 mmol, 42% over 3 steps) in very low purity.  
 
TLC (20% EtOAc/hexanes) 
 Rf = 0.54, stained by anisaldehyde. 
 
HRMS (ESI) 
 Calculated for C105H195NO17Si8 (M + Na)
+
:  1989.2477 
 Found:       1989.2449 
 
 
Acetal Protected 4.58 
Trimethyl acetyl chloride (400 μL, 3.25 mmol, 2 eq) was added to a solution of phenyl acetic 
acid (662 mg, 4.86 mmol, 3 eq) in THF (30 mL). Triethylamine (900 μL, 6.46 mmol, 4 eq) was 
added to the reaction, and it was stirred for 6 hours at 23 C. The reaction was placed in an ice 
bath, and DMSO (30 mL) was added over 2 minutes as the solution cooled. Once the reaction 
mixture reached 0 °C, AmB (1.50 g, 1.62 mmol, 1 eq) was added. The yellow-tan suspension 
was stirred for 90 minutes at 0 °C. The reaction was then poured into diethyl ether (1.8 L) with 
rapid stirring. After 15 minutes of stirring, the resulting yellow precipitate was vacuum filtered 
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and washed 3 times with diethyl ether (200 mL). The yellow powder was placed under vacuum 
for 8 hours prior to the next reaction. 
Three 1.5 gram batches of N-phenyl acyl amphotericin B were pooled together for the 
succeeding reactions. The yellow solid (5.00 g, 4.80 mmol, 1 eq) was dissolved in a mixture of 
methanol (90 mL, 0.05 M) and THF (90 mL) and the solution was cooled to 0 C. () 
Camphorsulfonic acid (223 mg, 0.96 mmol, 0.2 eq) was added to the cooled solution and the 
reaction was stirred for one hour at 0 C. The reaction was quenched at 0 C with triethylamine 
(130 L, 0.96 mmol, 0.2 eq) and the volume of the solvent was reduced in vacuo by 
approximately 50 percent. The solution was poured into 3.6 L of a 1:1 ether:hexane solution and 
the resulting precipitate was isolated via vacuum filtration. The yellow solid was taken forward 
to the next step without further purification.  
The yellow solid (ca 5 g, 4.8 mmol, 1 eq) was dissolved in methanol (80 mL) and p-
anisaldehyde methyl acetal (12 mL, 70 mmol, 146 eq) was added to the reaction. Subsequently, 
() camphorsulfonic acid (449 mg, 1.93 mmol, 0.4 eq) was added and the reaction was stirred at 
23 C for one hour. The reaction was quenched by the addition of triethylamine (270 L, 1.92 
mmol, 0.4 eq) and the solvent was removed in vacuo. The crude was purified via flash 
chromatography (SiO2; 3%  10% MeOH/DCM/0.15 AcOH) to yield 4.58 as an orange solid 
(3.20 g, 2.48 mmol, 52% over three steps) of approximately 70% purity which was carried 
forward without further purification. 
 
 
TLC (10% MeOH/DCM/0.1% AcOH) 
 Rf = 0.15 stained by anisaldeyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.42 (d, J = 8.5 Hz, 2H), 7.34 (d, J = 8.5 Hz, 4H), 7.27 (t, J = 7.5 Hz, 2H), 7.22 (app. t, 
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J = 7.5 Hz, 1H), 6.86 (dd, J = 3.0, 9.0 Hz, 4H), 6.44-6.19 (m, 12H), 5.87 (dd, J = 5.5, 
15.0 Hz, 1H), 5.56 (dd, J = 9.5, 13.5 Hz, 1H), 5.51 (s, 1H), 5.46 (s, 1H), 5.28-5.25 (m, 
1H), 4.67 (app. t, J = 6.0 Hz, 1H), 4.61 (s, 1H), 4.24-4.09 (m, 3H), 3.96-3.84 (m, 4H), 
3.77 (s, 6H), 3.65 (s, 2H), 3.44-3.42 (m, 1H), 3.38-3.29 (m, 3H), 3.04 (s, 3H), 2.57 (dd, J 
= 6.0, 16.5 Hz, 1H), 2.42-2.37 (m, 1H), 2.32-2.27 (m, 2H), 2.21 (app. t, J = 10.0 Hz, 1H), 
2.16-2.10 (m, 1H), 1.89-1.81 (m, 3H), 1.76-1.63 (m, 4H), 1.56-1.43 (m, 4H), 1.36-1.27 
(m, 3H), 1.21 (d, J = 5.5 Hz, 3H), 1.18 (d, J = 6.0 Hz, 3H), 1.10 (d, J = 6.5 Hz, 3H), 1.00 
(d, J = 7.5 Hz, 3H). 
 
13
C NMR (125 MHz, acetone-d6) 
 169.8, 160.6, 160.5, 136.9, 134.2, 133.8, 133.0, 132.9, 132.7, 132.6, 130.1, 129.1, 
128.3, 128.2, 127.3, 113.9, 101.1, 100.8, 100.6, 97.9, 81.1, 76.4, 74.4, 73.2, 72.9, 70.7, 
70.5, 67.2, 67.0, 57.2, 56.4, 55.5, 48.7, 43.6, 43.3, 41.5, 37.9, 34.0, 33.3, 18.9, 18.2, 17.6, 
11.9. 
 
HRMS (ESI) 
 calculated for C72H93NO20 (M+Na)
+
:   1314.6189 
 found:       1314.6213 
 
 
TBS Protected 4.59 
Prior to the reaction, 4.58 was coevaporated with acetonitrile (3 x 25 mL) and left under vacuum 
for a minimum of eight hours. The resulting orange solid (2.98 g, 2.31 mmol, 1 eq) was 
dissolved in dichloromethane (70 mL) and 2,6-lutidine (3.5 mL, 30 mmol, 13 eq) was added to 
the solution. The reaction was subsequently cooled to 0 C and tert-butyldimethylsilyl 
trifluromethane sulfonate (5 mL, 22 mmol, 9.5 eq) was added dropwise over approximately 15 
minutes. The reaction was stirred for 1 hour at 0 C and was then quenched by the addition of 50 
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mL saturated aqueous sodium bicarbonate. The biphasic mixture was transferred to a 2 L 
separatory funnel and was diluted with diethyl ether (1 L). The layers were separated and the 
organic phase was washed with saturated aqueous sodium bicarbonate (1 x 100 mL) and water (1 
x 100 mL). The combined aqueous washings were back-extracted with diethyl ether (1 x 50 mL) 
and the combined organic extracts were washed with saturated aqueous copper sulfate (5 x 100 
mL). The combined copper sulfate washings were back-extracted with diethyl ether (1 x 100 
mL) and the combined organic extracts were washed with water (1 x 100 mL) and brine (1 x 100 
mL), dried over sodium sulfate and concentrated in vacuo.  
The resulting brown oil was taken up in THF:MeOH:H2O (70 mL, 3:1:1 v/v/v) and 
potassium carbonate (3.2 g, 23 mmol, 10 eq) was added. Within approximately five minutes the 
reaction transitioned from turbid to clear. The reaction was stirred for 30 minutes at 23 C and 
was then quenched by the addition of 50 mL potassium phosphate buffer (50 mL, pH 7.0). The 
mixture was transferred to a 1 L separatory funnel and was extracted with diethyl ether (3 x 250 
mL). The combined organic extracts were dried over sodium sulfate and concentrated in vacuo. 
The crude was purified via flash chromatography (SiO2; 30%  100% EtOAc) to yield the title 
compound 4.59 as a yellow solid (1.21 g, 0.65 mmol, 28%). 
 
TLC (30% EtOAc/hexanes) 
Rf  = 0.2 stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6)  
 7.39 (d, J = 8.5 Hz, 2H), 7.37-7.27 (m, 4H), 7.24-7.22 (m, 1H), 6.98 (d, J = 7.5 Hz, 
1H), 6.87-6.84 (m, 4H), 6.50 (d, J = 9 Hz, 1H), 6.44-6.30 (m, 8H), 6.28-6.18 (m, 2H), 
6.06 (dd, J = 10, 15 Hz, 1H), 5.81 (dd, J = 6, 15 Hz, 1H), 5.66 (dd, J = 9.5, 15 Hz, 1H), 
5.45 (s, 2H) 4.85 (bs, 1H), 4.66 (app t, 6 Hz, 1H), 4.58 (s, 1H), 4.25 (dt, 4.5, 10.5 Hz, 
1H), 4.21-4.16 (m, 1H), 4.01-3.91(m, 2H), 3.92-3.87 (m, 3H), 3.79 (s, 3H), 3.71 (s, 3H), 
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3.71-3.69 (m, 1H), 3.60 (s, 3H), 3.58-3.55 (m, 1H), 3.42-3.37 (m, 2H), 3.05 (s, 3H), 2.52 
(dd, J = 7.5, 17.5 Hz, 1H), 2.41 (s, 2H), 2.27 (d, J = 5 Hz 1H), 2.28 (t, 3.5 Hz, 1H), 2.25-
2.23 (m, 1H), 2.11 (dd, J = 4, 12 Hz, 1H), 1.92-1.84 (m, 2H), 1.73-1.69 (m, 1H), 1.66-
1.61 (m, 1H), 1.59-1.47 (m, 2H), 1.44-1.40 (m, 1H), 1.34-1.27 (m, 2H), 1.23 (d, J = 6.5 
Hz, 3H), 1.18 (d, J = 6 Hz, 3H), 1.16-1.15 (m, 1H), 1.00 (d, J = 7 Hz, 3H), 0.95 (d, J = 7 
Hz, 3H), 0.928, (s, 9H), 0.899 (s, 9H), 0.865 (s, 9H), 0.845 (s, 9H), 0.757 (s, 9H), 0.120 
(s, 3H), 0.114 (s, 3H), 0.108 (s, 3H), 0.098 (s, 3H), 0.073 (s, 3H), 0.071 (s, 3H), 0.059 (s, 
3H), 0.029 (s, 3H), -0.044, (s, 3H), -0.054 (s, 3H), -0.134 (s, 3H). 
 
13
C NMR (125 MHz, acetone-d6) 
 173.5, 170.2, 169.4, 160.1, 160.0, 157.5, 135.6, 134.1, 133.8, 133.2, 132.9, 132.5, 
132.1, 132.0, 131.1, 130.6, 129.8, 129.7, 128.6, 128.1, 127.9, 127.8, 127.7, 120.4, 120.3, 
113.4, 113.3, 101.0, 100.8, 100.6, 100.4, 100.2, 97.6, 75.5, 74.4, 73.0, 72.8, 72.3, 68.2, 
67.0, 56.7, 56.0, 55.0, 54.9, 54.8, 43.2, 40.7, 26.2, 26.18, 26.05, 25.99, 25.91, 25.79, 
25.72, 25.60, 25.40, 23.80, 18.44, 18.30, 18.11, 17.87, -3.65, -3.75, -3.93, -4.27, -4.42,-
4.54, -4.63, -4.80, -5.22. 
 
HRMS (ESI) 
calculated for C102H163NO20Si5 (M + Na)
+
:   1885.0513 
found :               1885.0470 
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Trimethylsilyl ethyl ester 4.45 
A 200 mL round bottom flask was charged with penta tert-butyldimethyl silyl 4.59 (1.2 g, 0.61 
mmol, 1 eq) and THF (35 mL) was added. The solution was cooled to 0 C and 2-(trimethylsilyl) 
ethanol (0.28 mL, 1.9 mmol, 3 eq) was added followed by triphenylphosphine (420 mg, 1.6 
mmol, 2.5 eq). The reaction was stirred at 0 C for approximately 10 minutes and then 
diisopropyl azodicarboxylate (0.28 mL, 1.4 mmol, 2.2 eq) was added dropwise. The reaction was 
then transferred to a 45 C water bath and was stirred for 2 hours. After 2 hours the reaction was 
concentrated in vacuo and was subsequently dissolved in hexanes (100 mL). The hexanes 
solution was stirred for 10 minutes, the resulting precipitate was removed via vacuum filtration 
and the filtrate was concentrated in vacuo. The crude was purified via flash chromatography 
(SiO2; 0%  20% EtOAc/hexanes) to yield the trimethylsilyl ethyl ester 4.45 as yellow foamy 
solid (1.06 g, 0.539 mmol, 84%).  
 
TLC (20% EtOAc/hexanes) 
Rf  = 0.32, stained by anisaldehyde. 
1
H NMR (500 MHz, acetone d6) 
 7.38 (d, J = 8.5 Hz, 2H), 7.37-7.27 (m, 6H), 7.23-7.20 (m, 1H), 6.87-6.83 (m, 4H), 
6.42-6.30 (m, 9H), 6.25-6.18 (m, 2H), 6.07 (dd, J = 10, 15.5 Hz, 1H), 5.80 (dd, J = 6.5, 
14.5 Hz, 1H), 5.67 (dd J = 9.5, 15.5 Hz, 1H) 5.45 (s, 2H), 4.86 (bs, 1H), 4.61 (app t J = 7 
Hz, 1H), 4.57 (s, 1H), 4.24-4.15 (m, 4H), 4.02 (dt, J = 2, 6 Hz, 1H), 3.93-3.92 (m, 2H), 
3.89-3.85 (m, 3H), 3.78 (s, 3H), 3.77 (s, 3H), 3.75-3.71 (m, 2H), 3.57 (s, 3H), 3.41-3.37 
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(m, 3H), 3.06 (s, 3H), 2.52 (dd, J = 7.5, 17.5 Hz, 1H), 2.44-2.40 (m, 1H), 2.31 (app t, J = 
9.5 Hz, 1H), 2.28-2.24 (m, 3H), 2.00-1.95 (m, 1H), 1.89-1.85 (m, 1H), 1.81 (dd, J = 6.5, 
13.5 Hz, 1H), 1.72-1.69 (m, 1H), 1.65-1.60 (m, 2H), 1.54-1.50 (m, 1H), 1.45-1.43 (app d, 
J = 12.5 Hz, 1H), 1.23 (d, J  = 6 Hz, 3H), 1.21-1.20 (m, 1H), 1.18 (d, J = 9.5 Hz, 3H), 
1.01 (app t, J = 7 Hz, 1H), 1.06-1.04 (m, 1H), 1.01 (d, J = 6.5 Hz, 3H), 0.940 (d, J = 7 
Hz, 3H), 0.928 (s, 9H), 0.916-0.912 (m, 1H), 0.900 (s, 9H), 0.888-0.885 (m, 1H), 0.864 
(s, 9H), 0.842 (s, 9H), 0.749 (s, 9H), 0.118 (s, 3H), 0.107 (s, 3H), 0.099 (s, 3H), 0.069 (s, 
3H), 0.055 (s, 9H), 0.038 (s, 3H), 0.020 (s, 3H), -0.002 (s, 3H), -0.046 (s, 3H), -0.084 (s, 
3H), -0.169 (s, 3H).  
13
C NMR (125 MHz, acetone-d6) 
 172.7, 169.5, 169.4, 160.1, 160.0, 136.2, 135.7, 134.1, 133.7, 133.2, 133.1, 132.8, 
132.5, 132.3, 132.1, 132.0, 130.6, 129.7, 128.5, 128.0, 127.7, 126.9, 113.4, 101.0, 100.5, 
100.2, 98.1, 80.6, 75.4, 75.3, 74.3, 74.2, 72.9, 72.5, 72.3, 68.4, 67.2, 62.8, 58.8, 56.5, 
55.8, 55.0, 54.9, 54.8, 47.9, 43.5, 42.8, 40.8, 37.4, 36.2, 32.8, 32.2, 27.5, 27.4, 26.1, 26.0, 
25.9, 25.6, 25.3, 21.9, 21.8, 21.7, 19.3, 18.5, 18.3, 18.1, 17.9, 17.8, 17.7, -1.51, -1.72, -
2.01, -3.73, -3.77, -3.93, -4.28, -4.38, -4.49, -4.62, -4.74, -5.33. 
HRMS (ESI) 
calculated for C107H175NO20Si6 (M + Na)
+
:  1985.1221 
found:       1985.1249 
 
 
Bisaldehyde 4.60 
TMSE ester 4.45 (1.65 g, 0.840 mmol, 1 eq) was dissolved in CH2Cl2 (65 mL) and MeOH (3.9 
mL) and was cooled to -78 C.  Ozone was bubbled through the solution until a blue color 
persisted (~10 minutes) and then the excess ozone was bubbled out of the solution with a stream 
of argon. Tributylphosphine (2.1 mL, 8.40 mmol, 10 eq) was added at -78 
o
C with stirring, and 
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the cold bath was removed. The reaction was stirred for 30 minutes and then was poured into 
saturated aqueous NaHCO3 (100 mL). The layers were separated and the aqueous layer was 
extracted with Et2O (3 x 50 mL). The combined organic extracts were dried over Na2SO4 and 
concentrated in vacuo. The crude material was purified by flash chromatography (SiO2; 0%  
30% EtOAc/hexanes) to furnish bisaldehyde 4.60 as a white foamy solid (1.028 g, 0.559 mmol, 
67%). This material was taken on immediately to the next step as a precaution against 
decomposition.  
 
TLC (20% EtOAc/hexanes) 
 Rf = 0.27, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 9.67 (s, 1H), 9.53 (d, J = 1.5 Hz, 1 H), 7.39-7.21 (m, 9H), 6.86 (dd, J = 6.5, 8.5 Hz, 
4H), 5.52 (s, 2H), 5.12 (p, J = 6.5 Hz, 1H), 4.75 (s, 1H), 4.37 (dd, J = 2.5, 7.0 Hz, 1H), 
4.33-4.20 (m, 4H), 4.16-4.05 (m, 3H), 3.99 (t, J = 10.5 Hz, 1H), 3.92-3.88 (m, 2H), 3.84-
3.78 (m, 2H), 3.78 (s, 3H), 3.77 (s, 3H), 3.65 (t, J = 7.5 Hz, 1H), 3.59 (s, 2H), 3.49 (t, J = 
6.5 Hz, 1H), 3.15 (s, 3H), 2.56-2.52 (m, 3H), 2.29 (dd, J = 4.5, 13.5 Hz, 1H), 2.17 (t, J = 
10.0 Hz, 1H), 2.01-1.95 (m, 3H), 1.77-1.61 (m, 7H), 1.50 (t, J = 11.0 Hz, 1H), 1.41-1.24 
(m, 5H), 1.22 (d, J = 6.5 Hz, 3H), 1.19 (d, J = 6.5 Hz, 3H), 1.07 (d, J = 7.0 Hz, 3H), 0.94 
(d, J = 7 Hz, 3H), 0.92 (s, 9H), 0.88 (s, 9H), 0.87 (s, 9H), 0.85 (s, 9H), 0.76 (s, 9H), 0.15 
(s, 3H), 0.13 (s, 3H), 0.08 (s, 3H), 0.07 (s, 6H), 0.06 (s, 3H), 0.06 (s, 9H), 0.01 (s, 3H), 
0.00 (s, 3H), -0.07 (s, 3H), -0.12 (s, 3H). 
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Bisvinyl iodide 4.61 
A round bottom flask equipped with a stir bar was charged with CrCl2 (2.11 g, 17.19 mmol, 31 
eq) and THF (12.3 mL) and dioxane (3.1 mL) were added. Next, a solution of the bisaldehyde 
4.60 (1.028 g, 0.559 mmol, 1 eq) and iodoform (1.79 g, 4.55 mmol, 8.2 eq) in THF (4.6 mL) and 
dioxane (3.1 mL) was added dropwise via syringe. The flask containing 4.60 was washed twice 
with a mixture of THF (2.3 mL) and dioxane (1.6 mL) and these washes were added to the 
reaction. The resulting dark red slurry was stirred at 23 C for 2 hours before being poured into a 
1L Erlenmeyer flask containing saturated aqueous NaHCO3 (250 mL). The resulting green slurry 
was diluted with Et2O (250 mL), agitated in a separatory funnel, and filtered through a pad of 
celite. The filtrate layers were separated and the aqueous layer was extracted with diethyl ether 
(2 x 100 mL), then the combined organic layers were dried over Na2SO4 and concentrated. The 
crude material was purified by flash chromatography (SiO2; 0%  20% EtOAc/hexanes) to 
furnish bisvinyl iodide 4.61 as a white solid (0.536 g, 0.257 mmol, 46%). 
 
TLC (20% EtOAc/hexanes) 
 Rf = 0.37, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.40-7.37 (m, 4H), 7.33-7.28 (m, 3H), 7.24-7.22 (m, 1H), 6.87 (t, J = 8.0 Hz, 4H), 6.57 
(d, J = 14.0 Hz, 1H), 6.56 (dd, J = 8.0, 14.0 Hz, 1H), 6.47 (dd, J = 8.0 Hz, 14.5Hz, 1H), 
6.36 (d, J = 14.0 Hz, 1H), 6.20 (d, J = 14.5 Hz, 1H), 5.54 (s, 1H), 5.52 (s, 1H), 5.15 (p, J 
= 6.0 Hz, 1H), 4.60 (s, 1H), 4.38-4.14 (m, 6H), 4.02-3.97 (m, 2H), 3.94-3.87 (m, 3H), 
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3.86-3.80 (m, 1H), 3.78 (s, 3H), 3.77 (s, 3H), 3.68-3.65 (m, 2H), 3.58 (s, 2H), 3.55 (t, J = 
8.5Hz, 1H), 3.33 (p, J = 6.0 Hz, 1H), 3.13 (s, 3H), 2.59-2.47 (m, 3H), 2.29 (dd, J = 4.5, 
13.5 Hz, 1H), 2.15 (t, J = 10.0 Hz, 1H), 2.10-2.07 (m, 2H), 1.96-1.88 (m, 3H), 1.78-1.61 
(m, 8H), 1.50 (q, J = 12.5Hz, 1H), 1.43-1.28 (m, 3H), 1.23 (d, J = 6.0 Hz, 3H), 1.15 (d, J 
= 6.0 Hz, 3H), 1.04-0.99 (m, 2H), 0.97 (d, J = 7.0 Hz, 3H), 0.93 (s, 9H), 0.90 (s, 9H), 
0.88 (s, 9H), 0.85 (s, 9H), 0.77 (s, 9H), 0.12 (s, 3H), 0.10 (s, 3H), 0.09 (s, 3H), 0.07 (s, 
18H), 0.02 (s, 3H), 0.01 (s, 3H), -0.07 (s, 3H), -0.11 (s, 3H). 
 
13
C NMR (125 MHz, acetone-d6) 
 δ 172.8, 170.2, 170.1, 160.7, 160.6, 151.2, 147.7, 136.3, 132.5, 130.3, 129.1, 128.5, 
128.2, 127.4, 126.0, 113.9, 101.4, 101.2, 101.0, 100.4, 80.4, 80.2, 79.8, 77.0, 76.7, 76.2, 
74.8, 74.6, 74.1, 73.4, 71.7, 68.4, 67.6, 63.1, 58.3, 56.1, 55.5, 55.4, 48.5, 44.2, 44.0, 43.9, 
43.1, 42.8, 42.0, 39.7, 37.3, 33.0, 32.3, 26.6, 26.5, 26.4, 26.3, 26.0, 19.7, 19.0, 18.9, 18.8, 
18.8, 18.6, 18.3, 18.1, 16.5, 14.3, 11.2, -1.36, -3.25, -3.45, -3.57, -3.79, -3.87, -4.03, -
4.20, -4.34, -4.90. 
 
HRMS (ESI+) 
 calculated for C97H165NO20Si6I2 (M+Na)
+
:  2108.8528 
found:       2108.8557 
 
 
Methyl ester 4.62 
Prior to the reaction, bisvinyl iodide 4.61 was azeotropically dried via coevaporation with 
toluene (3 x 5 mL) and was left under vacuum for at least 1 hour. NaOMe (0.095 g, 1.75 mmol, 
10 eq) in MeOH (4.6 mL) was added to a solution of bisvinyl iodide 4.61 (0.366 g, 0.175 mmol, 
1 eq) in THF (2.3 mL). The reaction was stirred at 40 C for 2 hours and was then quenched with 
potassium phosphate buffer (10 mL, pH 7.0). The mixture was diluted with Et2O (20 mL) and 
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the layers were separated. The aqueous layer was extracted with Et2O (3 x 20 mL) and the 
combined organic extracts were dried over Na2SO4 and concentrated. Flash chromatography 
(SiO2; 0%  20% EtOAc/hexanes) yielded methyl ester 4.62 (0.192 g, 0.112 mmol, 64%) and 
recovered  bisvinyl iodide 4.61 (0.062 g, 0.030 mmol, 17%). 
 
TLC (20% EtOAc/hexanes) 
 Rf = 0.18, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.40-7.35 (m, 4H), 7.33-7.28 (m, 3H), 7.25-7.22 (m, 1H), 6.87 (t, J = 8.0 Hz, 4H), 6.57 
(d, J = 14.5 Hz, 1H), 6.47 (dd, J = 8.0, 14.5 Hz, 1H), 6.36 (d, J = 9.0 Hz, 1H), 5.52 (s, 
2H), 4.60 (s, 1H), 4.38-4.34 (m, 1H), 4.30-4.13 (m, 4H), 4.06-3.97 (m, 2H), 3.95-3.85 
(m, 3H), 3.84-3.80 (m, 1H), 3.78 (s, 3H), 3.77 (s, 3H), 3.68-3.65 (m, 1H), 3.63 (s, 3H), 
3.58 (s, 2H), 3.55 (t, J = 9.0 Hz, 1H), 3.33 (p, J = 6.5 Hz, 1H), 3.13 (s, 3H), 2.60-2.52 (m, 
2H), 2.29 (dd, J = 4.5, 13.0 Hz, 1H), 2.15 (t, J = 10.0 Hz, 1H), 1.77-1.60 (m, 8H), 1.54-
1.47 (m, 1H), 1.40-1.28 (m, 4H), 1.23 (d, J = 6.0 Hz, 3H), 1.08-1.00 (m, 2H), 0.90 (s, 
9H), 0.88 (s, 9H), 0.85 (s, 9H), 0.77 (s, 9H), 0.09 (s, 3H), 0.07 (s, 18H), 0.02 (s, 3H), 0.01 
(s, 3H), -0.07 (s, 3H), -0.11 (s, 3H). 
 
13
C NMR (125 MHz, acetone-d6) 
 172.2, 170.8, 169.7, 160.1, 147.1, 135.8, 133.9, 131.9, 129.7, 128.5, 127.9, 127.7, 
126.8, 120.6, 117.3, 113.3, 79.8, 79.6, 79.3, 76.4, 74.2, 74.0, 73.3, 72.8, 71.9, 67.8, 67.0, 
65.5, 62.5, 57.7, 55.6, 56.0, 54.9, 54.8, 51.1, 47.9, 43.4, 43.3, 42.2, 40.6, 39.1, 36.7, 32.4, 
31.8, 19.1, 18.4, 18.2, 18.0, 17.7, 17.5, -2.00, -3.85, -4.07, -4.52, -4.65, -4.80, -5.01, -
5.54. 
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HRMS (ESI) 
calculated for C83H138NO19ISi5 (M + Na)
+
:  1742.7652 
found:       1742.7677 
 
Dienyl MIDA boronate 4.46 
A 20 mL I-Chem vial equipped with a stir bar was charged with methyl ester 4.62 (0.219 g, 
0.127 mmol, 1 eq) and bisborylated compound 4.17
16,27
 (0.082 g, 0.267 mmol, 2.1 eq), sealed 
under argon, and taken into a glove box. PdCl2dppf∙CH2Cl2 (0.021 g, 0.025 mmol, 0.2 eq) and 
K3PO4 as a finely ground powder (0.162 g, 0.763 mmol, 6 eq) were added, followed by DMSO 
(6.4 mL). The reaction was sealed with a PTFE-lined cap, removed from the glove box, and 
stirred at 23 C for 24 hours. The solution was diluted with EtOAc (10 mL) and filtered through 
a pad of silica gel, washing with EtOAc (100 mL). The filtrate was washed with water (3 x 50 
mL) without agitation and brine (50 mL).  The combined aqueous layers were back-extracted 
with EtOAc (1 x 75 mL). The combined organic extracts were dried over Na2SO4 and 
concentrated in vacuo. The crude material was purified via flash chromatography (SiO2; 30%  
80% EtOAc/hexanes) to furnish dienyl MIDA boronate 4.46 as a white solid (0.158 g, 0.089 
mmol, 71%). 
 
TLC (EtOAc) 
 Rf = 0.60, stained by anisaldehyde. 
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1
H NMR (500 MHz, acetone-d6) 
δ 7.40-7.36 (m, 4H), 7.33-7.28 (m, 3H), 7.25-7.21 (m, 1H), 6.90-6.85 (m, 4H), 6.59 (dd, J 
= 10.0, 17.0 Hz, 1H), 6.37 (d, J = 9.5 Hz, 1H), 6.33 (dd, J = 10.5, 15.0 Hz, 1H), 5.66 (d, J 
= 17.5 Hz, 1H), 5.63 (dd, J = 8.0, 15.5 Hz, 1H), 5.52 (s, 1H), 5.51 (s, 1H), 4.62 (d, J = 1.0 
Hz, 1H), 4.41-4.37 (m, 1H), 4.30-4.12 (m, 6H), 4.04-3.96 (m, 4H), 3.92-3.86 (m, 3H), 
3.84-3.79 (m, 1H), 3.78 (s, 3H), 3.77 (s, 3H), 3.64-3.59 (m, 1H), 3.63 (s, 3H), 3.57 (s, 
2H), 3.55 (t, J = 8.0 Hz, 1H), 3.35 (p, J = 6.5 Hz, 1H), 3.10 (s, 3H), 2.95 (s, 3H), 2.60-
2.52 (m, 2H), 2.28 (dd, J = 5.0, 13.5 Hz, 1H), 2.15 (t, J = 10.5 Hz, 1H), 2.00-1.94 (m, 
1H), 1.77-1.61 (m, 8H), 1.50 (q, J = 11.5 Hz, 1H), 1.41-1.28 (m, 3H), 1.19 (d, J = 6.5 Hz, 
3H), 1.04-1.00 (m, 2H), 0.90 (s, 9H), 0.88 (s, 9H), 0.84 (s, 9H), 0.77 (s, 9H), 0.10 (s, 3H), 
0.07 (s, 6H), 0.06 (s, 12H), 0.05 (s, 3H), 0.02 (s, 3H), -0.07 (s, 3H), -0.12 (s, 3H). 
 
13
C NMR (125 MHz, acetone-d6) 
 δ 172.9, 171.3, 179.1, 168.9, 168.8, 160.6, 142.7, 136.3, 135.9, 135.1, 132.5, 132.4, 
130.2, 129.0, 128.4, 128.2, 127.4, 101.3, 101.1, 101.0, 100.0, 80.4, 78.0, 76.9, 74.8, 74.5, 
73.9, 73.4, 73.3, 72.2, 68.4, 67.9, 63.0, 62.3, 62.2, 58.3, 56.1, 55.5, 55.4, 51.6, 48.5, 47.3, 
44.0, 43.9, 42.7, 41.2, 40.3, 37.2, 32.9, 32.2, 31.4, 30.5, 28.4, 26.5, 26.3, 26.2, 25.9, 19.8, 
18.9, 18.7, 18.5, 18.2, 18.0, -1.4, -3.4, -3.5, -3.9, -4.0, -4.1, -4.3, -4.4, -5.0. 
 
 
11
B NMR (128 MHz, acetone-d6) 
 δ 11.6. 
 
HRMS (ESI+) 
 calculated for C90H147BN2O23Si5 (M+Na)
+
:  1796.9268 
found:       1796.9268 
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Dienyl pinacolboronic ester 4.63 
A 20-mL I-Chem vial was charged with dienyl MIDA boronate 4.46 (0.257 g, 0.145 mmol, 1 
eq), pinacol (0.052 g, 0.434 mmol, 3 eq), solid NaHCO3 (0.061 g, 0.723 mmol, 5 eq) and MeOH 
(3 mL) was then added. The reaction was stirred at 45 C for 3 hours and then was concentrated 
in vacuo and finely ground anhydrous CaCl2 (0.064 g, 0.579 mmol, 4 eq), solid NaHCO3 (0.024 
g, 0.289 mmol, 2 eq), and toluene (4.3 mL) were added to the resulting residue. The mixture was 
stirred at 23 C for 45 minutes, filtered through a pad of celite with toluene (50 mL) and 
concentrated to yield 4.63 (0.250 g, 0.143 mmol, >95%) as a white solid. The product was used 
directly in the next reaction without further purification. 
 
TLC (75% EtOAc/hexanes) 
 Rf = 0.80, stained by anisaldehyde. 
 
1
H NMR (400 MHz, acetone-d6) 
δ 7.40-7.36 (m, 4H), 7.33-7.28 (m, 4H), 7.15-7.11 (m, 1H), 6.97 (dd, J = 10.5, 17.5 Hz, 
1H), 6.87 (app. t, J = 8.5 Hz, 4H), 6.39-6.34 (m, 2H), 5.81 (dd, J = 7.5, 15.5 Hz, 1H), 
5.52 (s, 2H), 4.64 (s, 1H), 4.43-4.34 (m, 1H), 4.30-4.16 (m, 4H), 4.04-3.98 (m, 2H), 3.93-
3.89 (m, 2H), 3.83-3.81 (m, 1H), 3.78 (s, 3H), 3.77 (s, 3H), 3.67-3.61 (m, 1H), 3.63 (s, 
3H), 3.57 (s, 2H), 3.56 (app. t, J = 8.5 Hz, 1H), 3.36 (p, J = 8.5Hz, 1H), 3.12 (s, 3H), 
2.63-2.52  (m, 2H), 2.30-2.26 (m, 1H), 2.19-2.09 (m, 2H), 2.01-1.96 (m, 1H), 1.77-1.73 
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(m, 4H), 1.67-1.61 (m, 4H), 1.50 (q, J = 11.5 Hz, 1H), 1.43-1.28 (m, 3H), 1.24 (s, 12H), 
1.19 (d, J = 6Hz, 3H), 1.04-1.00 (m, 2H), 0.91 (s, 9H), 0.89 (s, 9H), 0.85 (s, 9H), 0.77 (s, 
9H), 0.11 (s, 3H), 0.07 (s, 12H), 0.06 (s, 6H), 0.03 (s, 6H), -0.07 (s, 3H), -0.11 (s, 3H). 
 
13
C NMR (100 MHz, acetone-d6) 
 δ 172.8, 171.3, 170.2, 160.6, 149.8, 138.5, 138.4, 136.3, 134.9, 132.5, 132.5, 130.2, 
129.1, 128.4, 128.2, 127.4, 113.9, 101.4, 101.2, 101.1, 100.2, 83.7, 80.4, 77.7, 77.0, 74.8, 
74.5, 73.9, 73.4, 72.2, 68.4, 67.8, 63.0, 58.4, 56.1, 55.5, 55.4, 51.6, 48.5, 44.0, 43.9, 42.8, 
41.2, 40.5, 37.2, 32.9, 32.3, 28.4, 26.6, 26.4, 26.3, 25.9, 25.2, 25.1, 19.8, 18.9, 18.8, 18.5, 
18.3, 18.1, -1.4, -3.3, -3.4, -3.9, -4.0, -4.1, -4.3, -4.4, -4.9. 
 
 
11
B NMR (128 MHz, acetone-d6) 
 δ 31.7. 
 
HRMS (ESI+) 
 calculated for C91H152BNO21Si5 (M+Na)
+
:  1768.9694 
found:       1768.9722 
 
 
Pentenyl MIDA Boronate 4.47 
A 20 mL I-Chem vial equipped with a stir bar was charged with pinacolboronic ester 4.63 (0.253 
g, 0.145 mmol, 1 eq) and triene 4.41
21
 (0.063 g, 0.174 mmol, 1.2 eq), sealed under argon, and 
taken into a glove box. PdCl2dppf∙CH2Cl2 (0.012 g, 0.014 mmol, 10 mol%) and K3PO4 as a 
finely ground powder (0.185 g, 0.870 mmol, 6 eq) were added, followed by DMSO (7.25 mL). 
The reaction was sealed with a PTFE-lined cap, removed from the glove box and stirred at 23 C 
for 8 hours. Then, the reaction was taken back into the glove box and additional trienyl iodide 
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4.41 (0.063 g, 0.174 mmol, 1.2 eq) and PdCl2dppf∙CH2Cl2 (0.012 g, 0.014 mmol, 10 mol%) were 
added. The reaction was sealed with a PTFE-lined cap, removed from the glovebox stirred at 23 
C for an additional 16 hours. The solution was diluted with EtOAc (10 mL) and filtered through 
a pad of silica gel, washing with EtOAc (100 mL). The filtrate was washed with water (3 x 50 
mL) and brine (50 mL) without agitation.  The combined aqueous layers were back-extracted 
with EtOAc (1 x 75 mL). The combined organic extracts were dried over Na2SO4 and 
concentrated in vacuo. The crude material was purified via flash chromatography (SiO2; 50%  
100% EtOAc/hexanes) to furnish pentenyl MIDA boronate 4.47 as a white solid (0.150 g, 0.081 
mmol, 56%). 
 
TLC (75% EtOAc/hexanes) 
 Rf = 0.25, stained by anisaldehyde. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.38 (app. t, J = 8.5 Hz, 4H), 7.32-7.28 (m, 3H), 7.25-7.22 (m, 1H), 6.87 (dd, J = 8.5, 
11.5 Hz, 4H), 6.63 (dd, J = 9.5, 17.5 Hz, 1H), 6.42-6.31 (m, 8H), 5.72 (d, J = 17.5 Hz, 
1H), 5.64 (dd, J = 8.0, 14.0 Hz, 1H), 5.52 (s, 1H), 5.51 (s, 1H), 4.61 (s, 1H), 4.41-4.37 
(m, 1H), 4.30-4.12 (m, 6H), 4.06-3.99 (m, 4H), 3.91-3.89 (m, 3H), 3.84-3.81 (m, 1H), 
3.78 (s, 3H), 3.77 (s, 3H), 3.67-3.60 (m, 1H), 3.63 (s, 3H), 3.57 (s, 2H), 3.54 (t, J = 8.0 
Hz, 1H), 3.36-3.32 (m, 1H), 3.11 (s, 3H), 2.98 (s, 3H), 2.61-2.52 (m, 2H), 2.28 (dd, J = 
4.5, 13.5 Hz, 1H), 2.15 (t, J = 10.5 Hz, 1H), 1.99-1.95 (m, 1H), 1.78-1.73 (m, 4H), 1.70-
1.59 (m, 4H), 1.50 (app. q, J = 11.5 Hz, 1H), 1.40-1.28 (m, 3H), 1.18 (d, J = 6.5 Hz, 3H), 
1.03-1.00 (m, 2H), 0.90 (s, 9H), 0.88 (s, 9H), 0.84 (s, 9H), 0.77 (s, 9H), 0.10 (s, 3H), 0.07 
(s, 6H), 0.06 (s, 12H), 0.05 (s, 3H), 0.02 (s, 3H), -0.07 (s, 3H), -0.11 (s, 3H). 
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13
C NMR (125 MHz, acetone-d6) 
 δ 172.9, 171.4, 170.2, 168.9, 160.7, 148.6, 143.3, 136.4, 136.0, 135.0, 134.6, 134.2, 
134.1, 134.0, 133.6, 132.6, 132.5, 130.2, 129.1, 128.5, 128.2, 127.4, 113.9, 101.4, 101.2, 
101.1, 100.1, 80.4, 78.1, 77.0, 74.8, 74.5, 73.9, 73.5, 73.4, 72.3, 68.5, 67.9, 66.0, 63.0, 
62.4, 62.2, 58.5, 56.1, 55.5, 55.4, 51.7, 48.5, 47.3, 44.1, 44.0, 42.8, 41.3, 40.5, 37.3, 33.0, 
32.3, 29.3, 28.4, 26.6, 26.4, 26.3, 26.0, 19.8, 19.0, 18.8, 18.6, 18.3, 18.1, 9.2, 5.0, -1.4, -
3.3, -3.4, -3.9, -4.0, -4.1, -4.3, -4.4, -4.9. 
 
 
11
B NMR (128 MHz, acetone-d6) 
 δ 11.4. 
 
HRMS (ESI+) 
 calculated for C96H153BN2O23Si5 (M+Na)
+
:  1876.9736 
found:       1876.9712 
 
 
Macrolactone 4.48 
A solution of the catalyst was prepared as follows: A 20 mL Wheaton vial equipped with a 
magnetic stir bar was charged with Pd(OAc)2 (2.2 mg, 0.0098 mmol) and 2-
cyclohexylphosphino-2’,4’,6’-isopropyl-1,1’-biphenyl (X-Phos, 9.3 mg, 0.0196 mmol). Toluene 
(1.35 mL) was added and the vial was sealed with a PTFE lined cap. The resulting mixture was 
stirred at 23 C for 45 minutes resulting in a yellow catalyst stock solution (0.00725 M in Pd). 
The above catalyst solution was then used in the following procedure: A 20 mL Wheaton 
vial with a PTFE cap was charged with pentenyl MIDA boronate 4.47 (100 mg, 0.0539 mmol, 1 
eq), and dienyl iodide 4.19 (15 mg, 0.0512 mmol, 0.95 eq). THF (2.7 mL, 0.02 M) was then 
added. Subsequently, the catalyst stock solution (372 L, 5 mol% Pd) was added and the 
resulting mixture was sealed with a teflon-lined septum cap. NaOH (1M aqueous, degassed, 270 
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L, 5 eq) was added and the reaction was stirred at 23 C for 30 minutes. Then, the reaction was 
placed in a 45 C aluminum heating block and was stirred for an additional 3 hours. The crude 
reaction mixture was filtered through a pad of silica gel and washed with ethyl acetate (50 mL). 
The solvent was removed in vacuo and the product was carried immediately forward to the 
saponification without further purification.  
To a 20 mL Wheaton vial with a PTFE cap containing the product of the Suzuki coupling 
was added THF:MeOH:H2O (5.12 mL, 3:1:1 v/v/v) and lithium hydroxide (107 mg, 2.56 mmol, 
50 eq). The reaction was stirred at 35 C in an aluminum heating block for 40 minutes. The 
reaction was quenched with potassium phosphate buffer (10 mL, pH 7.0) and the product was 
extracted with diethyl ether (3 x 10 mL). The combined organic extracts were washed, dried over 
sodium sulfate, and the solvent was removed in vacuo. The crude reaction product was carried 
immediately forward to the macrolactonization without further purification.  
CH2Cl2 (12.8 mL) was added to a 100 mL round bottom flask containing the product of 
the saponification. Then, a mixture of 2-methyl-6-nitrobenzoic acid (21.2 mg, 0.0614 mmol, 1.2 
eq) and DMAP (15 mg, 0.123 mmol, 2.4 eq) in DCM (20.5 mL) in a gastight glass syringe was 
added via dropwise addition over the course of 13 hours at 23 C with a syringe pump. At the 
end of the addition, the syringe was filled with CH2Cl2 (10 mL), and this solution was added to 
the reaction, which was then stirred for an additional hour. The reaction was then quenched with 
saturated aqueous sodium bicarbonate (25 mL) and the product was extracted with diethyl ether 
(3 x 50 mL). The combined organic extracts were dried over sodium sulfate and the solvent was 
removed in vacuo. The crude was purified via flash chromatography (SiO2; 0  15% 
EtOAc/hexanes) to yield macrolactone 4.48 as a yellow solid (52.3 mg, 0.0285 mmol, 56% over 
3 steps). 
 
TLC (15% EtOAc/hexanes) 
Rf = 0.67, stained by anisaldehyde. 
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1
H NMR (500 MHz, acetone-d6) 
 7.41-7.36 (m, 4H), 7.34-7.27 (m, 4H), 7.23-7.21 (m, 1H), 6.90-6.865 (m, 4H), 6.36-
6.15 (m, 12H), 5.79 (dd, J = 7, 14.5 Hz, 1H), 5.48 (s, 1H), 5.45 (s, 1H), 5.40 (dd, J = 9, 
15 Hz, 1H), 5.17 (app t, 6.5 Hz, 1H), 4.60 (app t, J = 7.5 Hz, 1H), 4.55 (s, 1H), 4.23-4.16 
(m, 3H), 4.04-4.00 (m, 2H), 3.91-3.85 (m, 3H), 3.78 (s, 3H), 3.77 (s, 3H), 3.73-3.71 (m, 
2H), 3.57 (s, 4H), 3.36 (dd, J = 10, 13.5 Hz, 1H), 3.07 (s, 3H), 2.61 (m, 1H), 2.40-2.28 
(m, 2H), 2.26-2.24 (m, 1H), 2.04-1.88 (m, 2H), 1.79-1.55 (m, 4H), 1.47-1.40 (m, 2H), 
1.38-1.28 (m, 2H), 1.18 (d, J = 6.5 Hz, 3H), 1.15-1.11 (m, 1H), 1.12-1.11 (m, 1H), 1.07 
(d, J = 6 Hz, 3H), 1.04-1.02 (m, 1H), 0.99 (d,  J = 6.5 Hz, 3H), 0.91 (d, J = 9 Hz, 3H), 
0.896 (s, 9H), 0.858 (s, 9H), 0.847 (bs, 18H), 0.750 (s, 9H), 0.109 (s, 3H), 0.067-0.057 
(m, 15H), 0.042 (s, 3H), -0.033 (s, 3H), -0.081 (s, 3H), -0.168 (s, 3H). 
 
13
C NMR (125 MHz, acetone-d6) 
 173.2, 170.2, 169.9, 160.7, 160.6, 139.6, 136.8, 134.5, 133.8, 133.5, 133.0, 132.6, 
132.3, 131.1, 130.3, 129.1, 129.0, 128.7, 128.3, 127.4, 114.0, 113.9, 101.6, 101.1, 100.9, 
98.9, 81.5, 76.4, 76.3, 74.8, 73.5, 73.4, 71.1, 69.0, 68.1, 63.4, 56.7, 56.3, 55.5, 55.4, 48.3, 
43.9, 41.9, 41.5, 37.9, 37.3, 35.4, 35.3, 33.1, 26.6, 26.5, 26.3, 26.0, 22.1, 19.8, 19.0, 18.6, 
18.3, 18.2, 14.8, 13.5, -1.34, -3.29, -3.34, -3.55, -3.90, -4.02, -4.89. 
 
HRMS (ESI) 
calculated for C101H161NO19Si5 (M + Na)
+
:  1855.0407 
found:       1855.0337 
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Bisketal 4.64 
To macrolactone 4.48 (70 mg, 0.0382 mmol, 1 eq) in THF (3.6 mL) was added dropwise TBAF 
(1.0M in THF, 0.19 mL, 5 eq). The reaction was stirred for 30 min. at 23 C and then was diluted 
with EtOAc (20 mL) and poured into a mixture of saturated aqueous NaHCO3 (10 mL) and brine 
(10 mL). The layers were separated and the aqueous layer was extracted with EtOAc (3 x 10 
mL). The combined organic extracts were dried over Na2SO4 and concentrated in vacuo. The 
crude material was purified by flash chromatography (SiO2; CH2Cl2:MeOH:AcOH 96.4:3.5:0.1) 
to furnish 60 mg of a mixture partially desilylated derivatives. Prior to the next reaction, this 
material was transferred to a Teflon vial and placed under vacuum with P2O5 for 4h to remove 
water. 
The solid was dissolved in MeOH (3.1 mL) and 2.3 mL of HF∙4 pyridine complex 
(prepared by adding 0.684 mL 70% HF
.
pyridine complex to 4 mL pyridine at 0 
o
C) was added 
dropwise. The resulting reaction mixture was heated to 40 
o
C and stirred for 14h. The reaction 
was quenched with TMSOMe (1 mL) and was stirred at 23 
o
C for 10 min. The solution was 
concentrated and purified by preparative RP-HPLC (Waters Sunfire prep C18 ODB 5 micron 30 x 
150 mm; 25 mL/min flow rate; gradient of 5  95% MeCN in 25 mM aqueous ammonium 
acetate over 5 min) to furnish 4.64 as a yellow solid (7.5 mg, 0.0059 mmol, 15%) and a mixture 
of monosilylated derivatives (6.9 mg, 0.0050 mmol, 13%) that were resubjected to the 
HF
.
pyridine conditions. 
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HPLC 
tR = 10.3 min; flow rate = 25 mL/min, Waters Sunfire prep C18 ODB 5 micron 30 x 150 
mm column gradient of 5  95% MeCN in 25 mM aqueous ammonium acetate over 5 
min. 
 
1
H NMR (500 MHz, acetone-d6) 
δ 7.42-7.34 (m, 5H), 7.30 (t, J = 8.0 Hz, 3H), 7.24-7.20 (m, 1H), 6.89-6.84 (m, 4H), 6.42-
6.20 (m, 12H), 5.86 (dd, J = 5.0, 15.0 Hz, 1H), 5.49 (s, 1H), 5.48 (dd, J = 9.0, 14.5 Hz, 
1H), 5.46 (s, 1H), 5.12 (dq, J = 5.0, 6.5 Hz, 1H), 4.67 (app t, J = 5.5 Hz, 1H), 4.61 (s, 
1H), 4.24-4.18 (m, 1H), 4.16-4.08 (m, 1H), 3.91 (app t, J = 10.5 Hz, 2H), 3.85-3.80 (m, 
1H), 3.78 (s, 3H), 3.77 (s, 3H), 3.71-3.66 (m, 1H), 3.64 (s, 2H), 3.59-3.56 (m, 1H), 3.50-
3.41 (m, 1H), 3.28 (broad s, 1H), 3.03 (s, 3H), 2.63 (dd, J = 5.5 Hz, 1H), 2.59 (s, 1H), 
2.38 (dd, J = 7.5, 11.0 Hz, 1H), 2.36-2.29 (m, 1H), 2.22-2.18 (m, 1H), 1.95-1.80 (m, 4H), 
1.78-1.58 (m, 5H), 1.52-1.42 (m, 3H), 1.38-1.22 (m, 6H), 1.20 (d, J = 4.5 Hz, 3H), 1.08 
(d, J = 6.5 Hz, 3H), 0.99 (d, J = 6.5 Hz, 3H), 0.86 (d, J = 7.0 Hz, 3H). 
 
13
C NMR (125 MHz, acetone-d6) 
 δ 173.1, 169.9, 160.7, 160.6, 140.0, 137.0, 136.1, 134.1, 134.0, 133.9, 133.7, 133.6, 
133.5, 133.0, 132.7, 132.6, 131.9, 130.1, 129.9, 129.1, 128.6, 128.4, 128.3, 127.3, 113.9, 
101.2, 100.9, 100.8, 98.0, 81.3, 76.5, 74.5, 74.4, 73.6, 73.3, 73.2, 71.3, 70.7, 68.9, 67.2, 
56.5, 55.5, 55.4, 48.6, 44.0, 43.3, 43.2, 41.6, 30.5, 28.7, 26.5, 26.1, 22.4, 21.9, 18.4, 18.1, 
14.9, 14.0, -4.1, -4.8. 
 
HRMS (ESI+) 
 calculated for C72H93NO19 (M+H)
+
:  1276.6420 
found:       1276.6448  
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N-phenylacyl C35-deoxyamphotericin B 4.65 
Prior to the reaction, acetyl chloride was freshly distilled from quinoline (20% v/v) and used 
immediately. The distillation apparatus was set up immediately before the distillation and was 
used only once per reaction. A 20 mL I-Chem vial was charged with acetonitrile (5 mL), water 
(250 L) and acetyl chloride (50 L). The vial was enclosed with a PTFE-lined cap and was 
stirred for 30 minutes at 23 C and then was cooled to 0 C and stirred for an additional 15 
minutes. Subsequently, the cooled acetonitrile:water solution (1.1 mL) was added to a 7 mL 
Wheaton vial containing 4.64 (10 mg, 7.8 mol). The vial was enclosed with a PTFE-lined cap 
and stirred at 0 C for 30 min. The reaction was quenched with triethylamine (50 L) and the 
resulting hazy solution was solubilized with the minimal amount of methanol. The crude was 
immediately purified by preparative RP-HPLC (Waters Sunfire prep C18 ODB 5 micron 30 x 150 
mm 25 mL/min flow rate 5%  95% MeCN in 25 mM aqueous ammonium acetate over 17 
minutes) to yield the title compound 4.65 as a yellow solid (2.6 mg, 2.5 mol, 32% over 2 
cycles).  
 
HPLC 
tR = 16.6 min; flow rate = 25 mL/min, Waters Sunfire prep C18 ODB 5 micron 30 x 150 
mm column gradient of 5  95% MeCN in 25 mM aqueous ammonium acetate over 17 
min. 
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1
H NMR (500 MHz, pyridine-d5 : CD3OD 1:1) 
 7.43 (d, J = 7.5 Hz, 2H), 7.29 (t, J = 8.0 Hz, 2H), 7.24-7.19 (m, 1H), 6.65 (dd, J = 11.0, 
14.0 Hz, 1H), 6.61 (dd, J = 10.0, 14.5 Hz, 1H), 6.55-6.25 (m, 12H), 4.90-4.81 (m, 2H), 
4.72 (broad s, 2H), 4.64 (t, J = 10.5 Hz, 1H), 4.43-4.38 (m, 1H), 4.29-4.25 (m, 1H), 4.14 
(s, 1H), 4.02-3.98 (m, 1H), 3.86 (d, J = 11.0 Hz, 1H), 3.77-3.65 (m, 2H), 3.57-3.46 (m, 
1H), 3.36-3.32 (m, 1H), 3.28-3.25 (m, 1H), 2.54 (dd, J = 9.0, 17.0 Hz, 1H), 2.39 (dd, J = 
4.0, 16.5 Hz, 1H), 2.36-2.26 (m, 2H), 2.13-2.05 (m, 1H), 2.00-1.49 (m, 10H), 1.42 (d, J = 
7.0 Hz, 3H), 1.35-1.22 (m, 6H), 1.17-1.11 (m, 1H), 1.08 (d, J = 6.5 Hz, 3H), 1.00 (d, J = 
6.5 Hz, 3H), 0.88 (d, J = 7.0 Hz, 3H).  
 
HRMS (ESI+) 
 calculated for C55H79NO17 (M+Na):   1048.5246 
 found:       1048.5238 
 
Purification of Penicillin G Amidase 
Penicillin G amidase (PGA) was purchased from Clea Technologies (Delft, The Netherlands) as 
a crude solution and was purified within one month of use using the following procedure. 2.5 mL 
of the crude PGA solution and 1.6 mL of saturated aqueous ammonium sulfate were each added 
to twelve individual 15 mL centrifuge tubes. The tubes were inverted several times to mix and 
were then left to stand for 5 minutes. Subsequently, the PGA/(NH4)2SO4 solutions were 
centrifuged at 4500xg for 20 minutes at 23 °C and after centrifugation the supernatants were 
transferred to fresh 15 mL centrifuge tubes and the brown pellets were discarded. To each 
supernatant was added 6 mL of saturated (NH4)2SO4 and the tubes were inverted several times to 
mix and then let stand for 5 minutes. Next, the samples were again centrifuged at 4500xg for 20 
minutes at 23 °C. The supernatants were discarded and the pellets were dissolved in 1.1M 
(NH4)2SO4 50 mM TRIS (pH 7.5). The samples were then purified using a 15 x 5 cm phenyl 
sepharose 6 (Sigma-Aldrich, St. Louis, MO) gel column. The sepharose column was pre-
equilibrated with 2 column volumes of 1.1M (NH4)2SO4 50 mM TRIS (pH 7.5) and the samples 
were then loaded. The protein was then eluted with one column volume each of 50 mM TRIS 
(pH 7.5) buffer of decreasing ionic strength in the order: 1.1M (NH4)2SO4, 0.9M (NH4)2SO4, 
0.7M (NH4)2SO4, 0.45M (NH4)2SO4, 0.25M (NH4)2SO4 and then two column volumes of MilliQ 
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H2O. Fractions were collected beginning with the 0.25M (NH4)2SO4 eluent and were analyzed 
for the presence of PGA using SDS-PAGE.  
 The loading buffer was prepared by dissolving 20 mg of dithiothreitol in 500 L 
Laemmli sample buffer (Bio-Rad, Hercules, CA). Then, 15 L of each fraction and 15 L of the 
loading buffer were added to individual 0.6 mL microcentrifuge tubes, mixed and then incubated 
at 95 °C for 5 minutes. The samples were cooled by incubating at 23 °C for 15 minutes and then 
12.5 L of each sample was loaded onto precast Mini-PROTEAN TGX (Bio-Rad) gels. The gels 
were run at 190V for 35 minutes using TRIS/glycine running buffer (125mM TRIS, 1.92M 
glycine, 0.5% SDS, pH 8.3). The gels were then stained with Brillant Blue staining solution 
(Sigma-Aldrich) for 30 minutes with gentle shaking. The stain was decanted and the gels were 
destained by three successive 30 minute destaining cycles using H2O:MeOH:AcOH (45:45:10, 
v/v/v).  Fractions containing PGA were then concentrated using Amicon Ultra centrifugal filter 
units (Sigma-Aldrich). PGA containing fractions were added to the filter units and centrifuged at 
4500xg for 20 minutes at 4 °C. Once all the samples had been concentrated, the collected PGA 
was suspended in 12 mL MilliQ H2O and stored at 4 °C. 
 
 
C35-deoxy amphotericin B (C35deOAmB) 
N-phenylacyl C35-deoxy AmB S23 (8 mg, 7.8 mol) was dissolved in MeOH (4 mL) and 0.25 
mL of this solution was added to 16 separate 7 mL Wheaton vials, each containing a magnetic 
stir bar. The MeOH was removed under a stream of N2 and the samples were left under vacuum 
overnight. The next morning, 0.5 mL of PGA solution was added to each vial, which was then 
vortexed for 30 seconds and enclosed under an atmosphere of argon with a PTFE-lined cap. The 
samples were incubated with stirring at 37 °C for 96 hours to reach >90% conversion as 
measured by analytical HPLC (the time required to reach >90% conversion varied by experiment 
from 72 to 120 hours). Once >90% conversion had been reached, the samples were removed to 
individual 15 mL centrifuge tubes, washing with MeOH. The total volume of each sample was 
214 
 
diluted to 5 mL with MeOH and the samples were centrifuged at 4500xg for 30 minutes at 23 °C. 
Following centrifugation, the supernatants were collected and the pellets were resuspended in 5 
mL MeOH and reexposed to the same centrifugation conditions. The supernatants from this 
second round to centrifugation were added to the initial supernatants and the volume of the 
solution was reduced to approximately 10 mL in vacuo. The reduced solution was then filtered 
through a small plug of celite, washing with copious amounts of MeOH. The solvent was then 
completely removed and the resulting yellow solid was taken up in 0.5 mL DMSO and diluted to 
1 mL with MeOH. The crude was purified via preparative RP-HPLC (Waters Sunfire prep C18 
ODB 5 micron 30 x 150 mm, 25 mL/min flow rate, gradient of 5%  95% MeCN in 25 mM 
aqueous ammonium acetate over 30 minutes) to yield C35deOAmB as a yellow solid (2.00 mg, 
0.0022 mmol, 28%).  
 
HPLC 
tR = 20.0 minutes; flow rate = 1.2 mL/min through a Waters Sunfire C18 ODB 5 micron 
4.6 x 150 mm column, gradient of 5  95% MeCN in 25 mM aqueous ammonium 
acetate over 30 minutes.  
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1
H NMR (500 MHz, pyridine-d5 : CD3OD 1:1) 
 6.68 (dd, J = 11.0, 14.5 Hz, 1H), 6.63 (dd, J = 10.5, 14.5 Hz, 1H), 6.56-6.38 (m, 9H), 
6.35-6.25 (m, 3H), 5.01 (s, 1H), 4.89-4.85 (m, 1H), 4.78-4.72 (m, 2H), 4.67 (t, J = 9.5 
Hz, 1H), 4.56 (s, 1H), 4.45-4.40 (m, 1H), 4.04-3.99 (m, 1H), 3.89-3.81 (m, 2H), 3.74-
3.62 (m, 2H), 2.55 (dd, J = 9.5, 17.5 Hz, 1H), 2.40 (dd, J = 3.5, 17.0 Hz, 1H), 2.36-2.28 
(m, 2H), 2.14-2.06 (m, 3H), 1.99-1.87 (m, 2H), 1.84-1.74 (m, 2H), 1.71-1.64 (m, 3H), 
1.60-1.53 (m, 3H), 1.45 (d, J = 5.5 Hz, 3H), 1.36-1.22 (m, 6H), 1.08 (d, J = 6.5 Hz, 3H), 
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1.00 (d, J = 6.5 Hz, 3H), 0.88 (d, J = 7.0 Hz, 3H). 
 
HRMS (ESI+) 
 calculated for C47H73NO16 (M+H):   908.5008 
 found:       908.5012 
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